食事のせいで、死なないために［病気別編］原注
◎はじめに
＊1 Monte T, Pritikin I. Pritikin: The Man Who Healed America’s Heart. Emmaus, PA: Rodale Press; 1988.
＊2 Gould KL, Ornish D, Scherwitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995;274: 894–901.
＊3 Ornish D, Scherwitz L, Billings J, et al. Intensive lifestyle changes for reversal of coronary heart disease. Five-year follow-up of the Lifestyle Heart Trial. JAMA. 1998;280:2001–7.
＊4 Ornish DM, Scherwitz LW, Doody RS, et al. Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA. 1983;249:54–9.
＊5 Ornish D. Intensive lifestyle changes and health reform. Lancet Oncol. 2009;10(7):638–9.
＊6 Adams KM, Kohlmeier M, Zeisel SH. Nutrition education in U.S. medical schools: latest update of a national survey. Acad Med. 2010;85(9):1537–42.
＊7 Jamal A, Dube SR, Malarcher AM, Shaw L, Engstrom MC. Tobacco use screening and counseling during physician office visits among adults. National Ambulatory Medical Care Survey and National Health Interview Survey, United States, 2005–2009. MMWR Morb Mortal Wkly Rep. 2012;61 Suppl:38–45.
◎Introduction
＊1 Berzlanovich AM, Keil W, Waldhoer T, Sim E, Fasching P, Fazeny-Dörner B. Do centenarians die healthy? An autopsy study. J Gerontol A Biol Sci Med Sci. 2005;60(7):862–5.
＊2 Kohn RR. Cause of death in very old people. JAMA. 1982;247(20):2793–7.
＊3 Berzlanovich AM, Keil W, Waldhoer T, Sim E, Fasching P, Fazeny-Dörner B. Do centenarians die healthy? An autopsy study. J Gerontol A Biol Sci Med Sci. 2005;60(7):862–5.
＊4 Lenders C, Gorman K, Milch H, et al. A novel nutrition medicine education model: the Boston University experience. Adv Nutr. 2013;4(1):1–7.
＊5 Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591–608.
＊6 Kris-Etherton PM, Akabas SR, Bales CW, et al. The need to advance nutrition education in the training of health care professionals and recommended research to evaluate implementation and effectiveness. Am J Clin Nutr. 2014;99(5 Suppl):1153S–66S.
＊7 Swift CS. Nutrition trends: implications for diabetes health care professionals. Diabetes Spectr. 2009;29(1):23–5.
＊8 Vetter ML, Herring SJ, Sood M, Shah NR, Kalet AL. What do resident physicians know about nutrition? An evaluation of attitudes, self-perceived proficiency and knowledge. J Am Coll Nutr. 2008;27(2):287–98.
＊9 Lazarus K, Weinsier RL, Boker JR. Nutrition knowledge and practices of physicians in a family-practice residency program: the effect of an education program provided by a physician nutrition specialist. Am J Clin Nutr. 1993;58(3):319–25.
＊10 Senate Committee on Business, Professions and Economic Development. Bill Analysis on SB 380. http://www.leginfo.ca.gov/pub/11-12/bill/sen/sb_0351-0400/sb_380_cfa_20110421_125358_sen_comm.html. Hearing held April 25, 2011. Accessed March 31, 2015.
＊11 The Medical Board of California. Continuing Medical Education. http://www.mbc.ca.gov/Licensees/Continuing_Education/. Nd. Accessed March 31, 2015.
＊12 Wizard Edison says doctors of future will give no medicine. Newark Advocate. January 2, 1903.
＊13 Stange KC, Zyzanski SJ, Jaén CR, et al. Illuminating the “black box.” A description of 4454 patient visits to 138 family physicians. J Fam Pract. 1998;46(5):377–89.
＊14 Aitken M, Johns Hopkins Bloomberg School of Public Health. The trillion dollar market for medicines: characteristics, dynamics and outlook. http://www.jhsph.edu/research/centers-and-institutes/center-for-drug-safety-and-effectiveness/academic-training/seminar-series/MUrray%20Aikten.pdf. February 24, 2014. Accessed March 29, 2015.
＊15 Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296(5568):695–8.
＊16 Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296(5568):695–8.
＊17 Robertson TL, Kato H, Rhoads GG, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol. 1977;39(2):239–43.
＊18 Mayo Clinic News Network. Nearly 7 in 10 Americans take prescription drugs, Mayo Clinic, Olmsted Medical Center Find. http://newsnetwork.mayoclinic.org/discussion/nearly-7-in-10-americans-take-prescription-drugs-mayo-clinic-olmsted-medical-center-find/. June 19, 2013. Accessed March 31, 2015.
＊19 Crimmins EM, Beltrán-Sánchez H. Mortality and morbidity trends: is there compression of morbidity? J Gerontol B Psychol Sci Soc Sci. 2011;66(1):75–86.
＊20 Crimmins EM, Beltrán-Sánchez H. Mortality and morbidity trends: is there compression of morbidity? J Gerontol B Psychol Sci Soc Sci. 2011;66(1):75–86.
＊21 Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352(11):1138–45.
＊22 Offord DR. Selection of levels of prevention. Addict Behav. 2000;25(6):833–42.
＊23 Gofrit ON, Shemer J, Leibovici D, Modan B, Shapira SC. Quaternary prevention: a new look at an old challenge. Isr Med Assoc J. 2000;2(7):498–500.
＊24 Strasser T. Reflections on cardiovascular diseases. Interdiscip Sci Rev. 1978;3(3):225–30.
＊25 Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–613.
＊26 Yancy CW. Is ideal cardiovascular health attainable? Circulation. 2011;123(8):835–7.
＊27 Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–613.
＊28 Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.
＊29 Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–613.
＊30 Shay CM, Ning H, Allen NB, et al. Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003–2008. Circulation. 2012;125(1):45–56.
＊31 Shay CM, Ning H, Allen NB, et al. Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003–2008. Circulation. 2012;125(1):45–56.
＊32 Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49(4):509–38.
＊33 US Centers for Disease Control and Prevention. Leading causes of death, 1900–1998. http://www.cdc.gov/nchs/data/dvs/lead1900_98.pdf. Accessed April 29, 2015.
＊34 Kochanek KD, Murphy SL, Xu J, Arias E. Mortality in the United States, 2013. NCHS Data Brief 2014;178.
＊35 Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
＊36 Popkin BM. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr. 2006;84(2):289–98.
＊37 Zhai F, Wang H, Du S, et al. Prospective study on nutrition transition in China. Nutr Rev. 2009;67 Suppl 1:S56–61.
＊38 Singh PN, Arthur KN, Orlich MJ, et al. Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians. Am J Clin Nutr. 2014;100 Suppl 1:359S–64S.
＊39 Singh PN, Arthur KN, Orlich MJ, et al. Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians. Am J Clin Nutr. 2014;100 Suppl 1:359S–64S.
＊40 McCarty MF. Proposal for a dietary “phytochemical index.” Med Hypotheses. 2004;63(5):813–7.
＊41 Mirmiran P, Bahadoran Z, Golzarand M, Shiva N, Azizi F. Association between dietary phytochemical index and 3-year changes in weight, waist circumference and body adiposity index in adults: Tehran Lipid and Glucose study. Nutr Metab (Lond). 2012;9(1):108.
＊42 Mirmiran P, Bahadoran Z, Golzarand M, Shiva N, Azizi F. Association between dietary phytochemical index and 3-year changes in weight, waist circumference and body adiposity index in adults: Tehran Lipid and Glucose study. Nutr Metab (Lond). 2012;9(1):108.
＊43 Golzarand M, Bahadoran Z, Mirmiran P, Sadeghian-Sharif S, Azizi F. Dietary phytochemical index is inversely associated with the occurrence of hypertension in adults: a 3-year follow-up (the Tehran Lipid and Glucose Study). Eur J Clin Nutr. 2015;69(3):392–8.
＊44 Golzarand M, Mirmiran P, Bahadoran Z, Alamdari S, Azizi F. Dietary phytochemical index and subsequent changes of lipid profile: a 3-year follow-up in Tehran Lipid and Glucose Study in Iran. ARYA Atheroscler. 2014;10(4):203–10.
＊45 Bahadoran Z, Karimi Z, Houshiar-Rad A, Mirzayi HR, Rashidkhani B. Dietary phytochemical index and the risk of breast cancer: a case control study in a population of Iranian women. Asian Pac J Cancer Prev. 2013;14(5):2747–51.
＊46 U.S. Department of Agriculture Economic Research Service. Loss-adjusted food availability. http://www.ers.usda.gov/datafiles/Food_Availabily_Per_Capita_Data_System/LossAdjusted_Food_Availability/calories.xls. September 30, 2014. Accessed April 29, 2015.
＊47 Bambs C, Kip KE, Dinga A, Mulukutla SR, Aiyer AN, Reis SE. Low prevalence of “ideal cardiovascular health” in a community-based population: the heart strategies concentrating on risk evaluation (Heart SCORE) study. Circulation. 2011;123(8):850–7.
＊48 Yancy CW. Is ideal cardiovascular health attainable? Circulation. 2011;123(8):835–7.
＊49 Ford ES, Bergmann MM, Krord J, Schienkiewitz A, Weikert C, Boeing H. Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study. Arch Intern Med. 2009;169(15):1355–62.
＊50 Platz EA, Willett WC, Colditz GA, Rimm EB, Spiegelman D, Giovannucci E. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control. 2000;11(7):579–88.
＊51 Wahls TL. The seventy percent solution. J Gen Intern Med. 2011;26(10):1215–6.
＊52 Ford ES, Bergmann MM, Boeing H, Li C, Capewell S. Healthy lifestyle behaviors and all-cause mortality among adults in the United States. Prev Med. 2012;55(1):23–7.
＊53 Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med. 2008;5(1):e12.
＊54 Jiang H, Ju Z, Rudolph KL. Telomere shortening and ageing. Z Gerontol Geriatr. 2007;40(5):314–24.
＊55 Mather KA, Jorm AF, Parslow RA, Christensen H. Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci. 2011;66(2):202–13.
＊56 Tsuji A, Ishiko A, Takasaki T, Ikeda N. Estimating age of humans based on telomere shortening. Forensic Sci Int. 2002;126(3):197–9.
＊57 Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011;14(1):28–34.
＊58 Huzen J, Wong LS, van Veldhuisen DJ, et al. Telomere length loss due to smoking and metabolic traits. J Intern Med. 2014;275(2):155–63.
＊59 Hou L, Savage SA, Blaser MJ, et al. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(11):3103–9.
＊60 Gu Y, Honig LS, Schupf N, et al. Mediterranean diet and leukocyte telomere length in a multiethnic elderly population. Age (Dordr). 2015;37(2):9758.
＊61 García-Calzón S, Moleres A, Martínez-González MA, et al. Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population. Clin Nutr. 2014;S0261–5614(14):00191–5.
＊62 García-Calzón S, Moleres A, Martínez-González MA, et al. Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population. Clin Nutr. 2014;S0261–5614(14):00191–5.
＊63 Leung CW, Laraia BA, Needham BL, et al. Soda and cell aging: associations between sugarsweetened beverage consumption and leukocyte telomere length in healthy adults from the National Health and Nutrition Examination Surveys. Am J Public Health. 2014;104(12):2425–31.
＊64 Nettleton JA, Diez-Roux A, Jenny NS, Fitzpatrick AL, Jacobs DR. Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2008;88(5):1405–12.
＊65 Gu Y, Honig LS, Schupf N, et al. Mediterranean diet and leukocyte telomere length in a multiethnic elderly population. Age (Dordr). 2015;37(2):9758.
＊66 Flanary BE, Kletetschka G. Analysis of telomere length and telomerase activity in tree species of various life-spans, and with age in the bristlecone pine Pinus longaeva. Biogerontology. 2005;6(2):101–11.
＊67 Ornish D, Lin J, Daubenmier J, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008;9(11):1048–57.
＊68 Skordalakes E. Telomerase and the benefits of healthy living. Lancet Oncol. 2008;9(11):1023–4.
＊69 Ornish D, Lin J, Chan JM, et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013;14(11):1112–20.
＊70 Mason C, Risques RA, Xiao L, et al. Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring). 2013;21(12):E549–54.
＊71 Ornish D, Lin J, Daubenmier J, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008;9(11):1048–57.
＊72 Ornish D, Lin J, Chan JM, et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013;14(11):1112–20.
＊73 Artandi SE, Depinho RA. Telomeres and telomerase in cancer. Carcinogenesis. 2010;31(1):9–18.
＊74 Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.
＊75 American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society;2015.
＊76 NHLBI Fact Book, Fiscal Year 2012. National Heart, Lung, and Blood Institute, NIH. http://www.nhlbi.nih.gov/files/docs/factbook/FactBook2012.pdf. February 2013. Accessed March 31, 2015.
＊77 Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.
＊78 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊79 American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society;2015.
＊80 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊81 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊82 Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.
＊83 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊84 American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society;2015.
＊85 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊86 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊87 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊88 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊89 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊90 Tuso PJ, Ismail MH, Ha BP, Bartolotto C. Nutritional update for physicians: plant-based diets. Perm J. 2013;17(2):61–6.
＊91 Egger GJ, Binns AF, Rossner SR. The emergence of “lifestyle medicine” as a structured approach for management of chronic disease. Med J Aust. 2009;190(3):143–5.
＊92 Hyman MA, Ornish D, Roizen M. Lifestyle medicine: treating the causes of disease. Altern Ther Health Med. 2009;15(6):12–4.
＊93 Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296(5568):695–8.
＊94 Hyman MA, Ornish D, Roizen M. Lifestyle medicine: treating the causes of disease. Altern Ther Health Med. 2009;15(6):12–4.
＊95 Allen J, Anderson DR, Baun B, et al. Reflections on developments in health promotion in the past quarter century from founding members of the American Journal of Health Promotion Editorial Board. Am J Health Promot. 2011;25(4):ei–eviii.
＊96 Tuso PJ, Ismail MH, Ha BP, Bartolotto C. Nutritional update for physicians: plant-based diets. Perm J. 2013;17(2):61–6.
＊97 Tuso PJ, Ismail MH, Ha BP, Bartolotto C. Nutritional update for physicians: plant-based diets. Perm J. 2013;17(2):61–6.
＊98 Tuso PJ, Ismail MH, Ha BP, Bartolotto C. Nutritional update for physicians: plant-based diets. Perm J. 2013;17(2):61–6.
＊99 Kono S. Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev. 2004;13(2):127–32.
＊100 Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296(5568):695–8.
＊101 Kono S. Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev. 2004;13(2):127–32.
＊102 Kulshreshtha A, Goyal A, Veledar E, et al. Association between ideal cardiovascular health and carotid intima-media thickness: a twin study. J Am Heart Assoc. 2014;3(1):e000282.
＊103 Corona M, Velarde RA, Remolina S, et al. Vitellogenin, juvenile hormone, insulin signaling, and queen honey bee longevity. Proc Natl Acad Sci USA. 2007;104(17):7128–33.
＊104 Kucharski R, Maleszka J, Foret S, Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science. 2008;319(5871):1827–30.
＊105 Gnyszka A, Jastrzebski Z, Flis S. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Res. 2013;33(8):2989–96.
＊106 Joven J, Micol V, Segura-Carretero A, Alonso-Villaverde C, Menéndez JA. Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease? Crit Rev Food Sci Nutr. 2014;54(8):985–1001.
＊107 Fang MZ, Wang Y, Ai N, et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003;63(22):7563–70.
＊108 Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood). 2007;232(2):227–34.
＊109 Dashwood RH, Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol. 2007;17(5):363–9.
＊110 Gryder BE, Sodji QH, Oyelere AK. Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med Chem. 2012;4(4):505–24.
＊111 Ornish D, Magbanua MJ, Weidner G, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA. 2008;105(24): 8369–74.
◆１ 心臓病で死なないために
＊1 Myerburg RJ, Junttila MJ. 2012. Sudden cardiac death caused by coronary heart disease. Circulation. 28;125(8):1043–52.
＊2 Campbell TC, Parpia B, Chen J. Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China study. Am J Cardiol. 1998;82(10B):18T-21T.
＊3 Shaper AG, Jones KW. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959. Int J Epidemiol. 2012;41(5):1221–5.
＊4 Thomas WA, Davies JN, O’Neal RM, Dimakulangan AA. Incidence of myocardial infarction correlated with venous and pulmonary thrombosis and embolism. A geographic study based on autopsies in Uganda, East Africa and St. Louis, U.S.A. Am J Cardiol. 1960;5:41–7.
＊5 Benfante R. Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: a review. Hum Biol. 1992;64(6):791–805.
＊6 Chen J, Campbell TC, Li J, Peto R. Diet, life-style and mortality in China: A study of the characteristics of 65 Chinese counties. New York: Oxford University Press; 1990.
＊7 Shaper AG, Jones KW. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959. Int J Epidemiol. 2012;41(5):1221–5.
＊8 De Biase SG, Fernandes SF, Gianini RJ, Duarte JL. Vegetarian diet and cholesterol and triglycerides levels. Arq Bras Cardiol. 2007;88(1):35–9.
＊9 Stoy PJ. Dental disease and civilization. Ulster Med J. 1951;20(2):144–58.
＊10 Kris-Etherton PM, Harris WS, Appel LJ, Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23(2):e20–30.
＊11 Shepherd CJ, Jackson AJ. Global fishmeal and fish-oil supply: inputs, outputs and markets. J Fish Biol. 2013;83(4):1046–66.
＊12 Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308(10):1024–33.
＊13 Kwak SM, Myung SK, Lee YJ, Seo HG. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012;172(9): 686–94.
＊14 Fodor JG, Helis E, Yazdekhasti N, Vohnout B. “Fishing” for the origins of the “Eskimos and heart disease” story: facts or wishful thinking? Can J Cardiol. 2014;30(8):864–8.
＊15 Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2(8666):757–61.
＊16 Burr ML. Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel. Proc Nutr Soc. 2007;66(1):9–15.
＊17 Burr ML, Ashfield-Watt PAL, Dunstan FDJ, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57(2):193–200.
＊18 Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308(10):1024–33.
＊19 Smith DA. ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults. Ann Intern Med. 2012;157(12):JC6–5.
＊20 Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. JAMA. 1953;152(12):1090–3.
＊21 Strong JP. Landmark perspective: Coronary atherosclerosis in soldiers. A clue to the natural history of atherosclerosis in the young. JAMA. 1986;256(20):2863–6.
＊22 Voller RD, Strong WB. Pediatric aspects of atherosclerosis. Am Heart J. 1981;101(6): 815–36.
＊23 Napoli C, D’Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100(11):2680–90.
＊24 Benjamin MM, Roberts WC. Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent). 2013;26(2):124–36.
＊25 McMahan CA, Gidding SS, Malcom GT, et al. Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis. Pediatrics. 2006;118(4): 1447–55.
＊26 Trumbo PR, Shimakawa T. Tolerable upper intake levels for trans fat, saturated fat, and cholesterol. Nutr Rev. 2011;69(5):270–8.
＊27 Roberts WC. It’s the cholesterol, stupid! Am J Cardiol. 2010;106(9):1364–6.
＊28 O’Keefe JH, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol. 2004;43(11):2142–6.
＊29 Esselstyn CB. In cholesterol lowering, moderation kills. Cleve Clin J Med. 2000;67(8):560–4.
＊30 Roberts WC. The cause of atherosclerosis. Nutr Clin Pract. 2008;23(5):464–7.
＊31 Roberts WC. The cause of atherosclerosis. Nutr Clin Pract. 2008;23(5):464–7.
＊32 King S. The best selling drugs since 1996-why AbbVie’s Humira is set to eclipse Pfizer’s Lipitor. http://www.forbes.com/sites/simonking/2013/07/15/the-best-selling-drugs-since-1996-why-abbvies-humira-is-set-to-eclipse-pfizers-lipitor/. July 15, 2013. Accessed May 1, 2015.
＊33 Ginter E, Kajaba I, Sauša M. Addition of statins into the public water supply? Risks of side effects and low cholesterol levels. Cas Lek Cesk. 2012;151(5):243–7.
＊34 Ferenczi EA, Asaria P, Hughes AD, Chaturvedi N, Francis DP. Can a statin neutralize the cardiovascular risk of unhealthy dietary choices? Am J Cardiol. 2010;106(4):587–92.
＊35 Draeger A, Monastyrskaya K, Mohaupt M, et al. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol. 2006;210(1):94–102.
＊36 Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in communitydwelling older adults. Q JM. 2009;102(9):625–33.
＊37 Jefferson E. FDA announces safety changes in labeling for some cholesterol-lowering drugs. US Food and Drug Administration website. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm293623.htm. February 28, 2012. Accessed February 14, 2015.
＊38 McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev. 2013;22(9):1529–37.
＊39 Jenkins DJ, Kendall CW, Marchie A, et al. The Garden of Eden-plant based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century. Comp Biochem Physiol, Part A Mol Integr Physiol. 2003;136(1):141–51.
＊40 Esselstyn CB. Is the present therapy for coronary artery disease the radical mastectomy of the twenty-first century? Am J Cardiol. 2010;106(6):902–4.
＊41 Kadoch MA. The power of nutrition as medicine. Prev Med. 2012;55(1):80.
＊42 Wakai K, Marugame T, Kuriyama S, et al. Decrease in risk of lung cancer death in Japanese men after smoking cessation by age at quitting: pooled analysis of three large-scale cohort studies. Cancer Sci. 2007;98(4):584–9.
＊43 Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol. 1997;79(3):350–4.
＊44 Erridge C. The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4. Br J Nutr. 2011;105(1):15–23.
＊45 Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001–7.
＊46 Ornish D, Scherwitz LW, Doody RS, et al. Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA. 1983;249(1):54–9.
＊47 Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001–7.
＊48 Ellis FR, Sanders TA. Angina and vegan diet. Am Heart J. 1977;93(6):803–5.
＊49 Sweeney M. Effects of very low-fat diets on anginal symptoms. Med Hypotheses. 2004;63(3):553.
＊50 Savarese G, Rosano G, D’amore C, et al. Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis. Int J Cardiol. 2013;169(4):262–70.
＊51 Hegsted M. Dietary Guidelines. Food Politics website. www.foodpolitics.com/wp-content/uploads/Hegsted.pdf. nd. Accessed February 14, 2015.
＊52 Campbell TC. The Low-Carb Fraud. Dallas, TX: BenBella Books, Inc.; 2014.
＊53 Herman J. Saving U.S. dietary advice from conflicts of interest. Food and Drug Law Journal 2010;65(20):285–316.
＊54 Herman J. Saving U.S. dietary advice from conflicts of interest. Food and Drug Law Journal 2010;65(20):285–316.
＊55 Goodwin JS, Goodwin JM. The tomato effect. Rejection of highly efficacious therapies. JAMA. 1984;251(18):2387–90.
＊56 Adams KM, Kohlmeier M, Zeisel SH. Nutrition education in U.S. medical schools: latest update of a national survey. Acad Med. 2010;85(9):1537–42.
＊57 Hearing of California Senate Bill 380. Vimeo website. http://vimeo.com/23744792. April 25, 2011. Accessed February 14, 2015.
＊58 Murray JL. Coke and the AAFP-the real thing or a dangerous liaison? Fam Med. 2010;42(1):57–8.
＊59 Blum A. AAFP-Coke editorial was music to [our] ears. J Fam Pract. 2010;59(2):74.
＊60 Brownell KD, Warner KE. The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q. 2009;87(1):259–94.
＊61 Brownell KD, Warner KE. The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q. 2009;87(1):259–94.
＊62 Simon, M. AND now a word from our sponsors. Eat Drinks Politics website. http://www.eatdrinkpolitics.com/wp-content/uploads/AND_Corporate_Sponsorship_Report.pdf. January 22, 2013. Accessed February 14, 2015.
＊63 Bruckert E, Pouchain D, Auboiron S, Mulet C. Cross-analysis of dietary prescriptions and adherence in 356 hypercholesterolaemic patients. Arch Cardiovasc Dis. 2012;105(11):557–65.
＊64 Barnard ND. The physician’s role in nutrition-related disorders: from bystander to leader. Virtual Mentor. 2013;15(4):367–72.
◆２ 肺疾患で死なないために
＊1 American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society;2015.
＊2 Howlader N, Noone AM, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. http://seer.cancer.gov/csr/1975_2011/. April 2014. Accessed February 27, 2015.
＊3 American Lung Association. Lung Cancer Fact Sheet. http://www.lung.org/lung-disease/lung-cancer/resources/facts-figures/lung-cancer-fact-sheet.html. 2015. Accessed February 14, 2015.
＊4 Moodie R, Stuckler D, Monteiro C, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet. 2013;381 (9867): 670–9.
＊5 American Cancer Society. When smokers quit-what are the benefits over time? http://www.cancer.org/healthy/stayawayfromtobacco/guidetoquittingsmoking/guide-to-quitting-smoking-benefits. 6 February 2015. Accessed February 26, 2015.
＊6 US Department of Health and Human Services. A Report of the Surgeon General. How Tobacco Smoke Causes Disease: What It Means to You. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010.
＊7 Riso P, Martini D, Møller P, et al. DNA damage and repair activity after broccoli intake in young healthy smokers. Mutagenesis. 2010;25(6):595–602.
＊8 Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127(4):679–95.
＊9 Wu X, Zhu Y, Yan H, et al. Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer. 2010;10:269.
＊10 Kim SY, Yoon S, Kwon SM, Park KS, Lee-Kim YC. Kale juice improves coronary artery disease risk factors in hypercholesterolemic men. Biomed Environ Sci. 2008;21(2):91–7.
＊11 Dressendorfer RH, Wade CE, Hornick C, Timmis GC. High-density lipoprotein-cholesterol in marathon runners during a 20-day road race. JAMA. 1982;247(12):1715–7.
＊12 Park W, Amin AR, Chen ZG, Shin DM. New perspectives of curcumin in cancer prevention. Cancer Prev Res (Phila). 2013;6(5):387–400.
＊13 Park W, Amin AR, Chen ZG, Shin DM. New perspectives of curcumin in cancer prevention. Cancer Prev Res (Phila). 2013;6(5):387–400.
＊14 Nagabhushan M, Amonkar AJ, Bhide SV. In vitro antimutagenicity of curcumin against environmental mutagens. Food Chem Toxicol. 1987;25(7):545–7.
＊15 Polasa K, Raghuram TC, Krishna TP, Krishnaswamy K. Effect of turmeric on urinary mutagens in smokers. Mutagenesis. 1992;7(2):107–9.
＊16 Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 2009;11(3):495–510.
＊17 Wu SH, Hang LW, Yang JS, et al. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade-and mitochondria-dependent pathways. Anticancer Res. 2010;30(6):2125–33.
＊18 Su CC, Lin JG, Li TM, et al. Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3. Anticancer Res. 2006;26(6B):4379–89.
＊19 Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 2009;11(3):495–510.
＊20 Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 2009;11(3):495–510.
＊21 Pallis AG, Syrigos KN. Lung cancer in never smokers: disease characteristics and risk factors. Crit Rev Oncol Hematol. 2013;88(3):494–503.
＊22 Chiang TA, Wu PF, Wang LF, Lee H, Lee CH, Ko YC. Mutagenicity and polycyclic aromatic hydrocarbon content of fumes from heated cooking oils produced in Taiwan. Mutat Res. 1997;381(2):157–61.
＊23 Katragadda HR, Fullana A, Sidhu S, Carbonell-Barrachina AA. Emissions of volatile aldehydes from heated cooking oils. Food Chem. 2010;120(1):59–65.
＊24 Jin ZY, Wu M, Han RQ, et al. House hold ventilation may reduce effects of indoor air pollutants for prevention of lung cancer: a case-control study in a Chinese population. PLoS ONE. 2014;9(7):e102685.
＊25 Seow A, Poh WT, Teh M, et al. Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev. 2000;9(11):1215–21.
＊26 Jedrychowski W, Perera FP, Tang D, et al. Impact of barbecued meat consumed in pregnancy on birth outcomes accounting for personal prenatal exposure to airborne polycyclic aromatic hydrocarbons: birth cohort study in Poland. Nutrition. 2012;28(4):372–7.
＊27 Perera FP, Li Z, Whyatt R, et al. Prenatal airborne polycyclic aromatic hydrocarbon exposure and child IQ at age 5 years. Pediatrics. 2009;124(2):e195–202.
＊28 Chen JW, Wang SL, Hsieh DP, Yang HH, Lee HL. Carcinogenic potencies of polycyclic aromatic hydrocarbons for back-door neighbors of restaurants with cooking emissions. Sci Total Environ. 2012;417–418:68–75.
＊29 Yang SC, Jenq SN, Kang ZC, Lee H. Identification of benzo[a]pyrene 7,8-diol 9,10-epoxide N2-deoxyguanosine in human lung adenocarcinoma cells exposed to cooking oil fumes from frying fish under domestic conditions. Chem Res Toxicol. 2000;13(10):1046–50.
＊30 Chen JW, Wang SL, Hsieh DP, Yang HH, Lee HL. Carcinogenic potencies of polycyclic aromatic hydrocarbons for back-door neighbors of restaurants with cooking emissions. Sci Total Environ. 2012 Feb 15;417–418:68–75.
＊31 Lijinsky W. N-Nitroso compounds in the diet. Mutat Res. 1999 Jul 15;443(1–2):129–38.
＊32 Thiébaud HP, Knize MG, Kuzmicky PA, Hsieh DP, Felton JS. Airborne mutagens produced by frying beef, pork and a soy-based food. Food Chem Toxicol. 1995;33(10):821–8.
＊33 Thiébaud HP, Knize MG, Kuzmicky PA, Hsieh DP, Felton JS. Airborne mutagens produced by frying beef, pork and a soy-based food. Food Chem Toxicol. 1995;33(10):821–8.
＊34 Mitsakou C, Housiadas C, Eleftheriadis K, Vratolis S, Helmis C, Asimakopoulos D. Lung deposition of fine and ultrafine particles outdoors and indoors during a cooking event and a no activity period. Indoor Air. 2007;17(2):143–52.
＊35 COPD Statistics across America. COPD Foundation website. http://www.copdfoundation.org/What-is-COPD/COPD-Facts/Statistics.aspx. 2015. Accessed February 14, 2015.
＊36 Tabak C, Smit HA, Räsänen L, et al. Dietary factors and pulmonary function: a cross sectional study in middle aged men from three European countries. Thorax. 1999;54(11):1021–6.
＊37 Walda IC, Tabak C, Smit HA, et al. Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries. Eur J Clin Nutr. 2002;56(7):638–43.
＊38 Varraso R, Jiang R, Barr RG, Willett WC, Camargo CA, Jr. Prospective study of cured meats consumption and risk of chronic obstructive pulmonary disease in men. Am J Epidemiol. 2007 Dec 15;166(12):1438–45.
＊39 Jiang R, Paik DC, Hankinson JL, Barr RG. Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults. Am J Respir Crit Care Med. 2007 Apr 15;175(8):798–804.
＊40 Jiang R, Camargo CA, Varraso R, Paik DC, Willett WC, Barr RG. Consumption of cured meats and prospective risk of chronic obstructive pulmonary disease in women. Am J Clin Nutr. 2008;87(4):1002–8.
＊41 Keranis E, Makris D, Rodopoulou P, et al. Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial. Eur Respir J. 2010;36(4):774–80.
＊42 Warner JO. Worldwide variations in the prevalence of atopic symptoms: what does it all mean? Thorax. 1999;54 Suppl 2:S46–51.
＊43 What Is Asthma? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/asthma/. August 4, 2014. Accessed February 14, 2015.
＊44 Warner JO. Worldwide variations in the prevalence of atopic symptoms: what does it all mean? Thorax. 1999;54 Suppl 2:S46–51.
＊45 Aït-Khaled N, Pearce N, Anderson HR, et al. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009;64(1):123–48.
＊46 Asher MI, Stewart AW, Mallol J, et al. Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One. Respir Res. 2010;11:8.
＊47 Ellwood P, Asher MI, Björkstén B, Burr M, Pearce N, Robertson CF. Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J. 2001;17(3):436–43.
＊48 Protudjer JL, Sevenhuysen GP, Ramsey CD, Kozyrskyj AL, Becker AB. Low vegetable intake is associated with allergic asthma and moderate-to-severe airway hyperresponsiveness. Pediatr Pulmonol. 2012;47(12):1159–69.
＊49 Bime C, Wei CY, Holbrook J, Smith LJ, Wise RA. Association of dietary soy genistein intake with lung function and asthma control: a post-hoc analysis of patients enrolled in a prospective multicentre clinical trial. Prim Care Respir J. 2012;21(4):398–404.
＊50 Agrawal S, Pearce N, Ebrahim S. Prevalence and risk factors for self-reported asthma in an adult Indian population: a cross-sectional survey. Int J Tuberc Lung Dis. 2013 17(2):275–82.
＊51 Tsai HJ, Tsai AC. The association of diet with respiratory symptoms and asthma in schoolchildren in Taipei, Taiwan. J Asthma. 2007;44(8):599–603.
＊52 Yusoff NA, Hampton SM, Dickerson JW, Morgan JB. The effects of exclusion of dietary egg and milk in the management of asthmatic children: a pilot study. J R Soc Promot Health. 2004;124(2):74–80.
＊53 Wood LG, Garg ML, Blake RJ, Garcia-Caraballo S, Gibson PG. Airway and circulating levels of carotenoids in asthma and healthy controls. J Am Coll Nutr. 2005;24(6):448–55.
＊54 Miller ER, Appel LJ, Risby TH. Effect of dietary patterns on measures of lipid peroxidation: results from a randomized clinical trial. Circulation. 1998;98(22):2390–5.
＊55 Wood LG, Garg ML, Smart JM, Scott HA, Barker D, Gibson PG. Manipulating antioxidant intake in asthma: a randomized controlled trial. Am J Clin Nutr. 2012;96(3):534–43.
＊56 Wood LG, Garg ML, Smart JM, Scott HA, Barker D, Gibson PG. Manipulating antioxidant intake in asthma: a randomized controlled trial. Am J Clin Nutr. 2012;96(3):534–43.
＊57 Patel S, Murray CS, Woodcock A, Simpson A, Custovic A. Dietary antioxidant intake, allergic sensitization and allergic diseases in young children. Allergy. 2009;64(12):1766–72.
＊58 Troisi RJ, Willett WC, Weiss ST, Trichopoulos D, Rosner B, Speizer FE. A prospective study of diet and adult-onset asthma. Am J Respir Crit Care Med. 1995;151(5):1401–8.
＊59 Wood LG, Garg ML, Smart JM, Scott HA, Barker D, Gibson PG. Manipulating antioxidant intake in asthma: a randomized controlled trial. Am J Clin Nutr. 2012;96(3):534–43.
＊60 Lindahl O, Lindwall L, Spångberg A, Stenram A, Ockerman PA. Vegan regimen with reduced medication in the treatment of bronchial asthma. J Asthma. 1985;22(1):45–55.
＊61 Lindahl O, Lindwall L, Spångberg A, Stenram A, Ockerman PA. Vegan regimen with reduced medication in the treatment of bronchial asthma. J Asthma. 1985;22(1):45–55.
＊62 Lindahl O, Lindwall L, Spångberg A, Stenram A, Ockerman PA. Vegan regimen with reduced medication in the treatment of bronchial asthma. J Asthma. 1985;22(1):45–55.
◆３ 脳疾患で死なないために
＊1 Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.
＊2 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊3 Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.
＊4 Grau-Olivares M, Arboix A. Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? Expert Rev Neurother. 2009;9(8):1201–17.
＊5 Aune D, Chan DS, Lau R, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011;343:d6617.
＊6 Aune D, Chan DS, Greenwood DC, et al. Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies. Ann Oncol. 2012;23(6):1394–402.
＊7 Yao B, Fang H, Xu W, et al. Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies. Eur J Epidemiol. 2014;29(2):79–88.
＊8 Threapleton DE, Greenwood DC, Evans CE, et al. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2013;347:f6879.
＊9 Maskarinec G, Takata Y, Pagano I, et al. Trends and dietary determinants of overweight and obesity in a multiethnic population. Obesity (Silver Spring). 2006;14(4):717–26.
＊10 Kim Y, Je Y. Dietary fiber intake and total mortality: a meta-analysis of prospective cohort studies. Am J Epidemiol. 2014;180(6):565–73.
＊11 Threapleton DE, Greenwood DC, Evans CE, et al. Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis. Stroke. 2013;44(5):1360–8.
＊12 Clemens R, Kranz S, Mobley AR, et al. Filling America’s fiber intake gap: summary of a roundtable to probe realistic solutions with a focus on grain-based foods. J Nutr. 2012;142(7):1390S–401S.
＊13 Threapleton DE, Greenwood DC, Evans CE, et al. Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis. Stroke. 2013;44(5):1360–8.
＊14 Whitehead A, Beck EJ, Tosh S, Wolever TM. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;100(6):1413–21.
＊15 Silva FM, Kramer CK, De Almeida JC, Steemburgo T, Gross JL, Azevedo MJ. Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with metaanalysis of randomized controlled trials. Nutr Rev. 2013;71(12):790–801.
＊16 Streppel MT, Arends LR, van ’t Veer P, Grobbee DE, Geleijnse JM. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005;165(2):150–6.
＊17 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊18 van de Laar RJ, Stehouwer CDA, van Bussel BCT, et al. Lower lifetime dietary fiber intake is associated with carotid artery stiffness: the Amsterdam Growth and Health Longitudinal Study. Am J Clin Nutr. 2012;96(1):14–23.
＊19 van de Laar RJ, Stehouwer CDA, van Bussel BCT, et al. Lower lifetime dietary fiber intake is associated with carotid artery stiffness: the Amsterdam Growth and Health Longitudinal Study. Am J Clin Nutr. 2012;96(1):14–23.
＊20 Casiglia E, Tikhonoff V, CaffiS, et al. High dietary fiber intake prevents stroke at a population level. Clin Nutr 2013;32(5):811–8.
＊21 Tikhonoff V, Palatini P, Casiglia E. Letter by Tikhonoff et al regarding article, “Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis,” Stroke. 2013;44(9):e109.
＊22 Threapleton DE, Greenwood DC, Burley VJ. Response to letter regarding article, “Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis,” Stroke. 2013;44(9):e110.
＊23 Eaton SB, Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med. 1985;312(5):283–9.
＊24 Cogswell ME, Zhang Z, Carriquiry AL, et al. Sodium and potassium intakes among US adults: NHANES 2003–2008. Am J Clin Nutr. 2012;96(3):647–57.
＊25 Cogswell ME, Zhang Z, Carriquiry AL, et al. Sodium and potassium intakes among US adults: NHANES 2003–2008. Am J Clin Nutr. 2012;96(3):647–57.
＊26 D’Elia L, Barba G, Cappuccio FP, et al. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol. 2011;57(10):1210–9.
＊27 U.S. Department of Agriculture. USDA National Nutrient Database for Standard Reference. http://ndb.nal.usda.gov/ndb/nutrients/index?fg=&nutrient1=306&nutrient2=&nutrient3=&subset=0&sort=c&totCount=0&offset=0&measureby=g. 2011. Accessed April 1, 2015.
＊28 U.S. Department of Agriculture Dietary Guidelines for Americans 2005. Appendix B-1. Food sources of potassium. http://www.health.gov/dietaryguidelines/dga2005/document/html/appendixb.htm. July 9, 2008. Accessed May 1, 2015.
＊29 Hu D, Huang J, Wang Y, Zhang D, Qu Y. Fruits and vegetables consumption and risk of stroke: a meta-analysis of prospective cohort studies. Stroke. 2014;45(6):1613–9.
＊30 Morand C, Dubray C, Milenkovic D, et al. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr. 2011;93(1):73–80.
＊31 Takumi H, Nakamura H, Simizu T, et al. Bioavailability of orally administered waterdispersible hesperetin and its effect on peripheral vasodilatation in human subjects: implication of endothelial functions of plasma conjugated metabolites. Food Funct. 2012;3(4):389–98.
＊32 Sansevero TB. The Profit Machine. Madrid: Cultiva Libros. 2009;59.
＊33 Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc. 1972;20(4):145–7.
＊34 Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979;59(3):527–605.
＊35 Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in Carcinogenesis. Free Radic Biol Med. 1994;16(1):99–109.
＊36 Rautiainen S, Larsson S, Virtamo J, et al. Total antioxidant capacity of diet and risk of stroke: a population-based prospective cohort of women. Stroke. 2012;43(2):335–40.
＊37 Del Rio D, Agnoli C, Pellegrini N, et al. Total antioxidant capacity of the diet is associated with lower risk of ischemic stroke in a large Italian cohort. J Nutr. 2011;141(1):118–23.
＊38 Satia JA, Littman A, Slatore CG, Galanko JA, White E. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol. 2009;169(7):815–28.
＊39 Hankey GJ. Vitamin supplementation and stroke prevention. Stroke. 2012;43(10):2814–8.
＊40 Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010 Jan 22;9:3.
＊41 Yang M, Chung SJ, Chung CE, et al. Estimation of total antioxidant capacity from diet and supplements in US adults. Br J Nutr. 2011;106(2):254–63.
＊42 Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010 Jan 22;9:3.
＊43 Bastin S, Henken K. Water Content of Fruits and Vegetables. ENRI-129. University of Kentucky College of Agriculture Cooperative Extension Service. http://www2.ca.uky.edu/enri/pubs/enri129.pdf. December 1997. Accessed March 3, 2015.
＊44 Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010 Jan 22;9:3.
＊45 Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010 Jan 22;9:3.
＊46 Kelly PJ, Morrow JD, Ning M, et al. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke. 2008;39(1):100–4.
＊47 Lilamand M, Kelaiditi E, Guyonnet S, et al. Flavonoids and arterial stiffness: promising perspectives. Nutr Metab Cardiovasc Dis. 2014;24(7):698–704.
＊48 Santhakumar AB, Bulmer AC, Singh I. A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk.-J Hum Nutr Diet. 2014;27(1):1–21.
＊49 Stoclet JC, Chataigneau T, Ndiaye M, et al. Vascular protection by dietary polyphenols. Eur J Pharmacol. 2004;500(1–3):299–313.
＊50 Moylan S, Berk M, Dean OM, et al. Oxidative & nitrosative stress in depression: why so much stress?. Neurosci Biobehav Rev. 2014;45:46–62.
＊51 Watzl B. Anti-inflammatory effects of plant-based foods and of their constituents. Int J Vitam Nutr Res. 2008;78(6):293–8.
＊52 Franzini L, Ardigi D, Valtueña S, et al. Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population. Nutr Metab Cardiovasc Dis. 2012;22(1):50–7.
＊53 Alzheimer’s Association factsheet. http://www.alz.org/documents_custom/2013_facts_figures_fact_sheet.pdf. March 2013. Accessed April 3, 2015.
＊54 de la Torre JC. A turning point for Alzheimer’s disease? Biofactors. 2012;38(2):78–83.
＊55 de la Torre JC. Alzheimer’s disease is incurable but preventable. J Alzheimers Dis. 2010;20(3):861–70.
＊56 Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10(9):819–28.
＊57 Singh-Manoux A, Kivimaki M, Glymour MM, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ. 2012;344:d7622.
＊58 Roher AE, Tyas SL, Maarouf CL, et al. Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia. Alzheimers Dement. 2011;7(4):436–44.
＊59 Barnard ND, Bush AI, Ceccarelli A, et al. Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease. Neurobiol Aging. 2014;35 Suppl 2:S74–8.
＊60 Ramirez-Bermudez J. Alzheimer’s disease: critical notes on the history of a medical concept. Arch Med Res. 2012;43(8):595–9.
＊61 Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR. An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde.” Clin Anat. 1995;8(6):429–31.
＊62 Kovacic JC, Fuster V. Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease. Mt Sinai J Med. 2012;79:664–73.
＊63 Cardiogenic Dementia. Lancet. 1977;1(8001):27–8.
＊64 Roher AE, Tyas SL, Maarouf CL, et al. Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia. Alzheimers Dement. 2011;7(4):436–44.
＊65 Roher AE, Tyas SL, Maarouf CL, et al. Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia. Alzheimers Dement. 2011;7(4):436–44.
＊66 Yarchoan M, Xie SX, Kling MA, et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain. 2012;135(Pt 12):3749–56.
＊67 Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center. Neurology. 2005;64(3):494–500.
＊68 de la Torre JC. Vascular risk factors: a ticking time bomb to Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2013;28(6):551–9.
＊69 Roher AE, Tyas SL, Maarouf CL, et al. Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia. Alzheimers Dement. 2011;7(4):436–44.
＊70 de la Torre JC. Vascular basis of Alzheimer’s pathogenesis. Ann N Y Acad Sci. 2002;977:196–215.
＊71 Zhu J, Wang Y, Li J, et al. Intracranial artery stenosis and progression from mild cognitive impairment to Alzheimer disease. Neurology. 2014;82(10):842–9.
＊72 Deschaintre Y, Richard F, Leys D, Pasquier F. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009;73(9):674–80.
＊73 Mizuno T, Nakata M, Naiki H, et al. Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture. J Biol Chem. 1999;274(21):15110–4.
＊74 Trumbo PR, Shimakawa T. Tolerable upper intake levels for trans fat, saturated fat, and cholesterol. Nutr Rev. 2011;69(5):270–8.
＊75 Benjamin MM, Roberts WC. Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent). 2013;26(2):124–36.
＊76 Corsinovi L, Biasi F, Poli G, et al. Dietary lipids and their oxidized products in Alzheimer’s disease. Mol Nutr Food Res. 2011;55 Suppl 2:S161–72.
＊77 Harris JR, Milton NGN. Cholesterol in Alzheimer’s disease and other amyloidogenic disorders. Subcell Biochem. 2010;51:47–75.
＊78 Puglielli L, Tanzi RE, Kovacs DM. Alzheimer’s disease: the cholesterol connection. Nat Neurosci. 2003;6(4):345–51.
＊79 Harris JR, Milton NGN. Cholesterol in Alzheimer’s disease and other amyloidogenic disorders. Subcell Biochem. 2010;51:47–75.
＊80 Reed B, Villeneuve S, Mack W, et al. Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol. 2014;71(2):195–200.
＊81 US Food and Drug Administration. Important safety label changes to cholesterol-lowering statin drugs. Silver Spring, MD: US Department of Health and Human Services; 2012. http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm. July 7, 2012. Accessed April 2, 2015.
＊82 Rojas-Fernandez CH, Cameron JC. Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations. Ann Pharmacother. 2012;46(4):549–57.
＊83 Grant WB. Dietary links to Alzheimer’s disease. Alzheimer Dis Rev. 1997;2:42–55.
＊84 Chandra V, Pandav R, Dodge HH, et al. Incidence of Alzheimer’s disease in a rural community in India: the Indo-US study. Neurology. 2001;57(6):985–9.
＊85 White L, Petrovitch H, Ross GW, et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia aging study. JAMA. 1996;276(12):955–60.
＊86 Grant WB. Dietary links to Alzheimer’s disease. Alzheimer Dis Rev. 1997;2:42–55.
＊87 Grant WB. Trends in diet and Alzheimer’s disease during the nutrition transition in Japan and developing countries. J Alzheimers Dis. 2014;38(3):611–20.
＊88 Chan KY, Wang W, Wu JJ, et al. Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990–2010: A systematic review and analysis. Lancet. 2013;381(9882):2016–23.
＊89 Grant WB. Trends in diet and Alzheimer’s disease during the nutrition transition in Japan and developing countries. J Alzheimers Dis. 2014;38(3):611–20.
＊90 Chandra V, Ganguli M, Pandav R, et al. Prevalence of Alzheimer’s disease and other dementias in rural India: the Indo-US study. Neurology. 1998;51(4):1000–8.
＊91 Shetty PS. Nutrition transition in India. Public Health Nutr. 2002;5(1A):175–82.
＊92 Giem P, Beeson WL, Fraser GE. The incidence of dementia and intake of animal products: preliminary findings from the Adventist Health Study. Neuroepidemiology. 1993;12(1):28–36.
＊93 Roses AD, Saunders AM. APOE is a major susceptibility gene for Alzheimer’s disease. Curr Opin Biotechnol. 1994;5(6):663–7.
＊94 Puglielli L, Tanzi RE, Kovacs DM. Alzheimer’s disease: the cholesterol connection. Nat Neurosci. 2003;6(4):345–51.
＊95 Chen X, Hui L, Soliman ML, Geiger JD. Altered cholesterol intracellular trafficking and the development of pathological hallmarks of sporadic AD. J Parkinsons Dis Alzheimers Dis. 2014;1(1).
＊96 Sepehrnia B, Kamboh MI, Adams-Campbell LL, et al. Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. Am J Hum Genet. 1989;45(4):586–91.
＊97 Grant WB. Dietary links to Alzheimer’s disease. Alzheimer Dis Rev. 1997;2:42–55.
＊98 Sepehrnia B, Kamboh MI, Adams-Campbell LL, et al. Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. Am J Hum Genet. 1989;45(4):586–91.
＊99 Hendrie HC, Murrell J, Gao S, Unverzagt FW, Ogunniyi A, Hall KS. International studies in dementia with particular emphasis on populations of African origin. Alzheimer Dis Assoc Disord. 2006;20(3 Suppl 2):S42–6.
＊100 Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002;137(3):149–55.
＊101 Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002;137(3):149–55.
＊102 Jost BC, Grossberg GT. The natural history of Alzheimer’s disease: a brain bank study. J Am Geriatr Soc. 1995;43(11):1248–55.
＊103 Del Tredici K, Braak H. Neurofibrillary changes of the Alzheimer type in very elderly individuals: neither inevitable nor benign: Commentary on ‘No disease in the brain of a 115-year-old woman.’ Neurobiol Aging. 2008;29(8):1133–6.
＊104 Barnard ND, Bush AI, Ceccarelli A, et al. Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease. Neurobiol Aging. 2014;35 Suppl 2:S74–8.
＊105 Lourida I, Soni M, Thompson-Coon J, et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology. 2013;24(4):479–89.
＊106 Roberts RO, Geda YE, Cerhan JR, et al. Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 2010;29(5):413–23.
＊107 Okereke OI, Rosner BA, Kim DH, et al. Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol. 2012;72(1):124–34.
＊108 Parletta N, Milte CM, Meyer BJ. Nutritional modulation of cognitive function and mental health. J Nutr Biochem. 2013;24(5):725–43.
＊109 Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, Guillemin GJ. Neuroprotective effect of natural products against Alzheimer’s disease. Neurochem Res. 2012;37(9):1829–42.
＊110 Shukitt-Hale B. Blueberries and neuronal aging. Gerontology. 2012;58(6):518–23.
＊111 Cherniack EP. A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders. Br J Nutr. 2012;108(5):794–800.
＊112 Johnson EJ. A possible role for lutein and zeaxanthin in cognitive function in the elderly. Am J Clin Nutr. 2012;96(5):1161S–5S.
＊113 Krikorian R, Shidler MD, Nash TA, et al. Blueberry supplementation improves memory in older adults. J Agric Food Chem. 2010;58(7):3996–4000.
＊114 Devore EE, Kang JH, Breteler MMB, et al. Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol. 2012;72(1):135–43.
＊115 Dai Q, Borenstein AR, Wu Y, et al. Fruit and vegetable juices and Alzheimer’s disease: the Kame Project. Am J Med. 2006;119(9):751–9.
＊116 Krikorian R, Nash TA, Shidler MD, Shukitt-Hale B, Joseph JA. Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br J Nutr. 2010;103(5):730–4.
＊117 Nurk E, Refsum H, Drevon CA, et al. Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study. Br J Nutr. 2010;104(8):1190–201.
＊118 Mullen W, Marks SC, Crozier A. Evaluation of phenolic compounds in commercial fruit juices and fruit drinks. J Agric Food Chem. 2007;55(8):3148–57.
＊119 Tarozzi A, Morroni F, Merlicco A, et al. Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25–35) oligomer-induced toxicity. Neurosci Lett. 2010;473(2):72–6.
＊120 Hattori M, Sugino E, Minoura K, et al. Different inhibitory response of cyanidin and methylene blue for filament formation of tau microtubule-binding domain. Biochem Biophys Res Commun. 2008;374(1):158–63.
＊121 Mandel SA, Weinreb O, Amit T, Youdim MB. Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols. Front Biosci (Schol Ed). 2012;4:581–98.
＊122 Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014;13(10):1045–60.
＊123 Hishikawa N, Takahashi Y, Amakusa Y, et al. Effects of turmeric on Alzheimer’s disease with behavioral and psychological symptoms of dementia. Ayu. 2012;33(4):499–504.
＊124 Akhondzadeh S, Sabet MS, Harirchian MH, et al. Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial. J Clin Pharm Ther. 2010;35(5):581–8.
＊125 Akhondzadeh S, Shafiee Sabet M, Harirchian MH, et al. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease. Psychopharmacology (Berl). 2010;207(4):637–43.
＊126 Hyde C, Peters J, Bond M, et al. Evolution of the evidence on the effectiveness and costeffectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer’s disease: systematic review and economic model. Age Ageing. 2013;42(1):14–20.
＊127 US Food and Drug Administation. ARICEPT® (Donepezil Hydrochloride Tablets) package insert. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/DrugMarketingAdvertisingandCommunications/UCM368444.pdf. Accessed April 2, 2015.
＊128 Toledo C, Saltsman K. Genetics by the Numbers. Inside Life Science, Bethesda, MD: National Institute of General Medical Sciences. http://publications.nigms.nih.gov/insidelifescience/genetics-numbers.html. June 11, 2012. Accessed March 3, 2015.
＊129 Mostoslavsky R, Esteller M, Vaquero A. At the crossroad of lifespan, calorie restriction, chromatin and disease: meeting on sirtuins. Cell Cycle. 2010;9(10):1907–12.
＊130 Julien C, Tremblay C, Emond V, et al. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol. 2009;68(1):48–58.
＊131 Cai W, Uribarri J, Zhu L, et al. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci USA. 2014;111(13):4940–5.
＊132 Cai W, Uribarri J, Zhu L, et al. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci USA. 2014;111(13):4940–5.
＊133 Rahmadi A, Steiner N, Münch G. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer’s disease. Clin Chem Lab Med. 2011;49(3):385–91.
＊134 Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010;65(9):963–75.
＊135 Srikanth V, Westcott B, Forbes J, et al. Methylglyoxal, cognitive function and cerebral atrophy in older people. J Gerontol A Biol Sci Med Sci. 2013;68(1):68–73.
＊136 Cai W, Uribarri J, Zhu L, et al. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci USA. 2014;111(13):4940–5.
＊137 Beeri MS, Moshier E, Schmeidler J, et al. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev. 2011;132(11–12):583–7.
＊138 Yaffe K, Lindquist K, Schwartz AV, et al. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology. 2011;77(14):1351–6.
＊139 Angeloni C, Zambonin L, Hrelia S. Role of methylglyoxal in Alzheimer’s disease. Biomed Res Int. 2014;2014:238485.
＊140 Vlassara H, Cai W, Goodman S, et al. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab. 2009;94(11):4483–91.
＊141 Cerami C, Founds H, Nicholl I, et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA. 1997;94(25):13915–20.
＊142 Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005;1043:461–6.
＊143 Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005;1043:461–6.
＊144 Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911–6.e12.
＊145 Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911–6.e12.
＊146 Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911–6.e12.
＊147 Cai W, Uribarri J, Zhu L, et al. Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci USA. 2014;111(13):4940–5.
◆４ 消化器がんで死なないために
＊1 Liu PH, Wang JD, Keating NL. Expected years of life lost for six potentially preventable cancers in the United States. Prev Med. 2013;56(5):309–13.
＊2 Bertram JS, Kolonel LN, Meyskens FL. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 1987;47(11):3012–31.
＊3 Hasleton PS. The internal surface area of the adult human lung. J Anat. 1972;112(Pt3):391–400.
＊4 Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307(5717):1920–5.
＊5 What are the key statistics about colorectal cancer? American Cancer Society website. http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics. Accessed March 3, 2015.
＊6 What are the key statistics about pancreatic cancer? American Cancer Society website. http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-key-statistics. Accessed March 3, 2015.
＊7 American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
＊8 What are the key statistics about colorectal cancer? American Cancer Society website. http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics. Accessed March 3, 2015.
＊9 American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
＊10 Screening for Colorectal Cancer. US Preventive Services Task Force website. http://www.uspreventiveservicestaskforce.org/Home/GetFile/1/467/colcancsumm/pdf. Accessed March 3, 2015.
＊11 International Monetary Fund. World Economic Outlook Database. http://bit.ly/1bNdlWu. April 2015. Accessed May 2, 2015.
＊12 World Bank. World Development Indicators. http://data.worldbank.org/country/india. 2011. Accessed May 2, 2015.
＊13 Bengmark S, Mesa MD, Gill A. Plant-derived health: the effects of turmeric and curcuminoids. Nutr Hosp. 2009;24(3):273–81.
＊14 Hutchins-Wolfbrandt A, Mistry AM. Dietary turmeric potentially reduces the risk of cancer. Asian Pac J Cancer Prev. 2011;12(12):3169–73.
＊15 Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10(20):6847–54.
＊16 Carroll RE, Benya RV, Turgeon DK, et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 2011;4(3):354–64.
＊17 Cruz-Correa M, Shoskes DA, Sanchez P, et al. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2006;4(8):1035–8.
＊18 Sharma RA, McLelland HR, Hill KA, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001;7(7):1894–900.
＊19 Singh S. From exotic spice to modern drug? Cell. 2007;130(5):765–8.
＊20 International Institute for Population Sciences & Macro International: National Family Health Survey (NFHS-3), 2005–06: India: Vol. I. Mumbai: IIPS; 2007.
＊21 What are the key statistics about colorectal cancer? American Cancer Society website. http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics. Accessed March 3, 2015.
＊22 Doll R. The geographical distribution of cancer. Br J Cancer. 1969;23(1):1–8.
＊23 Lipski E. Traditional non-Western diets. Nutr Clin Pract. 2010;25(6):585–93.
＊24 Burkitt DP. Epidemiology of cancer of the colon and rectum.1971. Dis. Colon Rectum. 1993;36(11): 1071–82.
＊25 Shaper AG, Jones KW. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959. Int J Epidemiol. 2012;41(5):1221–5.
＊26 Malila N, Hakulinen T. Epidemiological trends of colorectal cancer in the Nordic countries. Scand J Surg. 2003;92(1):5–9.
＊27 Englyst HN, Bingham SA, Wiggins HS, et al. Nonstarch polysaccharide consumption in four Scandinavian populations. Nutr Cancer. 1982;4(1):50–60.
＊28 Graf E, Eaton JW. Dietary suppression of colonic cancer. Fiber or phytate? Cancer. 1985;56(4):717–8.
＊29 Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and cancer risk-a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014;23(1):12–31.
＊30 Mellanby E. The rickets-producing and anti-calcifying action of phytate. J Physiol. 1949;109(3–4):488–533.
＊31 House WA, Welch RM, Van Campen DR. Effect of phytic acid on the absorption, distribution, and endogenous excretion of zinc in rats. J Nutr. 1982;112(5):941–53.
＊32 Urbano G, López-Jurado M, Aranda P, Vidal-Valverde C, Tenorio E, Porres J. The role of phytic acid in legumes: antinutrient or beneficial function? J Physiol Biochem. 2000;56(3):283–94.
＊33 López-González AA, Grases F, Roca P, Mari B, Vicente-Herrero MT, Costa-Bauzá A. Phytate (myo-inositol hexaphosphate) and risk factors for osteoporosis. J Med Food. 2008;11(4):747–52.
＊34 López-González AA, Grases F, Monroy N, et al. Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women. Eur J Nutr. 2013;52(2):717–26.
＊35 Arriero Mdel M, Ramis JM, Perelló J, Monjo M. Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts. PLoS ONE. 2012;7(8):e43187.
＊36 Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22(10):1479–91.
＊37 Singh PN, Fraser GE. Dietary risk factors for colon cancer in a low-risk population. Am J Epidemiol. 1998;148(8):761–74.
＊38 Manousos O, Day NE, Trichopoulos D, Gerovassilis F, Tzonou A, Polychronopoulou A. Diet and colorectal cancer: A case-control study in Greece. Int J Cancer. 1983;32(1):1–5.
＊39 Lanza E, Hartman TJ, Albert PS, et al. High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial. J Nutr. 2006;136(7):1896–1903.
＊40 Vucenik I, Shamsuddin AM. Protection against cancer by dietary IP6 and inositol. Nutr Cancer. 2006;55(2):109–25.
＊41 Vucenik I, Shamsuddin AM. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J Nutr. 2003;133(11-Suppl-1):3778S–84S.
＊42 Ogawa S, Kobayashi H, Amada S, et al. Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy. Int J Clin Oncol. 2010;15(1):52–8.
＊43 Vucenik I, Shamsuddin AM. Protection against cancer by dietary IP6 and inositol. Nutr Cancer. 2006;55(2):109–25.
＊44 Vucenik I, Passaniti A, Vitolo MI, Tantivejkul K, Eggleton P, Shamsuddin AM. Anti-angiogenic activity of inositol hexaphosphate (IP6). Carcinogenesis. 2004;25(11):2115–23.
＊45 Wang H, Khor TO, Shu L, et al. Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med Chem. 2012;12(10):1281–305.
＊46 Yang GY, Shamsuddin AM. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates. Anticancer Res. 1995;15 (6B):2479–87.
＊47 Shamsuddin AM, Yang GY, Vucenik I. Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res. 1996;16(6A):3287–92.
＊48 Vucenik I, Tantivejkul K, Zhang ZS, Cole KE, Saied I, Shamsuddin AM. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res. 1998;18(6A):4083–90.
＊49 Shamsuddin AM, Yang GY. Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells. Carcinogenesis. 1995;16(8):1975–9.
＊50 Shamsuddin AM. Anti-cancer function of phytic acid. Int J Food Sci Tech. 2002;37(7):769–82.
＊51 Sun J, Chu YF, Wu X, Liu RH. Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem. 2002;50(25):7449–54.
＊52 Olsson ME, Andersson CS, Oredsson S, Berglund RH, Gustavsson KE. Antioxidant levels and inhibition of cancer cell proliferation in vitro by extracts from organically and conventionally cultivated strawberries. J Agric Food Chem. 2006;54(4):1248–55.
＊53 Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal antiinflammatory drugs: nested case-control study. Lancet. 2005;365(9458):475–81.
＊54 Wang LS, Burke CA, Hasson H, et al. A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev Res (Phila). 2014;7(7): 666–74.
＊55 Wang LS, Burke CA, Hasson H, et al. A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev Res (Phila). 2014;7(7): 666–74.
＊56 Pan A, Sun Q, Bernstein AM, et al. Red meat consumption and mortality: Results from 2 prospective cohort studies. Arch Intern Med. 2012;172(7):555–63.
＊57 Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009;169(6):562–71.
＊58 Popkin BM. Reducing meat consumption has multiple benefits for the world’s health. Arch Intern Med. 2009;169(6):543.
＊59 Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10(1):9–17.
＊60 Hurrell R, Egli I. Iron bioavailability and dietary reference values. Am J Clin Nutr. 2010;91(5):1461S–7S.
＊61 Cook JD. Adaptation in iron metabolism. Am J Clin Nutr. 1990;51(2):301–8.
＊62 Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and cancer risk-a systematic review and metaanalysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014;23(1):12–31.
＊63 Yang W, Li B, Dong X, et al. Is heme iron intake associated with risk of coronary heart disease? A meta-analysis of prospective studies. Eur J Nutr. 2014;53(2):395–400.
＊64 Bao W, Rong Y, Rong S, Liu L. Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis. BMC Med. 2012;10:119.
＊65 Zacharski LR, Chow BK, Howes PS, et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst. 2008;100(14):996–1002.
＊66 Edgren G, Nyrén O, Melbye M. Cancer as a ferrotoxic disease: are we getting hard stainless evidence? J Natl Cancer Inst. 2008;100(14):976–7.
＊67 Corpet DE. Red meat and colon cancer: should we become vegetarians, or can we make meat safer? Meat Sci. 2011;89(3):310–6.
＊68 Farmer B, Larson BT, Fulgoni VL 3rd, Rainville AJ, Liepa GU. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the national health and nutrition examination survey 1999–2004. J Am Diet Assoc. 2011;111(6):819–27.
＊69 Iron deficiency-United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 2002;51(40):897–9.
＊70 Craig WJ, Mangels AR. Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc. 2009;109(7):1266–82.
＊71 Tiwari AK, Mahdi AA, Chandyan S, et al. Oral iron supplementation leads to oxidative imbalance in anemic women: a prospective study. Clin Nutr. 2011;30(2):188–93.
＊72 Saunders AV, Craig WJ, Baines SK, Posen JS. Iron and vegetarian diets. Med J Aust. 2013;199(4 Suppl): S11–6.
＊73 American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society;2014.
＊74 Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008;393(4):535–45.
＊75 Kolodecik T, Shugrue C, Ashat M, Thrower EC. Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Front Physiol. 2013;4:415.
＊76 Thiébaut AC, Jiao L, Silverman DT, et al. Dietary fatty acids and pancreatic cancer in the NIHAARP diet and health study. J Natl Cancer Inst. 2009;101(14):1001–11.
＊77 Landrigan PJ. Preface. Ann N Y Acad Sci. 1991;643:xv– xvi.
＊78 Weiner R, Rees D, Lunga FJ, Felix MA. Third wave of asbestos-related disease from secondary use of asbestos. A case report from industry. S Afr Med J. 1994;84(3):158–60.
＊79 Johnson ES, Zhou Y, Lillian Yau C, et al. Mortality from malignant diseases-update of the Baltimore union poultry cohort. Cancer Causes Control. 2010;21(2):215–21.
＊80 Felini M, Johnson E, Preacely N, Sarda V, Ndetan H, Bangara S. A pilot case-cohort study of liver and pancreatic cancers in poultry workers. Ann Epidemiol. 2011;21(10):755–66.
＊81 Lynch SM, Vrieling A, Lubin JH, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009;170(4):403–13.
＊82 Rohrmann S, Linseisen J, Nöthlings U, et al. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2013;132(3):617–24.
＊83 Rohrmann S, Linseisen J, Jakobsen MU, et al. Consumption of meat and dairy and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011;128(3):623–34.
＊84 Lotti M, Bergamo L, Murer B. Occupational toxicology of asbestos-related malignancies. Clin Toxicol (Phila). 2010;48(6):485–96.
＊85 Marvisi M, Balzarini L, Mancini C, Mouzakiti P. A new type of hypersensitivity pneumonitis: salami brusher’s disease. Monaldi Arch Chest Dis. 2012;77(1):35–7.
＊86 American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society;2014.
＊87 Bagnardi V, Rota M, Botteri E, et al. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013;24(2):301–8.
＊88 Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43(1):1–14.
＊89 Lagergren J, Bergström R, Lindgren A, Nyréyn O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825–31.
＊90 Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142–6.
＊91 Parasa S, Sharma P. Complications of gastro-oesophageal reflux disease. Best Pract Res Clin Gastroenterol. 2013;27(3):433–42.
＊92 El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5(1):17–26.
＊93 De Ceglie A, Fisher DA, Filiberti R, Blanchi S, Conio M. Barrett’s esophagus, esophageal and esophagogastric junction adenocarcinomas: the role of diet. Clin Res Hepatol Gastroenterol. 2011;35(1):7–16.
＊94 Navarro Silvera SA, Mayne ST, Risch H, et al. Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer. 2008;123(4):852–60.
＊95 Nebel OT, Castell DO. Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology. 1972;63(5):778–83.
＊96 Becker DJ, Sinclair J, Castell DO, Wu WC. A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol. 1989;84(7):782–6.
＊97 Charlton KE, Tapsell LC, Batterham MJ, et al. Pork, beef and chicken have similar effects on acute satiety and hormonal markers of appetite. Appetite. 2011;56(1):1–8.
＊98 Mitsukawa T, Takemura J, Ohgo S, et al. Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol. 1990;85(8):981–5.
＊99 Matsuki N, Fujita T, Watanabe N, et al. Lifestyle factors associated with gastroesophageal reflux disease in the Japanese population. J Gastroenterol. 2013;48(3):340–9.
＊100 Jung JG, Kang HW, Hahn SJ, et al. Vegetarianism as a protective factor for reflux esophagitis: a retrospective, cross-sectional study between Buddhist priests and general population. Dig Dis Sci. 2013;58(8):2244–52.
＊101 Fashner J, Gitu AC. Common gastrointestinal symptoms: risks of long-term proton pump inhibitor therapy. FP Essent. 2013;413:29–39.
＊102 Terry P, Lagergren J, Ye W, Nyrén O, Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer. 2000;87(5):750–4.
＊103 Ekström AM, Serafini M, Nyrén O, Hansson LE, Ye W, Wolk A. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer. 2000;87(1):133–40.
＊104 Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut. 2004;53(12):1730–5.
＊105 Coleman HG, Murray LJ, Hicks B, et al. Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis. Nutr Rev. 2013;71(7):474–82.
＊106 Burkitt DP. Hiatus hernia: is it preventable? Am J Clin Nutr. 1981;34(3):428–31.
＊107 Burkitt DP, James PA. Low-residue diets and hiatus hernia. Lancet. 1973;2(7821):128–30.
＊108 Burkitt DP, James PA. Low-residue diets and hiatus hernia. Lancet. 1973;2(7821):128–30.
＊109 Burkitt DP. Two blind spots in medical knowledge. Nurs Times. 1976;72(1):24–7.
＊110 Burkitt DP. Hiatus hernia: is it preventable? Am J Clin Nutr. 1981;34(3):428–31.
＊111 American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society;2014.
＊112 Polednak AP. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer. 2003;105(1):98–100.
＊113 Chen T, Yan F, Qian J, et al. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res (Phila). 2012;5(1):41–50.
＊114 Chen T, Yan F, Qian J, et al. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res (Phila). 2012;5(1):41–50.
＊115 Eaton SB, Konner M, Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med. 1988;84(4):739–49.
＊116 King DE, Mainous AG, Lambourne CA. Trends in dietary fiber intake in the United States, 1999–2008. J Acad Nutr Diet. 2012;112(5):642–8.
＊117 Zhang N, Huang C, Ou S. In vitro binding capacities of three dietary fibers and their mixture for four toxic elements, cholesterol, and bile acid. J Hazard Mater. 2011;186(1):236–9.
＊118 Moshfegh A, Goldman J, Cleveland l. What We Eat in America, NHANES 2001–2002: Usual Nutrient Intakes from Food Compared to Dietary Reference Intakes. Washington, D.C.: US Department of Agriculture Agricultural Research Service; 2005.
＊119 Murray CJ. Why is Japanese life expectancy so high?. Lancet. 2011;378(9797):1124–5.
＊120 Tada N, Maruyama C, Koba S, et al. Japanese dietary lifestyle and cardiovascular disease. J Atheroscler Thromb. 2011;18(9):723–34.
＊121 Maruchi N, Aoki S, Tsuda K, Tanaka Y, Toyokawa H. Relation of food consumption to cancer mortality in Japan, with special reference to international figures. Gan. 1977;68(1):1–13.
＊122 Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon, France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr/Pages/online.aspx. Accessed May 8, 2016.
＊123 Matsudo H, Hodgkin NM, Tanaka A. Japanese gastric cancer: potentially carcinogenic silicates (talc) from rice. Arch Pathol. 1974;97(6):366–8.
＊124 Horowitz RE. Gastric cancer in Japan. N Engl J Med. 2008;359(22):2393–4.
＊125 Merliss RR. Talc-treated rice and Japanese stomach cancer. Science. 1971;173(4002):1141–2.
＊126 Stemmermann GN, Kolonel LN. Talc-coated rice as a risk factor for stomach cancer. Am J Clin Nutr. 1978;31(11):2017–9.
＊127 Dye J. Johnson & Johnson ordered to pay $55 mln in talc-powder trial. Reuters.com. http://www.reuters.com/article/us-johnson-johnson-talc-verdict-idUSKCN0XT20L. Published May 3, 2016. Accessed May 9, 2016.
＊128 Letter from Alfred P. Wehner to Michael R. Chudkowsky, September 17,1997. http://www.fairwarning.org/wp-content/uploads/2015/04/Exhib199Wehner.pdf. Accessed May 11, 2016.
＊129 Sauvaget C, Lagarde F, Nagano J, Soda M, Koyama K, Kodama K. Lifestyle factors, radiation and gastric cancer in atomic-bomb survivors (Japan). Cancer Causes Control. 2005;16(7):773–80.
＊130 Forman D, Pisani P. Gastric cancer in Japan—honing treatment, seeking causes. N Engl J Med. 2008;359(5):448–51.
＊131 Inoue M, Tsugane S. Epidemiology of gastric cancer in Japan. Postgrad Med J. 2005;81(957):419–24.
＊132 Asaka M, Mabe K. Strategies for eliminating death from gastric cancer in Japan. Proc Jpn Acad, Ser B, Phys Biol Sci. 2014;90(7):251–8.
＊133 Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241..
＊134 Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci. 2014;59(8):1698–709.
＊135 Holcombe C. Helicobacter pylori: the African enigma. Gut. 1992;33(4):429–31.
＊136 Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40(3):250–60.
＊137 Parkin DM. The global health burden of infection – associated cancers in the year 2012. Int J Cancer 2006; 18: 3030–4.
＊138 Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci. 2014;59(8):1698–709.
＊139 Rocco A, Nardone G. Diet, H pylori infection and gastric cancer: evidence and controversies. World J Gastroenterol. 2007;13(21):2901–12.
＊140 Yamaguchi N, Kakizoe T. Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Lancet. 2001;2(2):88–94.
＊141 Goh KL, Cheah PL, Md N, Quek KF, Parasakthi N. Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: a prospective case control study. Am J Gastroenterol. 2007;102(1):40–5.
＊142 Wu S, Liang J, Zhang L, Zhu X, Liu X, Miao D. Fish consumption and the risk of gastric cancer: systematic review and meta-analysis. BMC Cancer. 2011;11:26
＊143 Haenszel W, Kurihara M, Segi M, Lee RK. Stomach cancer among Japanese in Hawaii. J Natl Cancer Inst. 1972;49(4):969–88.
＊144 Rocco A, Nardone G. Diet, H pylori infection and gastric cancer: evidence and controversies. World J Gastroenterol. 2007;13(21):2901–12.
＊145 Shimazu T, Tsuji I, Inoue M, et al. Alcohol drinking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2008;38(1):8–25.
＊146 Zeng SB, Weng H, Zhou M, Duan XL, Shen XF, Zeng XT. Long-term coffee consumption and risk of gastric cancer: A PRISMA-compliant dose-response meta-analysis of prospective cohort studies. Medicine (Baltimore). 2015;94(38):e1640.
＊147 Hou IC, Amarnani S, Chong MT, Bishayee A. Green tea and the risk of gastric cancer: epidemiological evidence. World J Gastroenterol. 2013;19(24):3713–22.
＊148 Chen W, Weisburger JH, Fiala ES, et al. Gastric carcinogenesis: 2-chloro-4-methylthiobutanoic acid, a novel mutagen in salted, pickled Sanma hiraki fish, or similarly treated methionine. Chem Res Toxicol. 1996;9(1):58–66.
＊149 Tricker AR. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. Eur J Cancer Prev. 1997;6(3):226–68.
＊150 Zhu H, Yang X, Zhang C, et al. Red and processed meat intake is associated with higher gastric cancer risk: a meta-analysis of epidemiological observational studies. PLoS ONE. 2013;8(8):e70955.
＊151 Bouvard V, Loomis D, Guyton KZ, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015;16(16):1599–600.
＊152 lARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Pickled Vegetables. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 56. Lyon, France: International Agency for Research on Cancer; 1993:85–113.
＊153 Ren JS, Kamangar F, Forman D, Islami F. Pickled food and risk of gastric cancer—a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prev. 2012;21(6):905–15.
＊154 Cheng SJ, Sala M, Li MH, Wang MY, Pot-deprun J, Chouroulinkov I. Mutagenic, transforming and promoting effect of pickled vegetables from Linxian county, China. Carcinogenesis. 1980;1(8):685–92.
＊155 Macdonald WC, Anderson FH, Hashimoto S. Histological effect of certain pickles on the human gastric mucosa. A preliminary report. Can Med Assoc J. 1967;96(23):1521–5.
＊156 Kim HJ, Lim SY, Lee JS, et al. Fresh and pickled vegetable consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci. 2010;101(2):508–16.
＊157 Rojas-Campos N, Sigarán MF, Bravo AV, Jimenez-Ulate F, Correa P. Salt enhances the mutagenicity of nitrosated black beans. Nutr Cancer. 1990;14(1):1–3.
＊158 Kim HJ, Lim SY, Lee JS, et al. Fresh and pickled vegetable consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci. 2010;101(2):508–16.
＊159 D’Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr. 2012;31(4):489–98.
＊160 Shikata K, Kiyohara Y, Kubo M, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer. 2006;119(1):196–201.
＊161 Wada K, Tsuji M, Tamura T, et al. Soy isoflavone intake and stomach cancer risk in Japan: from the Takayama study. Int J Cancer. 2015;137(4):885–92.
＊162 Ko KP, Park SK, Yang JJ, et al. Intake of soy products and other foods and gastric cancer risk: a prospective study. J Epidemiol. 2013;23(5):337–43.
＊163 Song P, Lu M, Yin Q, et al. Red meat consumption and stomach cancer risk: a meta-analysis. J Cancer Res Clin Oncol. 2014;140(6):979–92.
＊164 Ghoshal UC, Chaturvedi R, Correa P. The enigma of Helicobacter pylori infection and gastric cancer. Indian J Gastroenterol. 2010;29(3):95–100.
＊165 Zheng W, Lee SA. Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer. 2009;61(4):437–46.
＊166 Lee JG, Kim SY, Moon JS, Kim SH, Kang DH, Yoon HJ. Effects of grilling procedures on levels of polycyclic aromatic hydrocarbons in grilled meats. Food Chem. 2016;199:632–8.
＊167 Cross AJ, Pollock JR, Bingham SA. Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res. 2003;63(10):2358–60.
＊168 Ward MH, Cross AJ, Abnet CC, Sinha R, Markin RS, Weisenburger DD. Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach. Eur J Cancer Prev. 2012;21(2):134–8.
＊169 Tricker AR. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. Eur J Cancer Prev. 1997;6(3):226–68.
＊170 McColl KE. When saliva meets acid: chemical warfare at the oesophagogastric junction. Gut. 2005;54(1):1–3.
＊171 Calatayud S, Barrachina D, Esplugues JV. Nitric oxide: relation to integrity, injury, and healing of the gastric mucosa. Microsc Res Tech. 2001;53(5):325–35.
＊172 Grant J, Moriya A, Williams C, Mowat C, Preston T, Carswell A, Slater C, McColl E. Reaction of salivary nitrite with gastric acid and vitamin C relevant to proximal gastric cancer and Barrett’s oesophagus. Gastroenterology. 1999;116:A469.
＊173 D’Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr. 2012;31(4):489–98.
＊174 Lippi G, Mattiuzzi C. Meat consumption and cancer risk: is the definition of red meat always suitable?. Ann Oncol. 2012;23(11):2993–4.
＊175 D’Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr. 2012;31(4):489–98.
＊176 Pérez-Pérez GI, Israel DA. Role of iron in Helicobacter pylori: its influence in outer membrane protein expression and in pathogenicity. Eur J Gastroenterol Hepatol. 2000;12(12):1263–5.
＊177 Wang XQ, Terry PD, Cheng L, et al. Interactions between pork consumption, CagA status and IL-1B-31 genotypes in gastric cancer. World J Gastroenterol. 2014;20(25):8151–7.
＊178 Ngoan LT, Mizoue T, Fujino Y, Tokui N, Yoshimura T. Dietary factors and stomach cancer mortality. Br J Cancer. 2002;87(1):37–42.
＊179 Correa P, Malcom G, Schmidt B, et al. Review article: antioxidant micronutrients and gastric cancer. Aliment Pharmacol Ther. 1998;12 Suppl 1:73–82.
＊180 Serafini M, Jakszyn P, Luján-Barroso L, et al. Dietary total antioxidant capacity and gastric cancer risk in the European prospective investigation into cancer and nutrition study. Int J Cancer. 2012;131(4):E544–54.
＊181 Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements. Aliment Pharmacol Ther. 2008;28(6):689–703.
＊182 Herbert V. The value of antioxidant supplements vs their natural counterparts. J Am Diet Assoc. 1997;97(4):375–6.
＊183 Liu ZQ. Antioxidants may not always be beneficial to health. Nutrition. 2014;30(2):131–3.
＊184 Møller ME, Dahl R, Bøckman OC. A possible role of the dietary fibre product, wheat bran, as a nitrite scavenger. Food Chem Toxicol. 1988;26(10):841–5.
＊185 Terry P, Lagergren J, Ye W, Wolk A, Nyrén O. Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology. 2001;120(2):387–91.
＊186 Bae JM, Lee EJ, Guyatt G. Citrus fruit intake and stomach cancer risk: a quantitative systematic review. Gastric Cancer. 2008;11(1):23–32.
＊187 Zhang Y, Tang L. Discovery and development of sulforaphane as a cancer chemopreventive phytochemical. Acta Pharmacol Sin. 2007;28(9):1343–54.
＊188 Fahey JW, Haristoy X, Dolan PM, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci USA. 2002;99(11):7610–5.
＊189 Galan MV, Kishan AA, Silverman AL. Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report. Dig Dis Sci. 2004;49(7–8):1088–90.
＊190 Yanaka A, Fahey JW, Fukumoto A, et al. Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans. Cancer Prev Res (Phila). 2009;2(4):353–60.
＊191 Mirmiran P, Bahadoran Z, Golzarand M, Zojaji H, Azizi F. A comparative study of broccoli sprouts powder and standard triple therapy on cardiovascular risk factors following H.pylori eradication: a randomized clinical trial in patients with type 2 diabetes. J Diabetes Metab Disord. 2014;13:64.
＊192 Wu QJ, Yang Y, Wang J, Han LH, Xiang YB. Cruciferous vegetable consumption and gastric cancer risk: a meta-analysis of epidemiological studies. Cancer Sci. 2013;104(8):1067–73.
＊193 Haenszel W, Kurihara M, Segi M, Lee RK. Stomach cancer among Japanese in Hawaii. J Natl Cancer Inst. 1972;49(4):969–88.
＊194 Turati F, Pelucchi C, Guercio V, La Vecchia C, Galeone C. Allium vegetable intake and gastric cancer: a case-control study and meta-analysis. Mol Nutr Food Res. 2015;59(1):171–9.
＊195 Fleischauer AT, Arab L. Garlic and cancer: a critical review of the epidemiologic literature. J Nutr. 2001;131(3s):1032S–40S.
＊196 Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R. The role of diet and other environmental factors in the causation of gastric cancer in Iran—a population based study. Int J Cancer. 2009;125(8):1953–60.
＊197 Sivam GP. Protection against Helicobacter pylori and other bacterial infections by garlic. J Nutr. 2001;131(3s):1106S–8S.
＊198 You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98(14):974–83.
＊199 Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012;104(6):488–92.
＊200 You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98(14):974–83.
＊201 Asaka M, Mabe K. Strategies for eliminating death from gastric cancer in Japan. Proc Jpn Acad, Ser B, Phys Biol Sci. 2014;90(7):251–8.
＊202 Forman D, Pisani P. Gastric cancer in Japan—honing treatment, seeking causes. N Engl J Med. 2008;359(5):448–51.
◆５ 感染症で死なないために
＊1 Civil Practice And Remedies Code. Title 4. Liability in Tort. Chapter 96. False Disparagement of Perishable Food Products. Texas Constitution and Statutes. http://www.statutes.legis.state.tx.us/Docs/CP/htm/CP.96.htm. Accessed March 3, 2015.
＊2 Civil Practice and Remedies Code. Title 4. Liability in Tort. Chapter 96. False Disparagement of Perishable Food Products. Texas Constitution and Statutes. http://www.statutes.legis.state.tx.us/Docs/CP/htm/CP.96.htm. Accessed March 3, 2015.
＊3 Oppel Jr RA. Taping of farm cruelty is becoming the crime. New York Times. http://www.nytimes.com/2013/04/07/us/taping-of-farm-cruelty-is-becoming-the-crime.html. April 6, 2013. Accessed March 3, 2015.
＊4 Shrestha SS, Swerdlow DL, Borse RH, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis. 2011;52 Suppl 1:S75–82.
＊5 Wool house ME, Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerging Infect Dis. 2005;11(12):1842–7.
＊6 Epstein PR, Chivian E, Frith K. Emerging diseases threaten conservation. Environ Health Perspect. 2003;111(10):A506–7.
＊7 Espinosa de los Monteros LE, Galán JC, Gutiérrez M, et al. Allele-specific PCR method based on pncA and oxyR sequences for distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: intraspecific M. bovis pncA sequence polymorphism. J Clin Microbiol. 1998;36(1):239–42.
＊8 Esmail H, Barry CE, Young DB, Wilkinson RJ. The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond, B, Biol Sci. 2014;369(1645):20130437.
＊9 Daszak P, Cunningham AA. Emerging infectious diseases: a key role for conservation medicine. In: Aguirre AA, Ostfeld RS, Tabor GM, et al. Conservation Medicine: Ecological Health in Practice. Oxford: Oxford University Press; 2002: TK–TK.
＊10 McMichael AJ. Human Frontiers, Environments and Disease, Past Patterns, Uncertain Futures. Cambridge: Cambridge University Press; 2001.
＊11 Torrey EF, Yolken RH. Beasts of the Earth, Animals, Humans, and Disease. New Brunswick, NJ: Rutgers University Press; 2005.
＊12 McMichael AJ. Human Frontiers, Environments and Disease, Past Patterns, Uncertain Futures. Cambridge: Cambridge University Press; 2001.
＊13 Van Heuverswyn F, Peeters M. The origins of HIV and implications for the global epidemic. Curr Infect Dis Rep. 2007;9(4):338–46.
＊14 Whon TW, Kim MS, Roh SW, Shin NR, Lee HW, Bae JW. Metagenomic characterization of airborne viral DNA diversity in the near-surface atmosphere. J Virol. 2012;86(15):8221–31.
＊15 USDA. Microbiological testing of AMS purchased meat, poultry and egg commodities. http://www.ams.usda.gov/AMSv1.0/ams.fetchTemplateData.do?template=TemplateA&navID=MicrobialTestingofCommodities&rightNav1=MicrobialTestingofCommodities&topNav=&leftNav=&page=FPPMicroDataReports&resultType=&acct=lsstd. Accessed March 3, 2015.
＊16 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report. 2016;64(2).
＊17 How does the immune system work? PubMed Health. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0010386/. Accessed March 3, 2015.
＊18 U.S. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-08):1–24.
＊19 Gibson A, Edgar J, Neville C, et al. Effect of fruit and vegetable consumption on immune function in older people: a randomized controlled trial. Am J Clin Nutr. 2012;96(6):1429–36.
＊20 USDA. Food availability (per capita) Data System. Fresh kale: per capita availability adjusted for loss. http://www.ers.usda.gov/datafiles/Food_Availabily_Per_Capita_Data_System/Loss_Adjusted_Food_Availability/veg.xls. Accessed March 3, 2015.
＊21 Nishi K, Kondo A, Okamoto T, et al. Immunostimulatory in vitro and in vivo effects of a watersoluble extract from kale. Biosci Biotechnol Biochem. 2011;75(1):40–6.
＊22 Nishi K, Kondo A, Okamoto T, et al. Immunostimulatory in vitro and in vivo effects of a watersoluble extract from kale. Biosci Biotechnol Biochem. 2011;75(1):40–6.
＊23 Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307(5717):1920–5.
＊24 United States Census Bureau. Median and average square feet of floor area in new single-family houses completed by location. https://www.census.gov/const/C25Ann/sftotalmedavgsqft.pdf. Accessed April 3, 2015.
＊25 Sheridan BS, Lefrançois L. Intraepithelial lymphocytes: To serve and protect. Curr Gastroenterol Rep. 2010;12(6):513–21.
＊26 Hooper LV. You AhR what you eat: linking diet and immunity. Cell. 2011;147(3):489–91.
＊27 Esser C. Biology and function of the aryl hydrocarbon receptor: report of an international and interdisciplinary conference. Arch Toxicol. 2012;86(8):1323–9.
＊28 Veldhoen M. Direct interactions between intestinal immune cells and the diet. Cell Cycle. 2012 Feb 1;11(3):426–7.
＊29 Hooper LV. You AhR what you eat: linking diet and immunity. Cell. 2011;147(3):489–91.
＊30 Savouret JF, Berdeaux A, Casper RF. The aryl hydrocarbon receptor and its xenobiotic ligands: A fundamental trigger for cardiovascular diseases. Nutr Metab Cardiovasc Dis . 2003;13(2):104–13.
＊31 Ashida H, Fukuda I, Yamashita T, Kanazawa K. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett. 2000;476 (3):213–7.
＊32 Ashida H, Fukuda I, Yamashita T, Kanazawa K. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett. 2000;476 (3):213–7.
＊33 Alhaider AA, El Gendy MAM, Korashy HM, El-Kadi AOS. Camel urine inhibits the cytochrome P450 1a1 gene expression through an AhR-dependent mechanism in Hepa 1c1c7 cell line. J Ethnopharmacol. 2011;133(1):184–90.
＊34 Watts AR, Lennard MS, Mason SL, Tucker GT, Woods HF. Beeturia and the biological fate of beetroot pigments. PharmacoGenetics. 1993;3(6):302–11.
＊35 Yalindag-Ozturk N, Ozdamar M, Cengiz P. Trial of garlic as an adjunct therapy for multidrug resistant Pseudomonas aeruginosa pneumonia in a critically ill infant. J Altern Complement Med. 2011;17(4):379–80. Epub 2011 Apr 11.
＊36 Seeram NP. Recent trends and advances in berry health benefits research. J Agric Food Chem. 2010;58(7):3869–70.
＊37 Seeram NP. Berry fruits for cancer prevention: Current status and future prospects. J Agric Food Chem. 2008;56(3):630–5.
＊38 Caligiuri MA. Human natural killer cells. Blood. 2008;112(3):461–9.
＊39 McAnulty LS, Nieman DC, Dumke CL, et al. Effect of blueberry ingestion on natural killer cell counts, oxidative stress, and inflammation prior to and after 2. 5 H of running. Appl Physiol Nutr Metab. 2011;36(6):976–84.
＊40 Majdalawieh AF, Carr RI. In vitro investigation of the potential immunomodulatory and anticancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum). J Med Food. 2010;13(2):371–81.
＊41 Bager P, Wohlfahrt J, Westergaard T. Caesarean delivery and risk of atopy and allergic disease: Meta-analyses. Clin Exp Allergy. 2008;38(4):634–42
＊42 Benn CS, Thorsen P, Jensen JS, et al. Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood. J Allergy Clin Immunol. 2002;110(1):72–7
＊43 Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr. 2001;20(Suppl 2):149–56
＊44 Berggren A, Lazou Ahrhiang BL, Wang LH, Liao G. Randomised, double-blind and placebocontrolled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr. 2011;50(3):203–10.
＊45 Hao Q, Lu Z, Dong BR, Huang CQ, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2011;9:1–42
＊46 Homayoni Rad A, Akbarzadeh F, Mehrabany EV. Which are more important: prebiotics or probiotics? Nutrition. 2012;28(11–12):1196–7.
＊47 Vitali B, Minervini G, Rizzello CG, et al. Novel probiotic candidates for humans isolated from raw fruits and vegetables. Food Microbiol. 2012;31(1):116–25.
＊48 Nieman DC. Moderate exercise improves immunity and decreases illness rates. Am J Lifestyle Med. 2011;5(4):338–45.
＊49 Schwindt CD, Zaldivar F, Wilson L, et al. Do circulating leucocytes and lymphocyte subtypes increase in response to brief exercise in children with and without asthma? Br J Sports Med. 2007;41(1):34–40.
＊50 Nieman DC, Henson DA, Gusewitch G, et al. Physical activity and immune function in elderly women. Med Sci Sports Exerc. 1993;25(7):823–31.
＊51 Neville V, Gleeson M, Folland JP. Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Med Sci Sports Exerc. 2008;40(7):1228–36.
＊52 Otsuki T, Shimizu K, Iemitsu M, Kono I. Salivary secretory immunoglobulin A secretion increases after 4-weeks ingestion of chlorella-derived multicomponent supplement in humans: a randomized cross over study. Nutr J. 2011 Sep 9;10:91.
＊53 Klentrou P, Cieslak T, MacNeil M, Vintinner A, Plyley M. Effect of moderate exercise on salivary immunoglobulin A and infection risk in humans. Eur J Appl Physiol. 2002;87(2):153–8.
＊54 Nieman DC. Moderate exercise improves immunity and decreases illness rates. Am J Lifestyle Med. 2011;5(4):338–46.
＊55 Walsh NP, Gleeson M, Shephard RJ, et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev. 2011;17:6–63.
＊56 Akimoto T, Nakahori C, Aizawa K, Kimura F, Fukubayashi T, Kono I. Acu punc ture and responses of immunologic and endocrine markers during competition. Med Sci Sports Exerc. 2003;35(8):1296–302.
＊57 Neville V, Gleeson M, Folland JP. Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Med Sci Sports Exerc. 2008;40(7):1228–36.
＊58 Nieman DC. Exercise effects on systemic immunity. Immunol Cell Biol. 2000;78(5):496–501.
＊59 Otsuki T, Shimizu K, Iemitsu M, Kono I. Salivary secretory immunoglobulin A secretion increases after 4-weeks ingestion of chlorella-derived multicomponent supplement in humans: a randomized cross over study. Nutr J. 2011 Sep 9;10:91.
＊60 Halperin SA, Smith B, Nolan C, Shay J, Kralovec J. Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial. CMAJ. 2003 Jul 22;169(2):111–7.
＊61 Otsuki T, Shimizu K, Iemitsu M, Kono I. Chlorella intake attenuates reduced salivary SIgA secretion in kendo training camp participants. Nutr J. 2012 Dec 11;11:103.
＊62 Carpenter KC, Breslin WL, Davidson T, Adams A, McFarlin BK. Baker’s yeast β-glucan supplementation increases monocytes and cytokines post-exercise: implications for infection risk? Br J Nutr. 2013;109(3):478–86.
＊63 Carpenter KC, Breslin WL, Davidson T, Adams A, McCarlin BK. Baker’s yeast β-glucan supplementation increases monocytes and cytokines post-exercise: implications for infection risk? Br J Nutr. 2013;109(3):478–86.
＊64 Talbott S, Talbott J. Effect of BETA 1, 3/1, 6 GLUCAN on upper respiratory tract infection symptoms and mood state in marathon athletes. J Sports Sci Med. 2009 Dec 1;8(4):509–15.
＊65 Merrill RM, Isakson RT, Beck RE. The association between allergies and cancer: what is currently known? Ann Allergy Asthma Immunol. 2007;99(2):102–16.
＊66 Wakchaure GC. Production and marketing of mushrooms: global and national scenario. In: Singh M, ed. Mushrooms: Cultivation, Marketing and Consumption. Indian Council of Agricultural Research Directorate of Mushroom Research; 2011.
＊67 Jeong SC, Koyyalamudi SR, Pang G. Dietary intake of Agaricus bisporus white button mushroom accelerates salivary immunoglobulin A secretion in healthy volunteers. Nutrition. 2012;28(5):527–31.
＊68 Jeong SC, Koyyalamudi SR, Pang G. Dietary intake of Agaricusbisporus white button mushroom accelerates salivary immunoglobulin A secretion in healthy volunteers. Nutrition. 2012;28(5):527–31.
＊69 Moro C, Palacios I, Lozano M, et al. Anti-inflammatory activity of methanolic extracts from edible mushrooms in LPS activated RAW 264. 7 macrophages. Food Chemistry. 2012;130:350–5.
＊70 Jesenak M, Hrubisko M, Majtan J, Rennerova Z, Banovcin P. Anti-allergic effect of Pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections. Phytother Res. 2014;28(3):471–4.
＊71 Centers for Disease Control and Prevention. Estimates of foodborne illness in the United States. http://www.cdc.gov/foodborneburden/. Accessed March 3, 2015.
＊72 Batz MB, Hoffmann S, Morris Jr JG. Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Prot. 2012;75(7):1278–91.
＊73 Park S, Navratil S, Gregory A, et al. Multifactorial effects of ambient temperature, precipitation, farm management, and environmental factors determine the level of generic Escherichia coli contamination on preharvested spinach. Appl Environ Microbiol. 2015;81 (7): 2635–50.
＊74 Hoffmann S, Batz MB, Morris Jr JG. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 2012;75(7):1292–302.
＊75 Chai SJ, White PL. Salmonella enterica Serotype Enteritidis: increasing incidence of domestically acquired infections. Clin Infect Dis. 2012;54(Sup5): 488–97.
＊76 Salmonella. Centers for Disease Control and Prevention. http://www.cdc.gov/salmonella/. Accessed March 3, 2015.
＊77 Baura GD. The incredible inedible egg. IEEE Pulse. 2010 Nov– Dec;1(3):56, 62.
＊78 Krouse B. Opposing view on food safety: committed to safety. USA Today. http://usatoday30.usatoday.com/news/opinion/editorials/2010-08-30-editorial30_ST1_N.htm. Accessed March 3, 2015.
＊79 Davis AL, Curtis PA, Conner DE, McKee SR, Kerth LK. Validation of cooking methods using shell eggs inoculated with Salmonella serotypes Enteritidis and Heidelberg. Poult Sci. 2008;87(8):1637–42.
＊80 Stadelman WJ, Muriana PM, Schmieder H. The effectiveness of traditional egg-cooking practices for elimination of Salmonella enteritidis. Poult Sci. 1995;74(s1):119.
＊81 Humphrey TJ, Greenwood M, Gilbert RJ, Rowe B, Chapman PA. The survival of salmonellas in shell eggs cooked under simulated domestic conditions. Epidemiol Infect. 1989;103:35–45.
＊82 U.S. Food and Drug Administration. Playing it safe with eggs. http://www.fda.gov/food/resourcesforyou/Consumers/ucm077342.htm. Accessed March 3, 2015.
＊83 Batz MB, Hoffmann S, Morris Jr JG. Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Prot. 2012;75(7):1278–91.
＊84 Centers for Disease Control and Prevention. Multistate outbreak of multidrug-resistant Salmonella Heidelberg infections linked to Foster Farms brand chicken. http://www.cdc.gov/salmonella/heidelberg-10-13/. Accessed March 3, 2015.
＊85 USDA. Notice of Intended Enforcement. http://www.marlerblog.com/files/2013/10/foster-farms-est-6137a-p1.pdf. Accessed March 3, 2015.
＊86 Voetsch AC, Van Gilder TJ, Angulo FJ, et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis. 2004;38(Supplement-3): S127– S134.
＊87 USDA. Notice of Intended Enforcement. http://www.marlerblog.com/files/2013/10/foster-farms-est-6137a-p1.pdf. Accessed March 3, 2015.
＊88 Pierson D. Mexico blocks Foster Farms chicken imports amid salmonella fears. LA Times. http://articles.latimes.com/2013/oct/24/business/la-fi-foster-farms-mexico-20131025. Accessed March 3, 2015.
＊89 Supreme Beef Processors, Inc v United States Dept. of Agriculture, 275 F. 3d 432 (5th Cir 2001).
＊90 Fravalo P, Laisney MJ, Gillard MO, Salvat G, Chemaly M. Campylobacter transfer from naturally contaminated chicken thighs to cutting boards is inversely related to initial load. J Food Prot. 2009;72(9):1836–40.
＊91 Guyard-Nicodème M, Tresse O, Houard E, et al. Characterization of Campylobacter spp. transferred from naturally contaminated chicken legs to cooked chicken slices via a cutting board. Int J Food Microbiol. 2013 Jun 3;164(1):7–14.
＊92 Foster Farms Provides Food Safety Update. Close Up Media Website. http://closeupmedia.com/food/Foster-Farms-Provides-Food-Safety-Update.html. 2013. Accessed March 5, 2015.
＊93 Hoffmann S, Batz MB, Morris Jr JG. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 2012;75(7):1292–302.
＊94 Karapetian A. Model EU. Meatingplace. March 2010:91.
＊95 The high cost of cheap chicken. Consumer Reports. http://www.consumerreports.org/cro/magazine/2014/02/the-high-cost-of-cheap-chicken/index.htm. February 2014. Accessed March 5, 2015.
＊96 Antibiotic Resistance Threats in the United States, 2013. Centers for Disease Control and Prevention. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Accessed March 3, 2015.
＊97 Mayo Clinic Staff. Salmonella infection. The Mayo Clinic. http://www.mayoclinic.org/diseases-conditions/salmonella/basics/causes/con-20029017. Accessed March 3, 2015.
＊98 U.S. Food and Drug Administration. NARMS 2011 retail meat annual report. http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/UCM334834.pdf. Accessed April 3, 2015.
＊99 U.S. Food and Drug Administration. NARMS 2011 retail meat annual report. http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/UCM334834.pdf. Accessed April 3, 2015.
＊100 NA. Vital signs: incidence and trends of infection with pathogens transmitted commonly through food-foodborne diseases active surveillance network, 10 U.S. Sites, 1996–2010. MMWR Morb Mortal Wkly Rep. 2011;60(22):749–55.
＊101 Chai SJ, White PL, Lathrop SL, et al. Salmonella enterica serotype Enteritidis: increasing incidence of domestically acquired infections. Clin Infect Dis. 2012;54-Suppl-5(NA):S488–97.
＊102 Hoffmann S, Batz MB, Morris Jr JG. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 2012;75(7):1292–302.
＊103 511 F. 2d 331-American Public Health Association v. Butz. http://openjurist.org/511/f2d/331/american-public-health-association-v-butz. Accessed March 3, 2015.
＊104 Supreme Beef Processors v. U.S. Dept. of Agriculture. United States Court of Appeals, Fifth Circuit. http://www.leagle.com/decision/2001707275F3d432_1672. Accessed March 3, 2015.
＊105 Stamey TA, Timothy M, Millar M, Mihara G. Recurrent urinary infections in adult women. The role of introital enterobacteria. Calif Med. 1971;115(1):1–19.
＊106 Yamamoto S, Tsukamoto T, Terai A, Kurazono H, Takeda Y, Yoshida O. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J Urol. 1997;157(3):1127–9.
＊107 Bergeron CR, Prussing C, Boerlin P, et al. Chicken as reservoir for extraintestinal pathogenic Escherichia coli in humans, Canada. Emerging Infect Dis. 2012;18(3):415–21.
＊108 Jakobsen L, Garneau P, Bruant G, et al. Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis . 2012;31(6): 1121–9.
＊109 Foxman B, Barlow R, D’arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10(8):509–15.
＊110 Platell JL, Johnson JR, Cobbold RN, Trott DJ. Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol. 2011;153(1–2): 99–108.
＊111 Linton AH, Howe K, Bennett PM, Richmond MH, Whiteside EJ. The colonization of the human gut by antibiotic resistant Escherichia coli from chickens. J Appl Bacteriol. 1977;43(3):465–9.
＊112 Linton AH, Howe K, Bennett PM, Richmond MH, Whiteside EJ. The colonization of the human gut by antibiotic resistant Escherichia coli from chickens. J Appl Bacteriol. 1977;43(3):465–9.
＊113 Rusin P, Orosz-Coughlin P, Gerba C. Reduction of faecal coliform, coliform and heterotrophic plate count bacteria in the house hold kitchen and bathroom by disinfection with hypochlorite cleaners. J Appl Microbiol. 1998;85(5):819–28.
＊114 Cogan TA, Bloomfield SF, Humphrey TJ. The effectiveness of hygiene procedures for prevention of cross-contamination from chicken carcases in the domestic kitchen. Lett Appl Microbiol. 1999;29(5):354–8.
＊115 Cogan TA, Bloomfield SF, Humphrey TJ. The effectiveness of hygiene procedures for prevention of cross-contamination from chicken carcases in the domestic kitchen. Lett Appl Microbiol. 1999;29(5):354–8.
＊116 Cogan TA, Bloomfield SF, Humphrey TJ. The effectiveness of hygiene procedures for prevention of cross-contamination from chicken carcases in the domestic kitchen. Lett Appl Microbiol. 1999;29(5):354–8.
＊117 Linton AH, Howe K, Bennett PM, Richmond MH, Whiteside EJ. The colonization of the human gut by antibiotic resistant Escherichia coli from chickens. J Appl Bacteriol. 1977;43(3):465–9.
＊118 Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerging Infect Dis. 2011;17:7–15.
＊119 Batz MB, Hoffmann S, Morris Jr JG. Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Prot. 2012;75:1278–91.
＊120 Zheng H, Sun Y, Lin S, Mao Z, Jiang B. Yersinia enterocolitica infection in diarrheal patients. Eur J Clin Microbiol Infect Dis. 2008;27:741–52.
＊121 Bari ML, Hossain MA, Isshiki K, Ukuku D. Behavior of Yersinia enterocolitica in foods. J Pathog. 2011;2011:420732.
＊122 Ternhag A, Törner A, Svensson A, Ekdahl K, Giesecke J. Short-and long-term effects of bacterial gastrointestinal infections. Emerging Infect Dis. 2008;14:143–8.
＊123 Brix TH, Hansen PS, Hegedüs L, Wenzel BE. Too early to dismiss Yersinia enterocolitica infection in the aetiology of Graves’ disease: evidence from a twin case-control study. Clin Endocrinol (Oxf). 2008;69:491–6.
＊124 What’s in that pork? Consumer Reports. http://www.consumerreports.org/cro/magazine/2013/01/what-s-in-that-pork/index.htm. Accessed March 3, 2015.
＊125 Bari ML, Hossain MA, Isshiki K, Ukuku D. Behavior of Yersinia enterocolitica in foods. J Pathog. 2011;2011:420732.
＊126 Crowding pigs pays-if it’s managed properly. National Hog Farmer. November 15, 1993;62.
＊127 Poljak Z, Dewey CE, Martin SW, et al. Prevalence of Yersinia enterocolitica shedding and bioserotype distribution in Ontario finisher pig herds in 2001, 2002, and 2004. Prev Vet Med. 2010;93:110–20.
＊128 Hoffmann S, Batz MB, Morris Jr JG. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot. 2012;75:1292–1302.
＊129 Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed March 3, 2015.
＊130 Eyre DW, Cule ML, Wilson DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013 Sep 26;369(13):1195–205.
＊131 Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis. 2009;15(5):819–21.
＊132 Rupnik M, Songer JG. Clostridium difficile: its potential as a source of foodborne disease. Adv Food Nutr Res. 2010;60:53–66.
＊133 Rodriguez-Palacios A, Borgmann S, Kline TR, LeJeune JT. Clostridium difficile in foods and animals: history and measures to reduce exposure. Anim Health Res Rev. 2013;14(1):11–29.
＊134 Hensgrens MPM, Keessen EC, Squire MM, et al. European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD). Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect. 2012;18(7): 635–45.
＊135 Rupnik M, Songer JG. Clostridium difficile: its potential as a source of foodborne disease. Adv Food Nutr Res. 2010;60:53–66.
＊136 Sayedy L, Kothari D, Richards RJ. Toxic megacolon associated Clostridium difficile colitis. World J Gastrointest Endosc. 2010;2(8):293–7.
＊137 Gweon TG, Lee KJ, Kang DH, et al. A case of toxic megacolon caused by Clostridium difficile infection and treated with fecal microbiota transplantation. Gut Liver. 2015;9(2):247–50.
＊138 Weese JS. Clostridium difficile in food-innocent bystander or serious threat? Clin Microbiol Infect. 2010;16:3–10.
＊139 Jabbar U, Leischner J, Kasper D, et al. Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol. 2010;31(6):565–70.
＊140 Bhargava K, Wang X, Donabedian S, Zervos M, de Rocha L, Zhang Y. Methicillin-resistant Staphylococcus aureus in retail meat, Detroit, Michigan, USA. Emerging Infect Dis. 2011;17(6):1135–7.
＊141 Reinberg S. Scientists find MRSA germ in supermarket meats. http://usatoday30.usatoday.com/news/health/medical/health/medical/story/2011/05/Scientists-find-MRSA-germ-in-supermarket-meats/47105974/1. May 12, 2011. Accessed April 4, 2015.
◆６ 糖尿病で死なないために
＊1 Matthews DR, Matthews PC. Banting Memorial Lecture 2010. Type 2 diabetes as an ‘infectious’ disease: is this the Black Death of the 21st century? Diabet Med. 2011;28(1):2–9.
＊2 Centers for Disease Control and Prevention. Number (in millions) of civilian, noninstitutionalized persons with diagnosed diabetes, United States, 1980–2011. http://www.cdc.gov/diabetes/statistics/prev/national/figpersons.htm. March 28, 2013. Accessed May 3, 2015.
＊3 Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29.
＊4 Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014.
＊5 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊6 2014 Statistics Report. Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html. Updated October 24, 2014. Accessed March 3, 2015.
＊7 Lempainen J, Tauriainen S, Vaarala O, et al. Interaction of enterovirus infection and cow’s milkbased formula nutrition in type 1 diabetes-associated autoimmunity. Diabetes Metab Res Rev. 2012;28(2):177–85.
＊8 2014 Statistics Report. Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html. Updated October 24, 2014. Accessed March 3, 2015.
＊9 Rachek LI. Free fatty acids and skeletal muscle insulin Resistance. Prog Mol Biol Transl Sci. 2014;121:267–92.
＊10 2014 Statistics Report. Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html. Updated October 24, 2014. Accessed March 3, 2015.
＊11 Sweeney JS. Dietary factors that influence the dextrose tolerance test. Arch Intern Med. 1927;40(6):818–30.
＊12 Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin Resistance in humans. J Clin Invest. 1996;97(12):2859–65.
＊13 Roden M, Krssak M, Stingl H, et al. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes. 1999;48(2):358–64.
＊14 Santomauro AT, Boden G, Silva ME, et al. Overnight lowering of free fatty acids with Acipimox improves insulin Resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes. 1999;48(9):1836–41.
＊15 Krssak M, Falk Petersen K, Dresner A, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 1999;42(1): 113–6.
＊16 Lee S, Boesch C, Kuk JL, Arslanian S. Effects of an overnight intravenous lipid infusion on intramyocellular lipid content and insulin sensitivity in African-American versus Caucasian adolescents. Metab Clin Exp. 2013;62(3):417–23.
＊17 Roden M, Krssak M, Stingl H, et al. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes. 1999;48(2):358–64.
＊18 Himsworth HP. Dietetic factors influencing the glucose tolerance and the activity of insulin. J Physiol (Lond). 1934;81(1):29–48.
＊19 Tabák AG1, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes. Lancet. 2012;379(9833):2279–90.
＊20 Pratley RE. The early treatment of type 2 diabetes. Am J Med. 2013;126(9 Suppl 1):S2–9.
＊21 Reinehr T. Type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2013;4(6):270–81.
＊22 Pihoker C, Scott CR, Lensing SY, Cradock MM, Smith J. Non-insulin dependent diabetes mellitus in African-American youths of Arkansas. Clin Pediatr (Phila). 1998;37(2):97–102.
＊23 Dean H, Flett B. Natural history of type 2 diabetes diagnosed in childhood: long term follow-up in young adult years. Diabetes. 2002;51(s1):A24.
＊24 Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics. 2005;116(2):473–80.
＊25 Rocchini AP. Childhood obesity and a diabetes epidemic. N Engl J Med. 2002;346(11):854–5.
＊26 Lifshitz F. Obesity in children. J Clin Res Pediatr Endocrinol. 2008;1(2):53–60.
＊27 Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992;327(19):1350–5.
＊28 Sabaté J, Wien M. Vegetarian diets and childhood obesity prevention. Am J Clin Nutr. 2010;91(5):1525S–1529S.
＊29 Tonstad S, Butler T, Yan R, Fraser GE. Type of vegetarian diet, body weight, and prevalence of type 2 diabetes. Diabetes Care. 2009;32(5):791–6.
＊30 Sabaté J, Lindsted KD, Harris RD, Sanchez A. Attained height of lacto-ovo vegetarian children and adolescents. Eur J Clin Nutr. 1991;45(1):51–8.
＊31 Sabaté J, Wien M. Vegetarian diets and childhood obesity prevention. Am J Clin Nutr. 2010;91(5):1525S–1529S.
＊32 Cali AM, Caprio S. Prediabetes and type 2 diabetes in youth: an emerging epidemic disease? Curr Opin Endocrinol Diabetes Obes. 2008;15(2):123–7.
＊33 Ginter E, Simko V. Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol. 2012;771:42–50.
＊34 Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453(7196):783–7.
＊35 Roden M. How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci. 2004;19:92–6.
＊36 Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases? Am J Clin Nutr. 2009;89(5):1607S–1612S.
＊37 Tonstad S, Stewart K, Oda K, Batech M, Herring RP, Fraser GE. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis. 2013;23(4):292–9.
＊38 Nolan CJ, Larter CZ. Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it? J Gastroenterol Hepatol. 2009;24(5):703–6.
＊39 Evans WJ. Oxygen-carrying proteins in meat and risk of diabetes mellitus. JAMA Intern Med. 2013;173(14):1335–6.
＊40 Egnatchik RA, Leamy AK, Jacobson DA, Shiota M, Young JD. ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload. Mol Metab. 2014;3(5):544–53.
＊41 Estadella D, da Penha Oller do Nascimento CM, Oyama LM, Ribeiro EB, Dâmaso AR, de Piano A. Lipotoxicity: effects of dietary saturated and transfatty acids. Mediators Inflamm. 2013;2013:137579.
＊42 Perseghin G, Scifo P, De Cobelli F, et al. Intramyocellular triglyceride content is a determinant of in vivo insulin Resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes. 1999;48(8):1600–6.
＊43 Nolan CJ, Larter CZ. Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it? J Gastroenterol Hepatol. 2009;24(5):703–6.
＊44 Goff LM, Bell JD, So PW, Dornhorst A, Frost GS. Veganism and its relationship with insulin Resistance and intramyocellular lipid. Eur J Clin Nutr. 2005;59(2):291–8.
＊45 Gojda J, Patková J, Jaček M, et al. Higher insulin sensitivity in vegans is not associated with higher mitochondrial density. Eur J Clin Nutr. 2013;67(12):1310–5.
＊46 Goff LM, Bell JD, So PW, Dornhorst A, Frost GS. Veganism and its relationship with insulin Resistance and intramyocellular lipid. Eur J Clin Nutr. 2005;59(2):291–8.
＊47 Papanikolaou Y, Fulgoni VL. Bean consumption is associated with greater nutrient intake, reduced systolic blood pressure, lower body weight, and a smaller waist circumference in adults: results from the National Health and Nutrition Examination Survey 1999–2002. J Am Coll Nutr. 2008;27(5):569–76.
＊48 Mollard RC, Luhovyy BL, Panahi S, Nunez M, Hanley A, Anderson GH. Regular consumption of pulses for 8 weeks reduces metabolic syndrome risk factors in overweight and obese adults. Br J Nutr. 2012;108 Suppl 1:S111–22.
＊49 Cnop M, Hughes SJ, Igoillo-Esteve M, et al. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia. 2010;53(2):321–30.
＊50 Taylor R. Banting Memorial lecture 2012: reversing the twin cycles of type 2 diabetes. Diabet Med. 2013;30(3):267–75.
＊51 Cunha DA, Igoillo-Esteve M, Gurzov EN, et al. Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis. Diabetes. 2012;61(11):2763–75.
＊52 Cnop M, Hannaert JC, Grupping AY, Pipeleers DG. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology. 2002;143(9):3449–53.
＊53 Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 2003;52(3):726–33.
＊54 Xiao C, Giacca A, Carpentier A, Lewis GF. Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia. 2006;49(6):1371–9.
＊55 Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2003;78(1):91–8.
＊56 Cunha DA, Igoillo-Esteve M, Gurzov EN, et al. Death protein 5 and p53-upregulated modulator of apoptosis mediate the endoplasmic reticulum stress-mitochondrial dialog triggering lipotoxic rodent and human β-cell apoptosis. Diabetes. 2012;61(11):2763–75.
＊57 Welch RW. Satiety: have we neglected dietary non-nutrients? Proc Nutr Soc. 2011;70(2):145–54.
＊58 Barnard ND, Cohen J, Jenkins DJ, et al. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care. 2006;29(8):1777–83.
＊59 Trapp CB, Barnard ND. Usefulness of vegetarian and vegan diets for treating type 2 diabetes. Curr Diab Rep. 2010;10(2):152–8.
＊60 Pratley RE. The early treatment of type 2 diabetes. Am J Med. 2013;126(9 Suppl 1):S2–9.
＊61 Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Type 2 diabetes as a “coronary heart disease equivalent”: an 18-year prospective population-based study in Finnish subjects. Diabetes Care. 2005;28(12):2901–7.
＊62 Kahleova H, Matoulek M, Malinska H, et al. Vegetarian diet improves insulin Resistance and oxidative stress markers more than conventional diet in subjects with type 2 diabetes. Diabet Med. 2011;28(5):549–59.
＊63 Ornish D. Statins and the soul of medicine. Am J Cardiol. 2002;89(11):1286–90.
＊64 Kahleova H, Hrachovinova T, Hill M, et al. Vegetarian diet in type 2 diabetes-improvement in quality of life, mood and eating behaviour. Diabet Med. 2013;30(1):127–9.
＊65 Chiu THT, Huang HY, Chiu YF, et al. Taiwanese vegetarians and omnivores: dietary composition, prevalence of diabetes and IFG. PLoS ONE. 2014;9(2):e88547.
＊66 Chiu THT, Huang HY, Chiu YF, et al. Taiwanese vegetarians and omnivores: dietary composition, prevalence of diabetes and IFG. PLoS ONE. 2014;9(2):e88547.
＊67 Farmer B, Larson BT, Fulgoni VL III, et al. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the National Health and Nutrition Examination Survey 1999–2004. J Am Diet Assoc. 2011;111(6):819–27.
＊68 Farmer B, Larson BT, Fulgoni VL III, et al. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the National Health and Nutrition Examination Survey 1999–2004. J Am Diet Assoc. 2011;111(6):819–27.
＊69 Toth MJ, Poehlman ET. Sympathetic nervous system activity and resting metabolic rate in vegetarians. Metabolism. 1994;43(5):621–5.
＊70 Karlic H, Schuster D, Varga F, et al. Vegetarian diet affects genes of oxidative metabolism and collagen synthesis. Ann Nutr Metab. 2008;53(1):29–32.
＊71 Vergnaud AC, Norat T, Romaguera D, et al. Meat consumption and prospective weight change in participants of the EPIC-PANACEA study. Am J Clin Nutr. 2010;92(2):398–407.
＊72 The Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.
＊73 The Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.
＊74 Luan FL, Nguyen K. Intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(14):1519–20.
＊75 Blagosklonny MV. Prospective treatment of age-related diseases by slowing down aging. Am J Pathol. 2012;181(4):1142–6.
＊76 Madonna R, PandolfiA, Massaro M, et al. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004;47(3):532–6.
＊77 Lingvay I, Guth E, Islam A, et al. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care. 2013;36(9):2741–7.
＊78 Lingvay I, Guth E, Islam A, et al. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care. 2013;36(9):2741–7.
＊79 Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36(4):1047–55.
＊80 Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506–14.
＊81 Taheri S, Tahrani A, Barnett A. Bariatric surgery: a cure for diabetes? Pract Diabetes Int. 2009;26:356–8.
＊82 Vergnaud AC, Norat T, Romaguera D, et al. Meat consumption and prospective weight change in participants of the EPIC-PANACEA study. Am J Clin Nutr. 2010;92(2):398–407.
＊83 Gilsing AM, Weijenberg MP, Hughes LA, et al. Longitudinal changes in BMI in older adults are associated with meat consumption differentially, by type of meat consumed. J Nutr. 2012;142(2):340–9.
＊84 Wang Y, Lehane C, Ghebremeskel K, et al. Modern organic and broiler chickens sold for human consumption provide more energy from fat than protein. Public Health Nutr. 2010;13(3): 400–8.
＊85 National Cattlemen’s Beef Association, Young MK, Redson BA. New USDA data show 29 beef cuts now meet government guidelines for lean. http://www.beef.org/udocs/29leancuts.pdf. 2005. Accessed March 6, 2015.
＊86 Steven S, Lim EL, Taylor R. Dietary reversal of type 2 diabetes motivated by research knowledge. Diabet Med. 2010;27(6):724–5.
＊87 Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia. 2008;51(10):1781–9.
＊88 American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care. 2015;38(suppl 1):S1– S93.
＊89 Dunaief DM, Fuhrman J, Dunaief JL, et al. Glycemic and cardiovascular parameters improved in type 2 diabetes with the high nutrient density (HND) diet. Open Journal of Preventive Medicine. 2012;2(3):364–71.
＊90 Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506–14.
＊91 Steven S, Lim EL, Taylor R. Population response to information on reversibility of Type 2 diabetes. Diabet Med. 2013;30(4):e135–8.
＊92 Dunaief DM, Fuhrman J, Dunaief JL, et al. Glycemic and cardiovascular parameters improved in type 2 diabetes with the high nutrient density (HND) diet. Open J Prev Med. 2012;2(3):364–71.
＊93 Anderson JW, Ward K. High-carbohydrate, high-fiber diets for insulin-treated men with diabetes mellitus. Am J Clin Nutr. 1979;32(11):2312–21.
＊94 Anderson JW, Ward K. High-carbohydrate, high-fiber diets for insulin-treated men with diabetes mellitus. Am J Clin Nutr. 1979;32(11):2312–21.
＊95 Callaghan BC, Cheng H, Stables CL, et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521–34.
＊96 Said G. Diabetic neuropathy-a review. Nat Clin Pract Neurol. 2007;3(6):331–40.
＊97 Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.
＊98 Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.
＊99 Rabinowitch IM. Effects of the high carbohydrate-low calorie diet upon carbohydrate tolerance in diabetes mellitus. Can Med Assoc J. 1935;33(2):136–44.
＊100 Newborg B, Kempner W. Analysis of 177 cases of hypertensive vascular disease with papilledema; one hundred twenty-six patients treated with rice diet. Am J Med. 1955;19(1):33–47.
＊101 Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.
＊102 Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.
＊103 Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.
＊104 Crane MG, Zielinski R, Aloia R. Cis and trans fats in omnivores, lacto-ovo vegetarians and vegans. Am J Clin Nutr. 1988;48:920.
＊105 Tesfaye S, Chaturvedi N, Eaton SEM, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–50.
＊106 Newrick PG, Wilson AJ, Jakubowski J, et al. Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed). 1986;293(6554):1053–4.
＊107 McCarty MF. Favorable impact of a vegan diet with exercise on hemorheology: implications for control of diabetic neuropathy. Med Hypotheses. 2002;58(6):476–86.
＊108 Kempner W, Peschel RL, Schlayer C. Effect of rice diet on diabetes mellitus associated with vascular disease. Postgrad Med. 1958;24(4):359–71.
＊109 McCarty MF. Favorable impact of a vegan diet with exercise on hemorheology: implications for control of diabetic neuropathy. Med Hypotheses. 2002;58(6):476–86.
＊110 Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014. http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html. Updated October 24, 2014. Accessed March 6, 2015.
＊111 Nathan DM, Davidson MB, Defronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753–9.
＊112 Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care. 2010;33(11):2355–9.
＊113 Cardona-Morrell M, Rychetnik L, Morrell SL, Espinel PT, Bauman A. Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis. BMC Public Health. 2010;10:653.
＊114 Holman H. Chronic disease—the need for a new clinical education. JAMA. 2004;292(9):1057–9.
＊115 Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, D.C.: The National Academies Press, 2001:213. http://www.iom.edu/Reports/2001/Crossing-the-Quality-Chasm-A-New-Health-System-for-the-21st-Century.aspx.
◆７ 高血圧で死なないために
＊1 Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.
＊2 Das P, Samarasekera U. The story of GBD 2010: a “super-human” effort. Lancet. 2012;380 (9859):2067–70.
＊3 Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
＊4 Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
＊5 Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
＊6 Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013;15(3):134–6.
＊7 Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
＊8 American Heart Association. Understanding Blood Pressure Readings. http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/AboutHighBloodPressure/Understanding-Blood-Pressure-Readings_UCM_301764_Article.jsp. March 11, 2015. Accessed March 11, 2015.
＊9 Go AS, Bauman MA, Coleman King SM, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63(12):1230–8.
＊10 Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;(133):1–8.
＊11 Walker AR, Walker BF. High high-density-lipoprotein cholesterol in African children and adults in a population free of coronary heart disease. Br Med J. 1978;2(6148):1336–7.
＊12 Donnison CP. Blood pressure in the African native. Lancet. 1929;213(5497):6–7.
＊13 Macmahon S, Neal B, Rodgers A. Hypertension-time to move on. Lancet. 2005;365(9464):1108–9.
＊14 Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
＊15 Donnison CP. Blood pressure in the African native. Lancet. 1929;213(5497):6–7.
＊16 Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
＊17 Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
＊18 Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006;49(2):59–75.
＊19 Delahaye F. Should we eat less salt? Arch Cardiovasc Dis. 2013;106(5):324–32.
＊20 Jenkins DJ, Kendall CW. The garden of Eden: plant-based diets, the Genetic drive to store fat and conserve cholesterol, and implications for epidemiology in the 21st century. Epidemiology. 2006;17(2):128–30.
＊21 Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
＊22 Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
＊23 Celermajer DS, Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013;61(3):344–5.
＊24 Whelton PK, Appel LJ, Sacco RL, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126(24):2880–9.
＊25 Centers for Disease Control and Prevention. Sodium intake among adults-United States, 2005–2006. MMWR Morb Mortal Wkly Rep. 2010;59(24):746–9.
＊26 Bea glehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47.
＊27 Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III-Analysis of data from trials of salt reduction. BMJ. 1991;302(6780):819–24.
＊28 Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18;362(7):590–9.
＊29 MacGregor GA, Markandu ND, Best FE, et al. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet. 1982;1(8268):351–5.
＊30 MacGregor GA, Markandu ND, Sagnella GA, Singer DR, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989;2(8674):1244–7.
＊31 MacGregor GA, Markandu ND, Sagnella GA, Singer DR, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989;2(8674):1244–7.
＊32 Rudelt A, French S, Harnack L. Fourteen-year trends in sodium content of menu offerings at eight leading fast-food restaurants in the USA. Public Health Nutr. 2014;17(8):1682–8.
＊33 Suckling RJ, He FJ, Markandu ND, MacGregor GA. Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int. 2012;81(4):407–11.
＊34 He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346:f1325.
＊35 Celermajer DS, Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013;61(3):344–5.
＊36 Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a “no-salt” culture. Circulation. 1975;52(1):146–51.
＊37 Mancilha-Carvalho J de J, de Souza e Silva NA. The Yanomami Indians in the INTERSALT Study. Arq Bras Cardiol. 2003;80(3):289–300.
＊38 Celermajer DS, Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013;61(3):344–5.
＊39 Mancilha-Carvalho J de J, de Souza e Silva NA. The Yanomami Indians in the INTERSALT Study. Arq Bras Cardiol. 2003;80(3):289–300.
＊40 Mancilha-Carvalho J de J, Crews DE. Lipid profiles of Yanomamo Indians of Brazil. Prev Med. 1990;19(1):66–75.
＊41 Kempner W. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet. Ann Intern Med. 1949;31(5):821–56.
＊42 Klemmer P, Grim CE, Luft FC. Who and what drove Walter Kempner? The rice diet revisited. Hypertension. 2014;64(4):684–8.
＊43 Kempner W. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet. Ann Intern Med. 1949;31(5):821–56.
＊44 Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
＊45 Dickinson KM, Clifton PM, Keogh JB. Endothelial function is impaired after a high-salt meal in healthy subjects. Am J Clin Nutr. 2011;93(3):500–5.
＊46 DuPont JJ, Greaney JL, Wenner MM, et al. High dietary sodium intake impairs endotheliumdependent dilation in healthy salt-resistant humans. J Hypertens. 2013;31(3):530–6.
＊47 Dickinson KM, Clifton PM, Keogh JB. Endothelial function is impaired after a high-salt meal in healthy subjects. Am J Clin Nutr. 2011;93(3):500–5.
＊48 Greaney JL, DuPont JJ, Lennon-Edwards SL, Sanders PW, Edwards DG, Farquhar WB. Dietary sodium loading impairs microvascular function independent of blood pressure in humans: role of oxidative stress. J Physiol (Lond). 2012;590(Pt 21):5519–28.
＊49 Jablonski KL, Racine ML, Geolfos CJ, et al. Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure. J Am Coll Cardiol. 2013;61(3):335–43.
＊50 McCord JM. Analysis of superoxide dismutase activity. Curr Protoc Toxicol. 1999;Chapter 7:Unit 7.3.
＊51 Dickinson KM, Clifton PM, Burrell LM, Barrett PHR, Keogh JB. Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of Nitric Oxide production and markers of endothelial function. Atherosclerosis. 2014;232(1):211–6.
＊52 Huang Ti Nei Ching Su Wua [The Yellow Emperor’s Classic of Internal Medicine] (Veith I, Trans.) Oakland, CA: University of California Press; 1972:141.
＊53 Hanneman RL, Satin M. Comments to the Dietary Guidelines Committee on behalf of the Salt Institute. Comment ID: 000447. April 23, 2009.
＊54 Vital signs: food categories contributing the most to sodium consumption-United States, 2007–2008. MMWR Morb Mortal Wkly Rep. 2012;61(5):92–8.
＊55 Miller GD. Comments to the Dietary Guidelines Committee on behalf of the National Dairy Council, July 27, 2009.
＊56 Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
＊57 MacGregor G, de Wardener HE. Salt, blood pressure and health. Int J Epidemiol. 2002;31(2):320–7.
＊58 Appel LJ, Anderson CAM. Compelling evidence for public health action to reduce salt intake. N Engl J Med. 2010;362(7):650–2.
＊59 Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
＊60 Buying this chicken? Consum Rep. June 2008;7.
＊61 Drewnowski A, Rehm CD. Sodium intakes of US children and adults from foods and beverages by location of origin and by specific food source. Nutrients. 2013;5(6):1840–55.
＊62 U.S. Department of Agriculture, Agricultural Research Service. 2014. USDA National Nutrient Database for Standard Reference, Release 27. Pizza Hut 14″ pepperoni pizza, pan crust. http://ndb.nal.usda.gov/ndb/foods/show/6800. Accessed March 22, 2015.
＊63 Drewnowski A, Rehm CD. Sodium intakes of US children and adults from foods and beverages by location of origin and by specific food source. Nutrients. 2013;5(6):1840–55.
＊64 Blais CA, Pangborn RM, Borhani NO, Ferrell MF, Prineas RJ, Laing B. Effect of dietary sodium restriction on taste responses to sodium chloride: a longitudinal study. Am J Clin Nutr. 1986;44(2):232–43.
＊65 Tucker RM, Mattes RD. Are free fatty acids effective taste stimuli in humans? Presented at the symposium “The Taste for Fat: New Discoveries on the Role of Fat in Sensory Perception, Metabolism, Sensory Plea sure and Beyond” held at the Institute of Food Technologists 2011 Annual Meeting, New Orleans, LA, June 12, 2011. J Food Sci. 2012;77(3):S148–51.
＊66 Grieve FG, Vander Weg MW. Desire to eat high-and low-fat foods following a low-fat dietaryintervention. J Nutr Educ Behav. 2003;35(2):98–102.
＊67 Stewart JE, Newman LP, Keast RS. Oral sensitivity to oleic acid is associated with fat intake and body mass index. Clin Nutr. 2011;30(6):838–44.
＊68 Stewart JE, Keast RS. Recent fat intake modulates fat taste sensitivity in lean and overweight subjects. Int J Obes (Lond). 2012;36(6):834–42.
＊69 Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
＊70 Newson RS, Elmadfa I, Biro G, et al. Barriers for progress in salt reduction in the general population. An international study. Appetite. 2013;71:22–31.
＊71 Cappuccio FP, Capewell S, Lincoln P, McPherson K. Policy options to reduce population salt intake. BMJ. 2011;343:d4995.
＊72 Toldrá F, Barat JM. Strategies for salt reduction in foods. Recent Pat Food Nutr Agric. 2012;4(1):19–25.
＊73 Lin B-H, Guthrie J. Nutritional Quality of Food Prepared at Home and Away from Home, 1977–2008. USDA, Economic Research Service, December 2012.
＊74 Newson RS, Elmadfa I, Biro G, et al. Barriers for progress in salt reduction in the general population. An international study. Appetite. 2013;71:22–31.
＊75 Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.
＊76 U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th Edition, Washington, D.C.: US Government Printing Office, December 2010.
＊77 Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006;49(2):59–75.
＊78 Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
＊79 Tighe P, Duthie G, Vaughan N, et al. Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial. Am J Clin Nutr. 2010;92(4):733–40.
＊80 Diaconu CC, Balaceanu A, Bartos D. Diuretics, first-line antihypertensive agents: are they always safe in the elderly? Rom J Intern Med. 2014;52(2):87–90.
＊81 Li CI, Daling JR, Tang MT, Haugen KL, Porter PL, Malone KE. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Intern Med. 2013;173(17):1629–37.
＊82 Kaiser EA, Lotze U, Schiser HH. Increasing complexity: which drug class to choose for treatment of hypertension in the elderly? Clin Interv Aging. 2014;9:459–75.
＊83 Rasmussen ER, Mey K, Bygum A. Angiotensin-converting enzyme inhibitor-induced angioedema-a dangerous new epidemic. Acta Derm Venereol. 2014;94(3):260–4.
＊84 Tinetti ME, Han L, Lee DS, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–95.
＊85 Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142(7):1304–13.
＊86 Aune D, Chan DS, Lau R, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011;343:d6617.
＊87 Tighe P, Duthie G, Vaughan N, et al. Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial. Am J Clin Nutr. 2010;92(4):733–40.
＊88 Sun Q, Spiegelman D, van Dam RM, et al. White rice, brown rice, and risk of type 2 diabetes in US men and women. Arch Intern Med. 2010;170(11):961–9.
＊89 Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142(7):1304–13.
＊90 Mellen PB, Liese AD, Tooze JA, Vitolins MZ, Wagenknecht LE, Herrington DM. Whole-grain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr. 2007;85(6):1495–502.
＊91 Erkkilä AT, Herrington DM, Mozaffarian D, et al. Cereal fiber and whole-grain intake are associated with reduced progession of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease. Am Heart J. 2005;150(1):94–101.
＊92 Go AS, Bauman MA, Coleman King SM, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63(12):1230–8.
＊93 Mahmud A, Feely J. Low-dose quadruple antihypertensive combination: more efficacious than individual agents-a preliminary report. Hypertension. 2007;49(2):272–5.
＊94 Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM. Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation. 2011;123(15):1611–21.
＊95 Messerli FH, Bangalore S. Half a century of hydrochlorothiazide: facts, fads, fiction, and follies. Am J Med. 2011;124(10):896–9.
＊96 Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention ofcardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
＊97 Donnison CP. Blood pressure in the African native. Lancet. 1929;213(5497):6–7.
＊98 Morse WR, McGill MD, Beh YT. Blood pressure amongst aboriginal ethnic groups of Szechwan Province, West China. Lancet. 1937;229(5929):966–8.
＊99 Sacks FM, Kass EH. Low blood pressure in vegetarians: effects of specific foods and nutrients. Am J Clin Nutr. 1988;48(3 Suppl):795–800.
＊100 Go AS, Bauman MA, Coleman King SM, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63(12): 1230–8.
＊101 Sharma AM, Schorr U. Dietary patterns and blood pressure. N Engl J Med. 1997;337(9):637.
＊102 Chen Q, Turban S, Miller ER, Appel LJ. The effects of dietary patterns on plasma renin activity: results from the Dietary Approaches to Stop Hypertension trial. J Hum Hypertens. 2012;26(11):664–9.
＊103 Sacks FM, Rosner B, Kass EH. Blood pressure in vegetarians. Am J Epidemiol. 1974;100(5):390–8.
＊104 Donaldson AN. The relation of protein foods to hypertension. Cal West Med. 1926;24(3):328–31.
＊105 Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47(2):296–308.
＊106 Sacks FM, Obarzanek E, Windhauser MM, et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol. 1995;5(2):108–18.
＊107 Karanja NM, Obarzanek E, Lin PH, et al. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension trial. DASH Collaborative Research Group. J Am Diet Assoc. 1999;99(8 Suppl):S19–27.
＊108 Sacks FM, Kass EH. Low blood pressure in vegetarians: effects of specific foods and nutrients. Am J Clin Nutr. 1988;48(3 Suppl):795–800.
＊109 de Paula TP, Steemburgo T, de Almeida JC, Dall’Alba V, Gross JL, de Azevedo MJ. The role of Dietary Approaches to Stop Hypertension (DASH) diet food groups in blood pressure in type 2 diabetes. Br J Nutr. 2012;108(1):155–62.
＊110 Yokoyama Y, Nishimura K, Barnard ND, et al. Vegetarian diets and blood pressure: a metaanalysis. JAMA Intern Med. 2014;174(4):577–87.
＊111 Le LT, Sabaté J. Beyond meatless, the health effects of vegan diets: findings from the Adventist cohorts. Nutrients. 2014;6(6):2131–47.
＊112 Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases? Am J Clin Nutr. 2009;89(5):1607S–1612S.
＊113 Tonstad S, Stewart K, Oda K, Batech M, Herring RP, Fraser GE. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis. 2013;23(4):292–9.
＊114 Fraser GE. Vegetarian diets: what do we know of their effects on common chronic diseases? Am J Clin Nutr. 2009;89(5):1607S–1612S.
＊115 Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term low-calorie low-protein vegan diet and endurance exercise are associated with low cardiometabolic risk. Rejuvenation Res. 2007;10(2):225–34.
＊116 Akhtar S, Ismail T, Riaz M. Flaxseed-a miraculous defense against some critical maladies. Pak J Pharm Sci. 2013;26(1):199–208.
＊117 Rodriguez-Leyva D, Weighell W, Edel AL, et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013;62(6):1081–9.
＊118 Ninomiya T, Perkovic V, Turnbull F, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013;347:f5680.
＊119 Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. Flax and flaxseed oil: an ancient medicine & modern functional food. J Food Sci Technol. 2014;51(9):1633–53.
＊120 Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010;9:3.
＊121 Frank T, Netzel G, Kammerer DR, et al. Consumption of Hibiscus sabdariffa L. aqueous extract and its impact on systemic antioxidant potential in healthy subjects. J Sci Food Agric. 2012;92(10):2207–18.
＊122 Chang HC, Peng CH, Yeh DM, Kao ES, Wang CJ. Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans. Food Funct. 2014;5(4):734–9.
＊123 Mozaffari-Khosravi H, Jalali-Khanabadi BA, Afkhami-Ardekani M, Fatehi F. Effects of sourtea (Hibiscus sabdariffa) on lipid profile and lipoproteins in patients with type II diabetes. J Altern Complement Med. 2009;15(8):899–903.
＊124 Aziz Z, Wong SY, Chong NJ. Effects of Hibiscus sabdariffa L. on serum lipids: a systematic review and meta-analysis. J Ethnopharmacol. 2013;150(2):442–50.
＊125 Lin T-L. Lin H-H, Chen C-C, et al. Hibiscus sabdariffa extract reduces serum cholesterol in men and women. Nutr Res. 2007;27:140–5.
＊126 Hopkins AL, Lamm MG, Funk JL, Ritenbaugh C. Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies. Fitoterapia. 2013;85:84–94.
＊127 McKay DL, Chen CY, Saltzman E, Blumberg JB. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr. 2010;140(2):298–303.
＊128 Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52.
＊129 McKay DL, Chen CY, Saltzman E, Blumberg JB. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr. 2010;140(2):298–303.
＊130 Herrera-Arellano A, Flores-Romero S, Chávez-Soto MA, Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine. 2004;11(5):375–82.
＊131 US Food and Drug Administration. CAPOTEN® (Captopril Tablets, USP) http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018343s084lbl.pdf. Accessed March 19, 2015.
＊132 Hendricks JL, Marshall TA, Harless JD, Hogan MM, Qian F, Wefel JS. Erosive potentials of brewed teas. Am J Dent. 2013;26(5):278–82.
＊133 Malik J, Frankova A, Drabek O, Szakova J, Ash C, Kokoska L. Aluminium and other elements in selected herbal tea plant species and their infusions. Food Chem. 2013;139(1–4):728–34.
＊134 Förstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem. 2006;387(12):1521–33.
＊135 Franzini L, Ardigò D, Valtueña S, et al. Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population. Nutr Metab Cardiovasc Dis. 2012;22(1):50–7.
＊136 Webb AJ, Patel N, Loukogeorgakis S, et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension. 2008;51(3):784–90.
＊137 Smith RE, Ashiya M. Antihypertensive therapies. Nat Rev Drug Discov. 2007;6(8):597–8.
＊138 Kapil V, Khambata RS, Robertson A, Caulfield MJ, Ahluwalia A. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, doubleblind, placebo-controlled study. Hypertension. 2015;65(2):320–7.
＊139 Wylie LJ, Kelly J, Bailey SJ, et al. Beetroot juice and exercise: pharmacodynamic and doseresponse relationships. J Appl Physiol. 2013;115(3):325–36.
＊140 European Food Safety Authority. Nitrate in vegetables: scientific opinion of the panel on contaminants in the food chain. EFSA J. 2008;689:1–79.
＊141 Murphy M, Eliot K, Heuertz RM, Weiss E. Whole beetroot consumption acutely improves running performance. J Acad Nutr Diet. 2012;112(4):548–52.
＊142 Clements WT, Lee SR, Bloomer RJ. Nitrate ingestion: a review of the health and physical performance effects. Nutrients. 2014;6(11):5224–64.
＊143 Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr. 2009;90(1):1–10.
＊144 Bhupathiraju SN, Wedick NM, Pan A, et al. Quantity and variety in fruit and vegetable intake and risk of coronary heart disease. Am J Clin Nutr. 2013;98(6):1514–23.
＊145 Tamakoshi A, Tamakoshi K, Lin Y, Yagyu K, Kikuchi S. Healthy lifestyle and preventable death: findings from the Japan Collaborative Cohort (JACC) Study. Prev Med. 2009;48(5):486–92.
＊146 Wang F, Dai S, Wang M, Morrison H. Erectile dysfunction and fruit/vegetable consumption among diabetic Canadian men. Urology. 2013;82(6):1330–5.
＊147 Presley TD, Morgan AR, Bechtold E, et al. Acute effect of a high nitrate diet on brain perfusion in older adults. Nitric Oxide. 2011;24(1):34–42.
＊148 Engan HK, Jones AM, Ehrenberg F, Schagatay E. Acute dietary nitrate supplementation improves dry static apnea performance. Respir Physiol Neurobiol. 2012;182(2–3):53–9.
＊149 Bailey SJ, Winyard P, Vanhatalo A, et al. Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol. 2009;107(4):1144–55.
＊150 Murphy M, Eliot K, Heuertz RM, Weiss E. Whole beetroot consumption acutely improves running performance. J Acad Nutr Diet. 2012;112(4):548–52.
＊151 Lidder S, Webb AJ. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Br J Clin Pharmacol. 2013;75(3):677–96.
＊152 Wylie LJ, Kelly J, Bailey SJ, et al. Beetroot juice and exercise: pharmacodynamic and dose-response relationships. J Appl Physiol. 2013;115(3):325–36.
◆８ 肝臓疾患で死なないために
＊1 Chiras, DD. Human Biology. Burlington, MA: Jones & Bartlett Learning; 2015.
＊2 Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).
＊3 National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER stat fact sheets: liver and intrahepatic bile duct cancer. http://seer.cancer.gov/statfacts/html/livibd.html. Accessed May 3, 2015.
＊4 Holubek WJ, Kalman S, Hoffman RS. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2006;43(4):880.
＊5 Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–45.
＊6 CDC Morbidity and Mortality Weekly Report. Alcohol-attributable deaths and years of potential life l— United States, 2001. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5337a2.htm. September 24, 2004. Accessed March 2, 2015.
＊7 Centers for Disease Control and Prevention. Fact sheets-alcohol use and your health. http://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm. November 7, 2014. Accessed March 2, 2015.
＊8 Schwartz JM, Reinus JF. Prevalence and natural history of alcoholic liver disease. Clin Liver Dis. 2012;16(4):659–66.
＊9 Lane BP, Lieber CS. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Am J Pathol. 1966;49(4):593–603.
＊10 Mendenhall CL. Anabolic ste roid therapy as an adjunct to diet in alcoholic hepatic steatosis. Am J Dig Dis. 1968;13(9):783–91.
＊11 O’Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology. 2010;51(1):307–28.
＊12 Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004;24(3):217–32.
＊13 Galambos JT. Natural history of alcoholic hepatitis. 3. Histological changes. Gastroenterology. 1972;63(6):1026–35.
＊14 Woerle S, Roeber J, Landen MG. Prevalence of alcohol dependence among excessive drinkers in New Mexico. Alcohol Clin Exp Res. 2007;31(2):293–8.
＊15 Kaskutas LA. Alcoholics anonymous effectiveness: faith meets science. J Addict Dis. 2009;28(2):145–57.
＊16 Kechagias S, Ernersson å, Dahlqvist O, et al. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut. 2008;57(5):649–54.
＊17 McCarthy EM, Rinella ME. The role of diet and nutrient composition in nonalcoholic fatty liver disease. J Acad Nutr Diet. 2012;112(3):401–9.
＊18 Silverman JF, Pories WJ, Caro JF. Liver pathology in diabetes mellitus and morbid obesity: clinical, pathological and biochemical considerations. Pathol Annu. 1989;24:275–302.
＊19 Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2014;S1542–3565(14):00602–8.
＊20 Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007;47(5):711–7.
＊21 Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007;47(5):711–7.
＊22 Longato L. Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar? Fibrogenesis Tissue Repair. 2013;6(1):14.
＊23 Musso G, Gambino R, De Michieli F, et al. Dietary habits and their relations to insulin Resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003;37(4):909–16.
＊24 Kontogianni MD, Tileli N, Margariti A, et al. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr. 2014;33(4):678–83.
＊25 Kim EJ, Kim BH, Seo HS, et al. Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation. PLoS ONE. 2014;9(6):e97841.
＊26 Yasutake K, Nakamuta M, Shima Y, et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol. 2009;44(4):471–7.
＊27 Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease. Nature. 2010;464(7293):1357–61.
＊28 Ioannou GN, Haigh WG, Thorning D, Savard C. Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J Lipid Res. 2013;54(5):1326–34.
＊29 U.S. Department of Agriculture Agricultural Research Service. National Nutrient Database for Standard Reference Release 27. Basic Report: 21359, McDonald’s, sausage McMuffin with egg. http://ndb.nal.usda.gov/ndb/foods/show/6845. Accessed March 2, 2015.
＊30 Ioannou GN, Morrow OB, Connole ML, Lee SP. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology. 2009;50(1):175–84.
＊31 National Institute of Diabetes and Digestive and Kidney Diseases. Liver transplantation. http://www.niddk.nih.gov/health-information/health-topics/liver-disease/liver-transplant/Pages/facts.aspx. June 2010. Accessed March 2, 2015.
＊32 Lock G, Dirscherl M, Obermeier F, et al. Hepatitis C-contamination of toothbrushes: myth or reality? J Viral Hepat. 2006;13(9):571–3.
＊33 Bocket L, Chevaliez S, Talbodec N, Sobaszek A, Pawlotsky JM, Yazdanpanah Y. Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicer. Clin Microbiol Infect. 2011;17(2):238–41.
＊34 Teo CG. Much meat, much malady: changing perceptions of the epidemiology of hepatitis E. Clin Microbiol Infect. 2010;16(1):24–32.
＊35 Yazaki Y, Mizuo H, Takahashi M, et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol. 2003;84(Pt 9):2351–7.
＊36 Feagins AR, Opriessnig T, Guenette DK, Halbur PG, Meng XJ. Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol. 2007;88(Pt 3):912–7.
＊37 Feagins AR, Opriessnig T, Guenette DK, Halbur PG, Meng XJ. Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol. 2007;88(Pt 3):912–7.
＊38 Dalton HR, Bendall RP, Pritchard C, Henley W, Melzer D. National mortality rates from chronic liver disease and consumption of alcohol and pig meat. Epidemiol Infect. 2010;138(2):174–82.
＊39 Emerson SU, Arankalle VA, Purcell RH. Thermal stability of hepatitis E virus. J Infect Dis. 2005 Sep 1;192(5):930–3.
＊40 Centers for Disease Control and Prevention. What can you do to protect yourself and your family from food poisoning? http://www.cdc.gov/foodsafety/prevention.html. September 6, 2013. Accessed March 11, 2015.
＊41 Shinde NR, Patil TB, Deshpande AS, Gulhane RV, Patil MB, Bansod YV. Clinical profile, maternal and fetal outcomes of acute hepatitis E in pregnancy. Ann Med Health Sci Res. 2014;4(Suppl 2):S133–9.
＊42 Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142(7):1304–13.
＊43 Karl JP, Saltzman E. The role of whole grains in body weight regulation. Adv Nutr. 2012;3(5):697–707.
＊44 Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142(7): 1304–13.
＊45 Chang H-C, Huang C-N, Yeh D-M, Wang S-J, Peng C-H, Wang C-J. Oat prevents obesity and abdominal fat distribution, and improves liver function in humans. Plant Foods Hum Nutr. 2013;68(1):18–23.
＊46 Chang H-C, Huang C-N, Yeh D-M, Wang S-J, Peng C-H, Wang C-J. Oat prevents obesity and abdominal fat distribution, and improves liver function in humans. Plant Foods Hum Nutr. 2013;68(1):18–23.
＊47 Georgoulis M, Kontogianni MD, Tileli N, et al. The impact of cereal grain consumption on the development and severity of non-alcoholic fatty liver disease. Eur J Nutr. 2014;53(8):1727–35.
＊48 Arnesen E, Huseby N-E, Brenn T, Try K. The Tromse heart study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest. 1986;46(1):63–70.
＊49 Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology. 2005;129(6):1928–36.
＊50 Salgia R, Singal AG. Hepatocellular carcinoma and other liver lesions. Med Clin North Am. 2014;98(1):103–18.
＊51 Sang LX, Chang B, Li X-H, Jiang M. Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterol. 2013;13:34.
＊52 Lai GY, Weinstein SJ, Albanes D, et al. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer. 2013;109(5):1344–51.
＊53 Fujita Y, Shibata A, Ogimoto I, et al. The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer. 2006;94(5):737–9.
＊54 Danielsson J, Kangastupa P, Laatikainen T, Aalto M, Niemelä O. Dose-and gender-dependent interactions between coffee consumption and serum GGT activity in alcohol consumers. Alcohol Alcohol. 2013;48(3):303–7.
＊55 Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. Coffee reduces risk for hepatocellular carcinoma: an meta-analysis. Clin Gastroenterol Hepatol. 2013;11(11):1413–21.e1.
＊56 Cardin R, Piciocchi M, Martines D, Scribano L, Petracco M, Farinati F. Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial. Dig Liver Dis. 2013;45(6):499–504.
＊57 Torres DM, Harrison SA. Is it time to write a prescription for coffee? Coffee and liver disease. Gastroenterology. 2013;144(4):670–2.
＊58 Ng V, Saab S. Can daily coffee consumption reduce liver disease-related mortality? Clin Gastroenterol Hepatol. 2013;11(11):1422–3.
＊59 Torres DM, Harrison SA. Is it time to write a prescription for coffee? Coffee and liver disease. Gastroenterology. 2013;144(4):670–2.
＊60 Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl). 2004;176(1):1–29.
＊61 O’Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013;62(12):1043–51.
◆９ 血液がんで死なないために
＊1 Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol. 2012;30(14):1663–9.
＊2 National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Leukemia. http://seer.cancer.gov/statfacts/html/leuks.html. Accessed June 15, 2015.
＊3 American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
＊4 American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
＊5 American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
＊6 Key TJ, Appleby PN, Spencer EA, et al. Cancer incidence in British vegetarians. Br J Cancer. 2009;101(1):192–7.
＊7 Vegetarians less likely to develop cancer than meat eaters [news release]. London, UK: British Journal of Cancer; July 1, 2009. http://www.nature.com/bjc/press_releases/p_r_jul09_6605098.html. Accessed March 11, 2015.
＊8 Suppipat K, Park CS, Shen Y, Zhu X, Lacorazza HD. Sulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cells. PLoS ONE. 2012;7(12):e51251.
＊9 Han X, Zheng T, Foss F, et al. Vegetable and fruit intake and non-Hodgkin lymphoma survival in Connecticut women. Leuk Lymphoma. 2010;51(6):1047–54.
＊10 Thompson CA, Cerhan JR. Fruit and vegetable intake and survival from non-Hodgkin lymphoma: does an apple a day keep the doctor away? Leuk Lymphoma. 2010;51(6):963–4.
＊11 Thompson CA, Habermann TM, Wang AH, et al. Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin’s lymphoma: the Iowa Women’s Health Study. Int J Cancer. 2010;126(4):992–1003.
＊12 Holtan SG, O’Connor HM, Fredericksen ZS, et al. Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma. Int J Cancer. 2012;131(5):1158–68.
＊13 Holtan SG, O’Connor HM, Fredericksen ZS, et al. Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma. Int J Cancer. 2012;131(5):1158–68.
＊14 Thompson CA, Habermann TM, Wang AH, et al. Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin’s lymphoma: the Iowa Women’s Health Study. Int J Cancer. 2010;126(4):992–1003.
＊15 Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet. 2004;364(9441): 1219–28.
＊16 Jacobs DR, Tapsell LC. Food synergy: the key to a healthy diet. Proc Nutr Soc. 2013;72(2):200–6.
＊17 Elsayed RK, Glisson JK, Minor DS. Rhabdomyolysis associated with the use of a mislabeled “acai berry” dietary supplement. Am J Med Sci. 2011;342(6):535–8.
＊18 Zhang Y, Wang D, Lee RP, Henning SM, Heber D. Absence of pomegranate ellagitannins in the majority of commercial pomegranate extracts: implications for standardization and quality control. J Agric Food Chem. 2009;57(16):7395–400.
＊19 Zhang Y, Krueger D, Durst R, et al. International multidimensional authenticity specification (IMAS) algorithm for detection of commercial pomegranate juice adulteration. J Agric Food Chem. 2009;57(6):2550–7.
＊20 Del Pozo-Insfran D, Percival SS, Talcott ST. Açai (Euterpe oleracea Mart.) polyphenolics in their glycoside and aglycone forms induce apoptosis of HL-60 leukemia cells. J Agric Food Chem. 2006;54(4):1222–9.
＊21 Schauss AG, Wu X, Prior RL, et al. Antioxidant capacity and other bioactivities of the freezedried Amazonian palm berry, Euterpe oleraceae mart. (aSch). J Agric Food Chem. 2006;54(22):8604–10.
＊22 Jensen GS, Ager DM, Redman KA, Mitzner MA, Benson KF, Schauss AG. Pain reduction and improvement in range of motion after daily consumption of an açai (Euterpe oleracea Mart.) pulp-fortified polyphenolic-rich fruit and berry juice blend. J Med Food. 2011;14(7–8):702–11.
＊23 Udani JK, Singh BB, Singh VJ, Barrett ML. Effects of açai (Euterpe oleracea Mart.) berry preparation on metabolic parameters in a healthy overweight population: a pilot study. Nutr J. 2011;10:45.
＊24 Haytowitz DB, Bhagwat SA. USDA database for the oxygen radical capacity (ORAC) of selected foods, release 2. Washington, D.C.: United States Department of Agriculture; 2010.
＊25 American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society;2014.
＊26 Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113(22):5412–7.
＊27 Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113(22):5412–7.
＊28 Greenberg AJ, Vachon CM, Rajkumar SV. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia. 2012;26(4):609–14.
＊29 Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346(8):564–9.
＊30 Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 2003;101(3):1053–62.
＊31 Golombick T, Diamond TH, Badmaev V, Manoharan A, Ramakrishna R. The potential role of curcumin in patients with monoclonal gammopathy of undefined significance-its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker. Clin Cancer Res. 2009;15(18):5917–22.
＊32 Golombick T, Diamond TH, Manoharan A, Ramakrishna R. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, doubleblind placebo-controlled cross-over 4g study and an open-label 8g extension study. Am J Hematol. 2012;87(5):455–60.
＊33 Key TJ, Appleby PN, Spencer EA, et al. Cancer incidence in British vegetarians. Br J Cancer. 2009;101(1):192–7.
＊34 Rohrmann S, Linseisen J, Jakobsen MU, et al. Consumption of meat and dairy and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011;128(3):623–34.
＊35 U.S. Department of Agriculture Agricultural Research Service. National Nutrient Database for Standard Reference Release 27. Basic Report: 05358, Chicken, broiler, rotisserie, BBQ, breast meat and skin. http://ndb.nal.usda.gov/ndb/foods/show/1058. Accessed March 2, 2015.
＊36 Rohrmann S, Linseisen J, Jakobsen MU, et al. Consumption of meat and dairy and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011;128(3):623–34.
＊37 Chiu BC, Cerhan JR, Folsom AR, et al. Diet and risk of non-Hodgkin lymphoma in older women. JAMA. 1996;275(17):1315–21.
＊38 Daniel CR, Sinha R, Park Y, et al. Meat intake is not associated with risk of non-Hodgkin lymphoma in a large prospective cohort of U.S. men and women. J Nutr. 2012;142(6):1074–80.
＊39 Puangsombat K, Gadgil P, Houser TA, Hunt MC, Smith JS. Occurrence of heterocyclic amines in cooked meat products. Meat Sci. 2012;90(3):739–46.
＊40 ’t Mannetje A, Eng A, Pearce N. Farming, growing up on a farm, and haematological cancer mortality. Occup Environ Med. 2012;69(2):126–32.
＊41 Johnson ES, Zhou Y, Yau LC, et al. Mortality from malignant diseases-update of the Baltimore union poultry cohort. Cancer Causes Control. 2010;21(2):215–21.
＊42 Neasham D, SifiA, Nielsen KR, et al. Occupation and risk of lymphoma: a multicentre prospective cohort study (EPIC). Occup Environ Med. 2011;68(1):77–81.
＊43 Kalland KH, Ke XS, øyan AM. Tumour virology-history, status and future challenges. APMIS. 2009;117(5–6):382–99.
＊44 Centers for Disease Control and Prevention. Human Orf virus infection from house hold exposures-United States, 2009–2011. MMWR Morb Mortal Wkly Rep. 2012;61(14):245–8.
＊45 Benton EC. Warts in butchers-a cause for concern? Lancet. 1994;343(8906):1114.
＊46 Gubéran, Usel M, Raymond L, Fioretta G. Mortality and incidence of cancer among a cohort of self employed butchers from Geneva and their wives. Br J Ind Med. 1993;50(11):1008–16.
＊47 Johnson ES, Zhou Y, Yau LC, et al. Mortality from malignant diseases-update of the Baltimore union poultry cohort. Cancer Causes Control. 2010;21(2):215–21.
＊48 Johnson ES, Ndetan H, Lo KM. Cancer mortality in poultry slaughtering/processing plant workers belonging to a union pension fund. Environ Res. 2010;110(6):588–94.
＊49 Choi KM, Johnson ES. Occupational exposure assessment using antibody levels: exposure to avian leukosis/sarcoma viruses in the poultry industry. Int J Environ Health Res. 2011;21(4):306–16.
＊50 Choi KM, Johnson ES. Industrial hygiene assessment of reticuloendotheliosis viruses exposure in the poultry industry. Int Arch Occup Environ Health. 2011;84(4):375–82.
＊51 Choi KM, Johnson ES. Industrial hygiene assessment of reticuloendotheliosis viruses exposure in the poultry industry. Int Arch Occup Environ Health. 2011;84(4):375–82.
＊52 Johnson ES, Ndetan H, Lo KM. Cancer mortality in poultry slaughtering/processing plant workers belonging to a union pension fund. Environ Res. 2010;110(6):588–94.
＊53 ’t Mannetje A, Eng A, Pearce N. Farming, growing up on a farm, and haematological cancer mortality. Occup Environ Med. 2012;69(2):126–32.
＊54 Tranah GJ, Bracci PM, Holly EA. Domestic and farm-animal exposures and risk of non-Hodgkin’s lymphoma in a population-based study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2382–7.
＊55 Buehring GC, Philpott SM, Choi KY. Humans have antibodies reactive with Bovine leukemia virus. AIDS Res Hum Retroviruses. 2003;19(12):1105–13.
＊56 U.S. Department of Agriculture Animal and Plant Health Inspection Service. Bovine Leukosis Virus (BLV) on U.S. Dairy Operations, 2007. http://www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy07/Dairy07_is_BLV.pdf. October 2008. Accessed March 2, 2015.
＊57 Buehring GC, Shen HM, Jensen HM, Choi KY, Sun D, Nuovo G. Bovine leukemia virus DNA in human breast tissue. Emerging Infect Dis. 2014;20(5):772–82.
＊58 Tranah GJ, Bracci PM, Holly EA. Domestic and farm-animal exposures and risk of non-Hodgkin’s lymphoma in a population-based study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2382–7.
＊59 Schernhammer ES, Bertrand KA, Birmann BM, Sampson L, Willett WC, Feskanich D. Consumption of artificial sweetener-and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am J Clin Nutr. 2012;96(6):1419–28.
＊60 Lim U, Subar AF, Mouw T, et al. Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1654–9.
＊61 McCullough ML, Teras LR, Shah R, Diver WR, Gaudet MM, Gapstur SM. Artificially and sugar-sweetened carbonated beverage consumption is not associated with risk of lymphoid neoplasms in older men and women. J Nutr. 2014;144(12):2041–9.
◆10 腎臓病で死なないために
＊1 Stokes JB. Consequences of frequent hemodialysis: comparison to conventional hemodialysis and transplantation. Trans Am Clin Climatol Assoc. 2011;122:124–36.
＊2 Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.
＊3 Stevens LA, Li S, Wang C, et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2010;55(3 Suppl 2):S23–33.
＊4 Ryan TP, Sloand JA, Winters PC, Corsetti JP, Fisher SG. Chronic kidney disease prevalence and rate of diagnosis. Am J Med. 2007;120(11):981–6.
＊5 Hoerger TJ, Simpson SA, Yarnoff BO, et al. The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative. Am J Kidney Dis. 2015;65(3):403–11.
＊6 Dalrymple LS, Katz R, Kestenbaum B, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011;26(4):379–85.
＊7 Kumar S, Bogle R, Banerjee D. Why do young people with chronic kidney disease die early? World J Nephrol. 2014;3(4):143–55.
＊8 Lin J, Hu FB, Curhan GC. Associations of diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol. 2010;5(5):836–43.
＊9 Lin J, Hu FB, Curhan GC. Associations of diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol. 2010;5(5):836–43.
＊10 Virchow, R. Cellular Pathology as Based upon Physiological and Pathological Histology. Twenty Lectures Delivered in the Pathological Institute of Berlin During the Months of February, March and April, 1858. Philadelpia, PA: J. B. Lippincott and Co.; 1863.
＊11 Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982;2(8311):1309–11.
＊12 Hartroft WS. Fat emboli in glomerular capillaries of choline-deficient rats and of patients with diabetic glomerulosclerosis. Am J Pathol. 1955;31(3):381–97.
＊13 Gyebi L, Soltani Z, Reisin E. Lipid nephrotoxicity: new concept for an old disease. Curr Hypertens Rep. 2012;14(2):177–81.
＊14 US Burden of Disease Collaborators. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013 Aug 14;310(6):591–608.
＊15 Odermatt A. The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol Renal Physiol. 2011;301(5):F919–31.
＊16 van den Berg E, Hospers FA, Navis G, et al. Dietary acid load and rapid progression to endstage renal disease of diabetic nephropathy in Westernized South Asian people. J Nephrol. 2011;24(1):11–7.
＊17 Piccoli GB, Vigotti FN, Leone F, et al. Low-protein diets in CKD: how can we achieve them? A narrative, pragmatic review. Clin Kidney J. 2015;8(1):61–70.
＊18 Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982 Sep 9;307(11):652–9.
＊19 Wiseman MJ, Hunt R, Goodwin A, Gross JL, Keen H, Viberti GC. Dietary composition and renal function in healthy subjects. Nephron. 1987;46(1):37–42.
＊20 Nakamura H, Takasawa M, Kashara S, et al. Effects of acute protein loads of different sources on renal function of patients with diabetic nephropathy. Tohoku J Exp Med. 1989;159(2):153–62.
＊21 Simon AH, Lima PR, Almerinda M, Alves VF, Bottini PV, de Faria JB. Renal haemodynamic responses to a chicken or beef meal in normal individuals. Nephrol Dial Transplant. 1998;13(9):2261–4.
＊22 Kontessis P, Jones S, Dodds R, et al. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int. 1990;38(1):136–44.
＊23 Nakamura H, Takasawa M, Kashara S, et al. Effects of acute protein loads of different sources on renal function of patients with diabetic nephropathy. Tohoku J Exp Med. 1989;159(2):153–62.
＊24 Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y, Esmaill-Zadeh A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr. 2003;57(10):1292–4.
＊25 Kontessis PA, Bossinakou I, Sarika L, et al. Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients. Diabetes Care. 1995;18(9):1233–40.
＊26 Teixeira SR, Tappenden KA, Carson L, et al. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr. 2004;134(8):1874–80.
＊27 Stephenson TJ, Setchell KD, Kendall CW, Jenkins DJ, Anderson JW, Fanti P. Effect of soy protein-rich diet on renal function in young adults with insulin-dependent diabetes mellitus. Clin Nephrol. 2005;64(1):1–11.
＊28 Jibani MM, Bloodworth LL, Foden E, Griffiths KD, Galpin OP. Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status. Diabet Med. 1991;8(10):949–53.
＊29 Bosch JP, Saccaggi A, Lauer A, Ronco C, Belledonne M, Glabman S. Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate. Am J Med. 1983;75(6):943–50.
＊30 Liu ZM, Ho SC, Chen YM, Tang N, Woo J. Effect of whole soy and purified isoflavone daidzein on renal function-a 6-month randomized controlled trial in equol-producing postmenopausal women with prehypertension. Clin Biochem. 2014;47(13–14):1250–6.
＊31 Fioretto P, Trevisan R, Valerio A, et al. Impaired renal response to a meat meal in insulindependent diabetes: role of glucagon and prostaglandins. Am J Physiol. 1990;258(3 Pt 2):F675–83.
＊32 Frassetto L, Morris RC, Sellmeyer DE, Todd K, Sebastian A. Diet, evolution and aging-the pathophysiologic effects of the post-agricultural inversion of the potassium-to-sodium and baseto-chloride ratios in the human diet. Eur J Nutr. 2001;40(5):200–13.
＊33 Banerjee T, Crews DC, Wesson DE, et al. Dietary acid load and chronic kidney disease among adults in the United States. BMC Nephrol. 2014 Aug 24;15:137.
＊34 Sebastian A, Frassetto LA, Sellmeyer DE, Merriam RL, Morris RC. Estimation of the net acid load of the diet of ancestral preagricultural Homo sapiens and their hominid ancestors. Am J Clin Nutr. 2002;76(6):1308–16.
＊35 van den Berg E, Hospers FA, Navis G, et al. Dietary acid load and rapid progression to endstage renal disease of diabetic nephropathy in Westernized South Asian people. J Nephrol. 2011;24(1):11–7.
＊36 Uribarri J, Oh MS. The key to halting progression of CKD might be in the produce market, not in the pharmacy. Kidney Int. 2012;81(1):7–9.
＊37 Cohen E, Nardi Y, Krause I, et al. A longitudinal assessment of the natural rate of decline in renal function with age. J Nephrol. 2014;27(6):635–41.
＊38 Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982 Sep 9;307(11):652–9.
＊39 Frassetto LA, Todd KM, Morris RC, Sebastian A. Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents. Am J Clin Nutr. 1998;68(3):576–83.
＊40 Wiseman MJ, Hunt R, Goodwin A, Gross JL, Keen H, Viberti GC. Dietary composition and renal function in healthy subjects. Nephron. 1987;46(1):37–42.
＊41 Kempner W. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet. Ann Intern Med. 1949;31(5):821–56.
＊42 Barsotti G, Morelli E, Cupisti A, Meola M, Dani L, Giovannetti S. A low-nitrogen lowphosphorus vegan diet for patients with chronic renal failure. Nephron. 1996;74(2):390–4.
＊43 Deriemaeker P, Aerenhouts D, Hebbelinck M, Clarys P. Nutrient based estimation of acid-base balance in vegetarians and non-vegetarians. Plant Foods Hum Nutr. 2010;65(1):77–82.
＊44 Goraya N, Simoni J, Jo C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int. 2012;81(1):86–93.
＊45 Yaqoob MM. Treatment of acidosis in CKD. Clin J Am Soc Nephrol. 2013;8(3):342–3.
＊46 Goraya N, Simoni J, Jo C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int. 2012;81(1):86–93.
＊47 Wright JA, Cavanaugh KL. Dietary sodium in chronic kidney disease: a comprehensive approach. Semin Dial. 2010;23(4):415–21.
＊48 Uribarri J, Oh MS. The key to halting progression of CKD might be in the produce market, not in the pharmacy. Kidney Int. 2012;81(1):7–9.
＊49 Goldfarb S. Dietary factors in the pathogenesis and prophylaxis of calcium nephrolithiasis. Kidney Int. 1988;34(4):544–55.
＊50 Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–5.
＊51 Robertson WG, Peacock M, Hodgkinson A. Dietary changes and the incidence of urinary calculi in the U.K. between 1958 and 1976. J Chronic Dis. 1979;32(6):469–76.
＊52 Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci (Lond). 1979;57(3):285–8.
＊53 Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci (Lond). 1979;57(3):285–8.
＊54 Robertson WG, Peacock M, Heyburn PJ, et al. Should recurrent calcium oxalate stone formers become vegetarians? Br J Urol. 1979;51(6):427–31.
＊55 Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE. Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol. 2014;29(5):363–9.
＊56 Tracy CR, Best S, Bagrodia A, et al. Animal protein and the risk of kidney stones: A comparative metabolic study of animal protein sources. J Urol. 2014 Feb 8;192:137–41.
＊57 Bushinsky DA. Recurrent hypercalciuric nephrolithiasis-does diet help? N Engl J Med. 2002 Jan 10;346(2):124–5.
＊58 Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002 Jan 10;346(2):77–84.
＊59 Sorensen MD, Hsi RS, Chi T, et al. Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women’s Health Initiative report. J Urol. 2014;192(6):1694–9.
＊60 Mehta TH, Goldfarb DS. Uric acid stones and hyperuricosuria. Adv Chronic Kidney Dis. 2012;19(6):413–8.
＊61 de Vries A, Frank M, Liberman UA, Sperling O. Allopurinol in the prophylaxis of uric acid stones. Ann Rheum Dis. 1966;25(6 Suppl):691–3.
＊62 Siener R, Hesse A. The effect of a vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation. Eur J Nutr. 2003;42(6):332–7.
＊63 Siener R, Hesse A. The effect of a vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation. Eur J Nutr. 2003;42(6):332–7.
＊64 Trinchieri A. Development of a rapid food screener to assess the potential renal acid load of diet in renal stone formers (LAKE score). Arch Ital Urol Androl. 2012;84(1):36–8.
＊65 Chae JY, Kim JW, Kim JW, et al. Increased fluid intake and adequate dietary modification maybe enough for the successful treatment of uric acid stone. Urolithiasis. 2013;41(2):179–82.
＊66 Deriemaeker P, Aerenhouts D, Hebbelinck M, Clarys P. Nutrient based estimation of acid-base balance in vegetarians and non-vegetarians. Plant Foods Hum Nutr. 2010;65(1):77–82.
＊67 Adeva MM, Souto G. Diet-induced metabolic acidosis. Clin Nutr. 2011;30(4):416–21.
＊68 Dawson-Hughes B, Harris SS, Ceglia L. Alkaline diets favor lean tissue mass in older adults. Am J Clin Nutr. 2008;87(3):662–5.
＊69 Ritz E, Hahn K, Ketteler M, Kuhlmann MK, Mann J. Phosphate additives in food-a health risk. Dtsch Arztebl Int. 2012;109(4):49–55.
＊70 Ritz E, Hahn K, Ketteler M, Kuhlmann MK, Mann J. Phosphate additives in food-a health risk. Dtsch Arztebl Int. 2012;109(4):49–55.
＊71 Calvo MS, Uribarri J. Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population. Am J Clin Nutr. 2013;98(1):6–15.
＊72 Moe SM, Zidehsarai MP, Chambers MA, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(2):257–64.
＊73 Fukagawa M, Komaba H, Miyamoto K. Source matters: from phosphorus load to bioavailability. Clin J Am Soc Nephrol. 2011;6(2):239–40.
＊74 Murphy-Gutekunst L, Uribarri J. Hidden phosphorus-enhanced meats: Part 3. J Ren Nutr. 2005 15(4):E1– E4.
＊75 Ritz E, Hahn K, Ketteler M, Kuhlmann MK, Mann J. Phosphate additives in food-a health risk. Dtsch Arztebl Int. 2012;109(4):49–55.
＊76 Karp H, Ekholm P, Kemi V, et al. Differences among total and in vitro digestible phosphorus content of plant foods and beverages. J Ren Nutr. 2012;22(4):416–22.
＊77 Karp H, Ekholm P, Kemi V, Hirvonen T, Lamberg-Allardt C. Differences among total and in vitro digestible phosphorus content of meat and milk products. J Ren Nutr. 2012;22(3):344–9.
＊78 Karp H, Ekholm P, Kemi V, et al. Differences among total and in vitro digestible phosphorus content of plant foods and beverages. J Ren Nutr. 2012;22(4):416–22.
＊79 Murphy-Gutekunst L, Uribarri J. Hidden phosphorus-enhanced meats: Part 3. J Ren Nutr. 2005;15(4):E1– E4.
＊80 Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4(8):1370–3.
＊81 Benini O, D’Alessandro C, Gianfaldoni D, Cupisti A. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr. 2011;21(4):303–8.
＊82 Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4(8):1370–3.
＊83 Benini O, D’Alessandro C, Gianfaldoni D, Cupisti A. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr. 2011;21(4):303–8.
＊84 Shroff R. Phosphate is a vascular toxin. Pediatr Nephrol. 2013;28(4):583–93.
＊85 Shuto E, Taketani Y, Tanaka R, et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009;20(7):1504–12.
＊86 Gunther NW, He Y, Fratamico P. Effects of polyphosphate additives on the pH of processed chicken exudates and the survival of Campylobacter. J Food Prot. 2011;74(10):1735–40.
＊87 Sherman RA, Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis. 2009;54(1):18–23.
＊88 Sherman RA, Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis. 2009;54(1):18–23.
＊89 Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr. 2007;17(5):350–4.
＊90 American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
＊91 Kirkali Z, Cal C. Renal Cell Carcinoma: Overview. In Nargund VH, Raghavan D, Sandler HM, eds. Urological Oncology. London, UK: Springer; 2008:263–80.
＊92 Kirkali Z, Cal C. Renal Cell Carcinoma: Overview. In Nargund VH, Raghavan D, Sandler HM, eds. Urological Oncology. London, UK: Springer; 2008:263–80.
＊93 Ramírez N, Özel MZ, Lewis AC, Marcé RM, Borrull F, Hamilton JF. Exposure to nitrosamines in thirdhand tobacco smoke increases cancer risk in non-smokers. Environ Int. 2014;71:139–47.
＊94 Schick SF, Farraro KF, Perrino C, et al. Thirdhand cigarette smoke in an experimental chamber: evidence of surface deposition of nicotine, nitrosamines and polycyclic aromatic hydrocarbons and de novo formation of NNK. Tob Control. 2014;23(2):152–9.
＊95 Hecht SS. It is time to regulate carcinogenic tobacco-specific nitrosamines in cigarette tobacco. Cancer Prev Res (Phila). 2014;7(7):639–47.
＊96 Rodgman A, Perfetti TA. The Chemical Components of Tobacco and Tobacco Smoke. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2009.
＊97 Haorah J, Zhou L, Wang X, Xu G, Mirvish SS. Determination of total N-nitroso compounds and their precursors in frankfurters, fresh meat, dried salted fish, sauces, tobacco, and tobacco smoke particulates. J Agric Food Chem. 2001;49(12):6068–78.
＊98 Rohrmann S, Overvad K, Bueno-de-Mesquita HB, et al. Meat consumption and mortality-results from the European Prospective Investigation into Cancer and Nutrition. BMC Med. 2013;11:63.
＊99 Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009;169(6):562–71.
＊100 American Institute for Cancer Research. Recommendations for Cancer Prevention. http://www.aicr.org/reduce-your-cancer-risk/recommendations-for-cancer-prevention/recommendations_05_red_meat.html. April 17, 2011. Accessed March 2, 2015.
＊101 USDA. Additives in meat and poultry products. http://www.fsis.usda.gov/wps/portal/fsis/topics/food-safety-education/get-answers/food-safety-fact-sheets/food-labeling/additives-in-meat-andpoultry-products/additives-in-meat-and-poultry-products. March 24, 2015. Accessed May 3, 2015.
＊102 Sebranek JG, Jackson-Davis AL, Myers KL, Lavieri NA. Beyond celery and starter culture: advances in natural/organic curing processes in the United States. Meat Sci. 2012;92(3):267–73.
＊103 Dellavalle CT, Daniel CR, Aschebrook-Kilfoy B, et al. Dietary intake of nitrate and nitrite and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Br J Cancer. 2013;108(1):205–12.
＊104 Bartsch H, Ohshima H, Pignatelli B. Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention. Mutat Res. 1988;202(2):307–24.
＊105 Dellavalle CT, Daniel CR, Aschebrook-Kilfoy B, et al. Dietary intake of nitrate and nitrite and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Br J Cancer. 2013;108(1):205–12.
＊106 Liu B, Mao Q, Wang X, et al. Cruciferous vegetables consumption and risk of renal cell carcinoma: a meta-analysis. Nutr Cancer. 2013;65(5):668–76.
◆11 乳がんで死なないために
＊1 American Cancer Society. Breast Cancer Facts & Figures 2013–2014. http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042725.pdf. 2013. Accessed March 10, 2015.
＊2 Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of longterm follow-up. Cancer. 2005;103(12):2481–4.
＊3 Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987;56(6): 814–9.
＊4 Soto AM, Brisken C, Schaeberle C, Sonnenschein C. Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors. J Mammary Gland Biol Neoplasia. 2013;18(2):199–208.
＊5 Del Monte U. Does the cell number 10(9) still really fit one gram of tumor tissue? Cell Cycle. 2009;8(3):505–6.
＊6 Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993;328(17):1237–43.
＊7 Friberg S, Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol. 1997;65(4):284–97.
＊8 Philippe E, Le Gal Y. Growth of seventy-eight recurrent mammary cancers. Quantitative study. Cancer. 1968;21(3):461–7.
＊9 Kuroishi T, Tominaga S, Morimoto T, et al. Tumor growth rate and prognosis of breast cancer mainly detected by mass screening. Jpn J Cancer Res. 1990;81(5):454–62.
＊10 American Association for Cancer Research. Studies weigh cost, effectiveness of mammography. Cancer Discov. 2014;4(5):OF5.
＊11 Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987;56(6): 814–9.
＊12 American Institute for Cancer Research. Recommendations for Cancer Prevention. http://www.aicr.org/reduce-your-cancer-risk/recommendations-for-cancer-prevention/. September 12, 2014. Accessed March 10, 2015.
＊13 American Institute for Cancer Research. AICR, the China Study, and Forks Over Knives. http://www.aicr.org/about/advocacy/the-china-study.html. January 9, 2015. Accessed March 10, 2015.
＊14 Hastert TA, Beresford SAA, Patterson RE, Kristal AR, White E. Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(9):1498–508.
＊15 Barnard RJ, Gonzalez JH, Liva ME, Ngo TH. Effects of a low-fat, high-fiber diet and exercise program on breast cancer risk factors in vivo and tumor cell growth and apoptosis in vitro. Nutr Cancer. 2006;55(1):28–34.
＊16 Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control. 2002;13(10):929–35.
＊17 Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1441–8.
＊18 IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 96, Alcohol Consumption and Ethyl Carbamate. Lyon, France: International Agency for Research on Cancer; 2010.
＊19 Stewart BW, Wild CP, eds. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer; 2014.
＊20 Bagnardi V, Rota M, Botteri E, et al. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013;24(2):301–8.
＊21 Linderborg K, Salaspuro M, Väkeväinen S. A single sip of a strong alcoholic beverage causes exposure to carcinogenic concentrations of acetaldehyde in the oral cavity. Food Chem Toxicol. 2011;49(9):2103–6.
＊22 Lachenmeier DW, Gumbel-Mako S, Sohnius EM, Keck-Wilhelm A, Kratz E, Mildau G. Salivary acetaldehyde increase due to alcohol-containing mouthwash use: a risk factor for oral cancer. Int J Cancer. 2009;125(3):730–5.
＊23 Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA. 2011;306(17):1884–90.
＊24 Shufelt C, Merz CN, Yang Y, et al. Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot study. J Womens Health (Larchmt). 2012;21(3):281–4.
＊25 Eng ET, Williams D, Mandava U, Kirma N, Tekmal RR, Chen S. Anti-aromatase chemicals in red wine. Ann N Y Acad Sci. 2002;963:239–46.
＊26 Shufelt C, Merz CN, Yang Y, et al. Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot study. J Womens Health (Larchmt). 2012;21(3):281–4.
＊27 Chen S, Sun XZ, Kao YC, Kwon A, Zhou D, Eng E. Suppression of breast cancer cell growth with grape juice. Pharmaceutical Biology. 1998;36(Suppl 1):53–61.
＊28 Chen S, Sun XZ, Kao YC, Kwon A, Zhou D, Eng E. Suppression of breast cancer cell growth with grape juice. Pharmaceutical Biology. 1998;36(Suppl 1):53–61.
＊29 Adams LS, Zhang Y, Seeram NP, Heber D, Chen S. Pomegranate ellagitannin-derived compounds exhibit anti-proliferative and anti-aromatase activity in breast cancer cells in vitro. Cancer Prev Res (Phila). 2010;3(1):108–13.
＊30 Chen S, Oh SR, Phung S, et al. Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). Cancer Res. 2006;66(24):12026–34.
＊31 Mishal AA. Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporos Int. 2001;12(11):931–5.
＊32 Cardinali DP, Pévet P. Basic aspects of melatonin action. Sleep Med Rev. 1998;2(3):175–90.
＊33 Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine. 2005;27(2):179–88.
＊34 Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley SW. Total visual blindness is protective against breast cancer. Cancer Causes Control. 2009;20(9):1753–6.
＊35 He C, Anand ST, Ebell MH, Vena JE, Robb SW. Circadian disrupting exposures and breast cancer risk: a meta-analysis. Int Arch Occup Environ Health. 2015 Jul;88(5):533–47.
＊36 Hurley S, Goldberg D, Nelson D, et al. Light at night and breast cancer risk among California teachers. Epidemiology. 2014;25(5):697–706.
＊37 Bauer SE, Wagner SE, Burch J, Bayakly R, Vena JE. A case-referent study: light at night and breast cancer risk in Georgia. Int J Health Geogr. 2013;12:23.
＊38 Kloog I, Haim A, Stevens RG, Barchana M, Portnov BA. Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Int. 2008;25(1):65–81.
＊39 Li Q, Zheng T, Holford TR, Boyle P, Zhang Y, Dai M. Light at night and breast cancer risk: results from a population-based case-control study in Connecticut, USA. Cancer Causes Control. 2010;21(12):2281–5.
＊40 Basler M, Jetter A, Fink D, Seifert B, Kullak-Ublick GA, Trojan A. Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care (Basel). 2014;9(3):182–7.
＊41 Nagata C, Nagao Y, Shibuya C, Kashiki Y, Shimizu H. Association of vegetable intake with urinary 6-sulfatoxymelatonin level. Cancer Epidemiol Biomarkers Prev. 2005;14(5):1333–5.
＊42 Schernhammer ES, Feskanich D, Niu C, Dopfel R, Holmes MD, Hankinson SE. Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses’ Health Study cohorts. Am J Clin Nutr. 2009;90(4):975–85.
＊43 Gonçalves AK, Dantas Florencio GL, Maisonnette de Atayde Silva MJ, Cobucci RN, Giraldo PC, Cote NM. Effects of physical activity on breast cancer prevention: a systematic review. J Phys Act Health. 2014;11(2):445–54.
＊44 Friedenreich CM, Woolcott CG, McTiernan A, et al. Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol. 2010;28(9):1458–66.
＊45 Kossman DA, Williams NI, Domchek SM, Kurzer MS, Stopfer JE, Schmitz KH. Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer. J Appl Physiol. 2011;111(6):1687–93.
＊46 Thune I, Furberg AS. Physical activity and cancer risk: dose-response and cancer, all sites and site-specific. Med Sci Sports Exerc. 2001;33(6 Suppl):S530–50.
＊47 Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Lifetime exercise activity and breast cancer risk among post-menopausal women. Br J Cancer. 1999;80(11):1852–8.
＊48 Peters TM, Moore SC, Gierach GL, et al. Intensity and timing of physical activity in relation to postmenopausal breast cancer risk: the prospective NIH-AARP diet and health study. BMC Cancer. 2009;9:349.
＊49 Friedenreich CM, Cust AE. Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med. 2008;42(8):636–47.
＊50 Hildebrand JS, Gapstur SM, Campbell PT, Gaudet MM, Patel AV. Recreational physical activity and leisure-time sitting in relation to postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2013;22(10):1906–12.
＊51 Widmark, EMP. Presence of cancer-producing substances in roasted food. Nature. 1939;143:984.
＊52 National Cancer Institute. Chemicals in Meat Cooked at High Temperatures and Cancer Risk. http://www.cancer.gov/cancertopics/factsheet/Risk/cooked-meats. Reviewed October 15, 2010. Accessed March 10, 2015.
＊53 Shaughnessy DT, Gangarosa LM, Schliebe B, et al. Inhibition of fried meat-induced colorectal DNA damage and altered systemic genotoxicity in humans by crucifera, chlorophyllin, and yogurt. PLoS ONE. 2011;6(4):e18707.
＊54 Zaidi R, Kumar S, Rawat PR. Rapid detection and quantification of dietary mutagens in food using mass spectrometry and ultra performance liquid chromatography. Food Chem. 2012;135(4):2897–903.
＊55 Thiébaud HP, Knize MG, Kuzmicky PA, Hsieh DP, Felton JS. Airborne mutagens produced by frying beef, pork and a soy-based food. Food Chem Toxicol. 1995;33(10):821–8.
＊56 Zheng W, Lee SA. Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer. 2009;61(4):437–46.
＊57 Goldfinger SE. By the way, doctor. In your May issue you say that eating medium or well-done beef increases one’s risk for stomach cancer. But what about the dangers of eating rare beef?. Harv Health Lett. 1999;24(5):7.
＊58 Frandsen H, Frederiksen H, Alexander J. 2-Amino-1-methyl-6-(5-hydroxy-)phenylimidazo[4,5-b]pyridine (5-OH-PhIP), a biomarker for the genotoxic dose of the heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Food Chem Toxicol. 2002;40(8):1125–30.
＊59 Frandsen H. Biomonitoring of urinary metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) following human consumption of cooked chicken. Food Chem Toxicol. 2008;46(9):3200–5.
＊60 Steck SE, Gaudet MM, Eng SM, et al. Cooked meat and risk of breast cancer—lifetime versus recent dietary intake. Epidemiology. 2007;18(3):373–82.
＊61 Zheng W, Gustafson DR, Sinha R, et al. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst. 1998;90(22):1724–9.
＊62 Rohrmann S, Lukas Jung SU, Linseisen J, Pfau W. Dietary intake of meat and meat-derived heterocyclic aromatic amines and their correlation with DNA adducts in female breast tissue. Mutagenesis. 2009;24(2):127–32.
＊63 Santella RM, Gammon M, Terry M, et al. DNA adducts, DNA repair genotype/phenotype and cancer risk. Mutat Res. 2005;592(1–2):29–35.
＊64 Lauber SN, Ali S, Gooderham NJ. The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity. Carcinogenesis. 2004;25(12):2509–17.
＊65 Debruin LS, Martos PA, Josephy PD. Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in the milk of healthy women. Chem Res Toxicol. 2001;14(11):1523–8.
＊66 Lauber SN, Ali S, Gooderham NJ. The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity. Carcinogenesis. 2004;25(12):2509–17.
＊67 Debruin LS, Martos PA, Josephy PD. Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in the milk of healthy women. Chem Res Toxicol. 2001;14(11):1523–8.
＊68 Bessette EE, Yasa I, Dunbar D, Wilkens LR, Le Marchand L, Turesky RJ. Biomonitoring of carcinogenic heterocyclic aromatic amines in hair: a validation study. Chem Res Toxicol. 2009;22(8): 1454–63.
＊69 Grose KR, Grant JL, Bjeldanes LF, et al. Isolation of the carcinogen IQ from fried egg patties. J Agric Food Chem. 1986;34(2):201–2.
＊70 Holland RD, Gehring T, Taylor J, Lake BG, Gooderham NJ, Turesky RJ. Formation of a mutagenic heterocyclic aromatic amine from creatinine in urine of meat eaters and vegetarians. Chem Res Toxicol. 2005;18(3):579–90.
＊71 Magagnotti C, Orsi F, Bagnati R, et al. Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans. Int J Cancer. 2000;88(1): 1–6.
＊72 Lauber SN, Gooderham NJ. The cooked meat-derived mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine promotes invasive behaviour of breast cancer cells. Toxicology. 2011;279(1–3):139–45.
＊73 Lauber SN, Gooderham NJ. The cooked meat-derived mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine promotes invasive behaviour of breast cancer cells. Toxicology. 2011;279(1–3):139–45.
＊74 Vergnaud AC, Romaguera D, Peeters PH, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study. Am J Clin Nutr. 2013;97(5):1107–20.
＊75 Danilo C, Frank PG. Cholesterol and breast cancer development. Current Opinion in Pharmacology. 2012;12(6):677.
＊76 Firestone RA. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjug Chem. 1994 5(2):105–13.
＊77 Rudling MJ, Ståhle L, Peterson CO, Skoog L. Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients. Br Med J (Clin Res Ed). 1986;292(6520):580–2.
＊78 Danilo C, Frank PG. Cholesterol and breast cancer development. Current Opinion in Pharmacology. 2012;12(6):677–82.
＊79 Antalis CJ, Arnold T, Rasool T, Lee B, Buhman KK, Siddiqui RA. High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation. Breast Cancer Res Treat. 2010;122(3):661–70.
＊80 Firestone RA. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjug Chem. 1994;5(2):105–13.
＊81 Kitahara CM, Berrington de González A, Freedman ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 2011;29(12):1592–8.
＊82 Undela K, Srikanth V, Bansal D. Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Res Treat. 2012;135(1):261–9.
＊83 McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev. 2013;22(9):1529–37.
＊84 Centers for Disease Control and Prevention. Data table for Figure 17. Statin drug use in the past 30 days among adults 45 years of age and over, by sex and age: United States, 1988–1994, 1999–2002, and 2005–2008. National Health and Nutrition Examination Survey. Chartbook: Centers for Disease Control; 2010. http://www.cdc.gov/nchs/data/hus/2010/fig17.pdf. Accessed March 25, 2015.
＊85 Maunsell E, Drolet M, Brisson J, Robert J, Deschell L. Dietary change after breast cancer: extent, predictors, and relation with psychological distress. J Clin Oncol. 2002;20(4):1017–25.
＊86 Pierce JP, Stefanick ML, Flatt SW, et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol. 2007;25(17):2345–51.
＊87 Li Q, Holford TR, Zhang Y, et al. Dietary fiber intake and risk of breast cancer by menopausal and estrogen receptor status. Eur J Nutr. 2013;52(1):217–23.
＊88 Li Q, Holford TR, Zhang Y, et al. Dietary fiber intake and risk of breast cancer by menopausal and estrogen receptor status. Eur J Nutr. 2013;52(1):217–23.
＊89 Howe GR, Hirohata T, Hislop TG, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990;82(7):561–9.
＊90 Dong J-Y, He K, Wang P, Qin LQ. Dietary fiber intake and risk of breast cancer: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2011;94(3):900–5.
＊91 Aune D, Chan DS, Greenwood DC, et al. Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies. Ann Oncol. 2012;23(6):1394–402.
＊92 Clemens R, Kranz S, Mobley AR, et al. Filling America’s fiber intake gap: summary of a roundtable to probe realistic solutions with a focus on grain-based foods. J Nutr. 2012;142(7):1390S–401S.
＊93 Farmer B, Larson BT, Fulgoni VL, Rainville AJ, Liepa GU. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the National Health and Nutrition Examination Survey 1999–2004. J Am Diet Assoc. 2011;111(6):819–27.
＊94 Rizzo NS, Jaceldo-Siegl K, Sabate J, Fraser GE. Nutrient profiles of vegetarian and nonvegetarian dietary patterns. J Acad Nutr Diet. 2013;113(12):1610–9.
＊95 Dewell A, Weidner G, Sumner MD, Chi CS, Ornish D. A very-low-fat vegan diet increases intake of protective dietary factors and decreases intake of pathogenic dietary factors. J Am Diet Assoc. 2008;108(2):347–56.
＊96 Gallus S, Talamini R, Giacosa A, et al. Does an apple a day keep the oncologist away? Ann Oncol. 2005;16(11):1841–4.
＊97 Wolfe K, Wu X, Liu RH. Antioxidant activity of apple peels. J Agric Food Chem. 2003;51(3):609–14.
＊98 Sun J, Liu RH. Apple phytochemical extracts inhibit proliferation of estrogen-dependent and estrogen-independent human breast cancer cells through cell cycle modulation. J Agric Food Chem. 2008;56(24):11661–7.
＊99 Wolfe K, Wu X, Liu RH. Antioxidant activity of apple peels. J Agric Food Chem. 2003;51(3):609–14.
＊100 Reagan-Shaw S, Eggert D, Mukhtar H, Ahmad N. Antiproliferative effects of apple peel extract against cancer cells. Nutr Cancer. 2010;62(4):517–24.
＊101 Steck SE, Gaudet MM, Eng SM, et al. Cooked meat and risk of breast cancer—lifetime versus recent dietary intake. Epidemiology. 2007;18(3):373–82.
＊102 Murray S, Lake BG, Gray S, et al. Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man. Carcinogenesis. 2001;22(9):1413–20.
＊103 Murray S, Lake BG, Gray S, et al. Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man. Carcinogenesis. 2001;22(9):1413–20.
＊104 Murray S, Lake BG, Gray S, et al. Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man. Carcinogenesis. 2001;22(9):1413–20.
＊105 Thiébaud HP, Knize MG, Kuzmicky PA, Hsieh DP, Felton JS. Airborne mutagens produced by frying beef, pork and a soy-based food. Food Chem Toxicol. 1995;33(10):821–8.
＊106 Boggs DA, Palmer JR, Wise LA, et al. Fruit and vegetable intake in relation to risk of breast cancer in the Black Women’s Health Study. Am J Epidemiol. 2010;172(11):1268–79.
＊107 Boggs DA, Palmer JR, Wise LA, et al. Fruit and vegetable intake in relation to risk of breast cancer in the Black Women’s Health Study. Am J Epidemiol. 2010;172(11):1268–79.
＊108 Tiede B, Kang Y. From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer. Cell Res. 2011;21(2):245–57.
＊109 Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med. 2011;17(3):313–9.
＊110 Karrison TG, Ferguson DJ, Meier P. Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst. 1999;91(1):80–5.
＊111 Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7(11):834–46.
＊112 Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med. 2011;17(3):313–9.
＊113 Li Y, Zhang T, Korkaya H, et al. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res. 2010;16(9):2580–90.
＊114 Cornblatt BS, Ye L, Dinkova-Kostova AT, et al. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis. 2007;28(7):1485–90.
＊115 Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA. 1997;94(19):10367–72.
＊116 Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. Flax and flaxseed oil: an ancient medicine & modern functional food. J Food Sci Technol. 2014;51(9):1633–53.
＊117 Smeds AI, Eklund PC, Sjöholm RE, et al. Quantification of a broad spectrum of lignans in cereals, oilseeds, and nuts. J Agric Food Chem. 2007;55(4):1337–46.
＊118 Rosolowich V, Saettler E, Szuck B, et al. Mastalgia. J Obstet Gynaecol Can. 2006;170:49–57.
＊119 Phipps WR, Martini MC, Lampe JW, Slavin JL, Kurzer MS. Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol Metab. 1993;77(5):1215–9.
＊120 Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15(1):36–47.
＊121 Knekt P, Adlercreutz H, Rissanen H, Aromaa A, Teppo L, Heliövaara M. Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer? Br J Cancer. 2000;82(5):1107–10.
＊122 Buck K, Zaineddin AK, Vrieling A, Linseisen J, Chang-Claude J. Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr. 2010;92(1):141–53.
＊123 Abarzua S, Serikawa T, Szewczyk M, Richter DU, Piechulla B, Briese V. Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20. Arch Gynecol Obstet. 2012;285(4):1145–51.
＊124 Fabian CJ, Kimler BF, Zalles CM, et al. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside. Cancer Prev Res (Phila). 2010;3(10):1342–50.
＊125 Buck K, Vrieling A, Zaineddin AK, et al. Serum enterolactone and prognosis of postmenopausal breast cancer. J Clin Oncol. 2011;29(28):3730–8.
＊126 Guglielmini P, Rubagotti A, Boccardo F. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. Breast Cancer Res Treat. 2012;132(2):661–8.
＊127 McCann SE, Thompson LU, Nie J, et al. Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat. 2010;122(1):229–35.
＊128 Åberg UW, Saarinen N, Abrahamsson A, Nurmi T, Engblom S, Dabrosin C. Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo. PLoS ONE. 2011;6(9):e25720.
＊129 Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res. 2005;11(10):3828–35.
＊130 Mueller SO, Simon S, Chae K, Metzler M, Korach KS. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci. 2004;80(1):14–25.
＊131 Oseni T, Patel R, Pyle J, Jordan VC. Selective estrogen receptor modulators and phytoestrogens. Planta Med. 2008;74(13):1656–65.
＊132 Oseni T, Patel R, Pyle J, Jordan VC. Selective estrogen receptor modulators and phytoestrogens. Planta Med. 2008;74(13):1656–65.
＊133 Nagata C, Mizoue T, Tanaka K, et al. Soy intake and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2014;44(3):282–95.
＊134 Chen MN, Lin CC, Liu CF. Efficacy of phytoestrogens for menopausal symptoms: a metaanalysis and systematic review. Climacteric. 2015;18(2):260–9.
＊135 Chi F, Wu R, Zeng YC, Xing R, Liu Y, Xu ZG. Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev. 2013;14(4):2407–12.
＊136 Bhagwat S, Haytowitz DB, Holden JM. USDA Database for the Isoflavone Content of Selected Foods, Release 2.0. http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/isoflav/Isoflav_R2.pdf. September 2008. Accessed March 26, 2015.
＊137 Nechuta SJ, Caan BJ, Chen WY, et al. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr. 2012;96(1):123–32.
＊138 Chi F, Wu R, Zeng YC, Xing R, Liu Y, Xu ZG. Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev. 2013;14(4):2407–12.
＊139 Kang HB, Zhang YF, Yang JD, Lu KL. Study on soy isoflavone consumption and risk of breast cancer and survival. Asian Pac J Cancer Prev. 2012;13(3):995–8.
＊140 Bosviel R, Dumollard E, Déchelotte P, Bignon YJ, Bernard-Gallon D. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS. 2012;16(5):235–44.
＊141 National Breast Cancer Coalition. National Breast Cancer Coalition survey reveals that heightened breast cancer awareness has insufficient impact on knowledge. http://www.prnewswire.com/news-releases/national-breast-cancer-coalition-survey-reveals-that-heightenedbreast-cancer-awareness-has-insufficient-impact-on-knowledge-58248962.html. October 1, 2007. Accessed March 23, 2015.
＊142 Colditz GA, Willett WC, Hunter DJ, et al. Family history, age, and risk of breast cancer. Prospective data from the Nurses’ Health Study. JAMA. 1993;270(3):338–43.
＊143 Bal A, Verma S, Joshi K, et al. BRCA1-methylated sporadic breast cancers are BRCAlike in showing a basal phenotype and absence of ER expression. Virchows Arch. 2012;461(3):305–12.
＊144 Bosviel R, Dumollard E, Déchelotte P, Bignon YJ, Bernard-Gallon D. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS. 2012;16(5):235–44.
＊145 Magee PJ, Rowland I. Soy products in the management of breast cancer. Curr Opin Clin Nutr Metab Care. 2012;15(6):586–91.
＊146 Parkin DM, Fernández LM. Use of statistics to assess the global burden of breast cancer. Breast J. 2006;12 Suppl 1:S70–80.
＊147 Wu AH, Butler LM. Green tea and breast cancer. Mol Nutr Food Res. 2011;55(6):921–30.
＊148 Korde LA, Wu AH, Fears T, et al. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1050–9.
＊149 Wakchaure GC. Chapter 3: Production and marketing of mushrooms: Global and national scenario. In : Mushrooms: Singh N, Cijay B, Kamal S, Wakchaure GC, eds. Cultivation, Marketing and Consumption. Himachal Pradesh-173213, India: Directorate of Mushroom Research; 2014:15–22.
＊150 Zhang M, Huang J, Xie X, Holman CD. Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer. 2009;124(6):1404–8.
＊151 Ganz PA. A teachable moment for oncologists: cancer survivors, 10 million strong and growing! J Clin Oncol. 2005;23(24):5458–60.
＊152 Ganz PA. A teachable moment for oncologists: cancer survivors, 10 million strong and growing! J Clin Oncol. 2005;23(24):5458–60.
◆12 自殺性うつ病で死なないために
＊1 Centers for Disease Control and Prevention. National Center for Health Statistics. Deaths: Final Data for 2013, table 18. http://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_02.pdf. Accessed March 20, 2015.
＊2 Sartorius N. The economic and social burden of depression. J Clin Psychiatry. 2001;62 Suppl 15: 8–11.
＊3 Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948.
＊4 Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27.
＊5 Chida Y, Steptoe A. Positive psychological well-being and mortality: a quantitative review of prospective observational studies. Psychosom Med. 2008;70(7):741–56.
＊6 Chida Y, Steptoe A. Positive psychological well-being and mortality: a quantitative review of prospective observational studies. Psychosom Med. 2008;70(7):741–56.
＊7 Grant N, Wardle J, Steptoe A. The relationship between life satisfaction and health behavior: a cross-cultural analysis of young adults. Int J Behav Med. 2009;16(3):259–68.
＊8 Cohen S, Doyle WJ, Turner RB, Alper CM, Skoner DP. Emotional style and susceptibility to the common cold. Psychosom Med. 2003;65(4):652–7.
＊9 Cohen S, Alper CM, Doyle WJ, Treanor JJ, Turner RB. Positive emotional style predicts re sistance to illness after experimental exposure to rhinovirus or influenza A virus. Psychosom Med. 2006;68(6):809–15.
＊10 Beezhold BL, Johnston CS, Daigle DR. Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults. Nutr J. 2010;9:26.
＊11 Beezhold BL, Johnston CS, Daigle DR. Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults. Nutr J. 2010;9:26.
＊12 Knutsen SF. Lifestyle and the use of health Services. Am J Clin Nutr. 1994;59(5 Suppl):1171S–1175S.
＊13 Beezhold BL, Johnston CS, Daigle DR. Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults. Nutr J. 2010;9:26.
＊14 Fisher M, Levine PH, Weiner B, et al. The effect of vegetarian diets on plasma lipid and platelet levels. Arch Intern Med. 1986;146(6):1193–7.
＊15 Institute of Medicine. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Washington, D.C.: National Academies Press; 2006.
＊16 Vaz JS, Kac G, Nardi AE, Hibbeln JR. Omega-6 fatty acids and greater likelihood of suicide risk and major depression in early pregnancy. J Affect Disord. 2014;152–154:76–82.
＊17 National Cancer Institute. Table 4: Food Sources of Arachidonic Acid. http://appliedresearch.cancer.gov/diet/foodsources/fattyacids/table4.html. Modified October 18, 2013. Accessed March 11, 2015.
＊18 Hirota S, Adachi N, Gomyo T, Kawashima H, Kiso Y, Kawabata T. Low-dose arachidonic acid intake increases erythrocytes and plasma arachidonic acid in young women. Prostaglandins Leukot Essent Fatty Acids. 2010;83(2):83–8.
＊19 Beezhold BL, Johnston CS, Daigle DR. Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults. Nutr J. 2010;9:26.
＊20 Beezhold BL, Johnston CS. Restriction of meat, fish, and poultry in omnivores improves mood: a pilot randomized controlled trial. Nutr J. 2012;11:9.
＊21 Beezhold BL, Johnston CS, Daigle DR. Restriction of flesh foods in omnivores improves mood: a pilot randomized controlled trial. American Public Health Association Annual Conference, November 7–11, 2009. Philadelphia, PA.
＊22 Katcher HI, Ferdowsian HR, Hoover VJ, Cohen JL, Barnard ND. A worksite vegan nutrition program is well-accepted and improves health-related quality of life and work productivity. Ann Nutr Metab. 2010;56(4):245–52.
＊23 Katcher HI, Ferdowsian HR, Hoover VJ, Cohen JL, Barnard ND. A worksite vegan nutrition program is well-accepted and improves health-related quality of life and work productivity. Ann Nutr Metab. 2010;56(4):245–52.
＊24 Mishra S, Xu J, Agarwal U, Gonzales J, Levin S, Barnard ND. A multicenter randomized controlled trial of a plant-based nutrition program to reduce body weight and cardiovascular risk in the corporate setting: the GEICO study. Eur J Clin Nutr. 2013;67(7):718–24.
＊25 Agarwal U, Mishra S, Xu J, Levin S, Gonzales J, Barnard ND. A multicenter randomized controlled trial of a nutrition intervention program in a multiethnic adult population in the corporate setting reduces depression and anxiety and improves quality of life: The GEICO Study. Am J Health Promot. 2015;29(4):245–54.
＊26 Tsai AC, Chang T-L, Chi S-H. Frequent consumption of vegetables predicts lower risk of depression in older Taiwanese—results of a prospective population-based study. Public Health Nutr. 2012;15(6):1087–92.
＊27 Gomez-Pinilla F, Nguyen TTJ. Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders. Nutr Neurosci. 2012;15(3):127–33.
＊28 Meyer JH, Ginovart N, Boovariwala A, et al. Elevated monoamine oxidase A levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry. 2006;63(11):1209–16.
＊29 de Villiers JC. Intracranial haemorrhage in patients treated with monoamineoxidase inhibitors. Br J Psychiatry. 1966;112(483):109–18.
＊30 Dixon Clarke SE, Ramsay RR. Dietary inhibitors of monoamine oxidase A. J Neural Transm. 2011;118(7):1031–41.
＊31 Lai JS, Hiles S, Bisquera A, Hure AJ, McEvoy M, Attia J. A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. Am J Clin Nutr. 2014;99(1):181–97.
＊32 White BA, Horwath CC, Conner TS. Many apples a day keep the blues away—daily experiences of negative and positive affect and food consumption in young adults. Br J Health Psychol. 2013;18(4):782–98.
＊33 Odjakova M, Hadjiivanova C. Animal neurotransmitter substances in plants. Bulg J Plant Physiol. 1997;23:94–102.
＊34 Ghirri A, Cannella C, Bignetti E. The psychoactive effects of aromatic amino acids. Curr Nutr Food Science. 2011;7(1):21–32.
＊35 Allen JA, Peterson A, Sufit R, et al. Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthritis Rheum. 2011;63(11):3633–9.
＊36 Fernstrom JD, Faller DV. Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem. 1978;30(6):1531–8.
＊37 Wurtman RJ, Wurtman JJ, Regan MM, McDermott JM, Tsay RH, Breu JJ. Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios. Am J Clin Nutr. 2003;77(1):128–32.
＊38 Wurtman JJ, Brzezinski A, Wurtman RJ, Laferrere B. Effect of nutrient intake on premenstrual depression. Am J Obstet Gynecol. 1989;161(5):1228–34.
＊39 Brinkworth GD, Buckley JD, Noakes M, Clifton PM, Wilson CJ. Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function. Arch Intern Med. 2009;169(20):1873–80.
＊40 Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science. 1972;178(4059):414–6.
＊41 Hudson C, Hudson S, MacKenzie J. Protein-source tryptophan as an efficacious treatment for social anxiety disorder: a pilot study. Can J Physiol Pharmacol. 2007;85(9):928–32.
＊42 Schweiger U, Laessle R, Kittl S, Dickhaut B, Schweiger M, Pirke KM. Macronutrient intake, plasma large neutral amino acids and mood during weight-reducing diets. J Neural Transm. 1986;67(1–2):77–86.
＊43 Ferrence SC, Bendersky G. Therapy with saffron and the goddess at Thera. Perspect Biol Med. 2004;47(2):199–226.
＊44 Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a doubleblind, randomized pilot trial. J Ethnopharmacol. 2005;97(2):281–4.
＊45 Gohari AR, Saeidnia S, Mahmoodabadi MK. An overview on saffron, phytochemicals, and medicinal properties. Pharmacogn Rev. 2013;7(13):61–6.
＊46 Fukui H, Toyoshima K, Komaki R. Psychological and neuroendocrinological effects of odor of saffron (Crocus sativus). Phytomedicine. 2011;18(8–9):726–30.
＊47 Lucas M, O’Reilly EJ, Pan A, et al. Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults. World J Biol Psychiatry. 2014;15(5):377–86.
＊48 Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol. 1993;3(4):375–81.
＊49 Tanskanen A, Tuomilehto J, Viinamnen H, Vartiainen E, Lehtonen J, Puska P. Heavy coffee drinking and the risk of suicide. Eur J Epidemiol. 2000;16(9):789–91.
＊50 Guo X, Park Y, Freedman ND, et al. Sweetened beverages, coffee, and tea and depression risk among older US adults. PLoS ONE. 2014;9(4):e94715.
＊51 Maher TJ, Wurtman RJ. Possible neurologic effects of aspartame, a widely used food additive. Environ Health Perspect. 1987;75:53–7.
＊52 Walton RG, Hudak R, Green-Waite RJ. Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population. Biol Psychiatry. 1993;34(1–2):13–7.
＊53 Lindseth GN, Coolahan SE, Petros TV, Lindseth PD. Neurobehavioral effects of aspartame consumption. Res Nurs Health. 2014;37(3):185–93.
＊54 U.S. Food and Drug Administration. Aspartame: Commissioner’s final decision. Fed Reg. 1981;46: 38285–308.
＊55 Lindseth GN, Coolahan SE, Petros TV, Lindseth PD. Neurobehavioral effects of aspartame consumption. Res Nurs Health. 2014;37(3):185–93.
＊56 White house CR, Boullata J, McCauley LA. The potential toxicity of artificial sweeteners. AAOHN J. 2008;56(6):251–9.
＊57 Aspartame Information Center: Consumer Products. Aspartame website. http://www.aspartame.org/about/consumer-products/#.VF_cyr74tSU. Updated 2015. Accessed March 11, 2015.
＊58 White house CR, Boullata J, McCauley LA. The potential toxicity of artificial sweeteners. AAOHN J. 2008;56(6):251–9.
＊59 Yeung RR. The acute effects of exercise on mood state. J Psychosom Res. 1996;40(2):123–41.
＊60 Goodwin RD. Association between physical activity and mental disorders among adults in the United States. Prev Med. 2003;36(6):698–703.
＊61 Blumenthal JA, Babyak MA, Moore KA, et al. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159(19):2349–56.
＊62 Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69(7):587–96.
＊63 Pandya CD, Howell KR, Pillai A. Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:214–23.
＊64 Michel TM, Pülschen D, Thome J. The role of oxidative stress in depressive disorders. Curr Pharm Des. 2012;18(36):5890–9.
＊65 McMartin SE, Jacka FN, Colman I. The association between fruit and vegetable consumption and mental health disorders: evidence from five waves of a national survey of Canadians. Prev Med. 2013;56(3–4):225–30.
＊66 Beydoun MA, Beydoun HA, Boueiz A, Shroff MR, Zonderman AB. Antioxidant status and its association with elevated depressive symptoms among US adults: National Health and Nutrition Examination Surveys 2005–6. Br J Nutr. 2013;109(9):1714–29.
＊67 Niu K, Guo H, Kakizaki M, et al. A tomato-rich diet is related to depressive symptoms among an elderly population aged 70 years and over: a population-based, cross-sectional analysis. J Affect Disord. 2013;144(1–2):165–70.
＊68 Payne ME, Steck SE, George RR, Steffens DC. Fruit, vegetable, and antioxidant intakes are lower in older adults with depression. J Acad Nutr Diet. 2012;112(12):2022–7.
＊69 Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health. 2007;61(7):631–7.
＊70 Tolmunen T, Hintikka J, Ruusunen A, et al. Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother Psychosom. 2004;73(6):334–9.
＊71 Sharpley AL, Hockney R, McPeake L, Geddes JR, Cowen PJ. Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial. J Affect Disord. 2014;167:306–11.
＊72 Penn E, Tracy DK. The drugs don’t work? Antidepressants and the current and future pharmacological management of depression. Ther Adv Psychopharmacol. 2012;2(5):179–88.
＊73 Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252–60.
＊74 Kirsch I. Antidepressants and the placebo effect. Z Psychol. 2014;222(3):128–34.
＊75 Kirsch I. Antidepressants and the placebo response. Epidemiol Psichiatr Soc. 2009;18(4):318–22.
＊76 Spence D. Are antidepressants overprescribed? Yes. BMJ. 2013;346:f191.
＊77 Sugarman MA, Loree AM, Baltes BB, Grekin ER, Kirsch I. The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales. PLoS ONE. 2014;9(8):e106337.
＊78 Kirsch I. Antidepressants and the placebo effect. Z Psychol. 2014;222(3):128–34.
＊79 Blease C. Deception as treatment: the case of depression. J Med Ethics. 2011;37(1):13–6.
＊80 Kirsch I. Antidepressants and the placebo effect. Z Psychol. 2014;222(3):128–34.
＊81 Kirsch I. Antidepressants and the placebo effect. Z Psychol. 2014;222(3):128–34.
◆13 前立腺がんで死なないために
＊1 Jahn JL, Giovannucci EL, Stampfer MJ. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. Int J Cancer. 2014;Dec 29.
＊2 Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst. 2009;101(6):374–83.
＊3 Centers for Disease Control and Prevention. Prostate Cancer Statistics. http://www.cdc.gov/cancer/prostate/statistics/index.htm. Updated September 2, 2014. Accessed March 11, 2015.
＊4 Maruyama K, Oshima T, Ohyama K. Exposure to exogenous estrogen through intake of commercial milk produced from pregnant cows. Pediatr Int. 2010;52(1):33–8.
＊5 Danby FW. Acne and milk, the diet myth, and beyond. J Am Acad Dermatol. 2005;52(2):360–2.
＊6 Afeiche M, Williams PL, Mendiola J, et al. Dairy food intake in relation to semen quality and reproductive hormone levels among physically active young men. Hum Reprod. 2013;28(8):2265–75.
＊7 Maruyama K, Oshima T, Ohyama K. Exposure to exogenous estrogen through intake of commercial milk produced from pregnant cows. Pediatr Int. 2010;52(1):33–8.
＊8 Steinman G. Mechanisms of twinning: VII. Effect of diet and heredity on the human twinning rate. J Reprod Med. 2006;51(5):405–10.
＊9 Melnik BC, John SM, Schmitz G. Milk is not just food but most likely a Genetic transfection system activating mTORC1 signaling for postnatal growth. Nutr J. 2013;12:103.
＊10 Ludwig DS, Willett WC. Three daily servings of reduced-fat milk: an evidence-based recommendation? JAMA Pediatr. 2013;167(9):788–9.
＊11 Ludwig DS, Willett WC. Three daily servings of reduced-fat milk: an evidence-based recommendation? JAMA Pediatr. 2013;167(9):788–9.
＊12 Tate PL, Bibb R, Larcom LL. Milk stimulates growth of prostate cancer cells in culture. Nutr Cancer. 2011;63(8):1361–6.
＊13 Ganmaa D, Li XM, Qin LQ, Wang PY, Takeda M, Sato A. The experience of Japan as a clue to the etiology of testicular and prostatic cancers. Med Hypotheses. 2003;60(5):724–30.
＊14 Ganmaa D, Li XM, Wang J, Qin LQ, Wang PY, Sato A. Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices. Int J Cancer. 2002;98(2):262–7.
＊15 Epstein SS. Unlabeled milk from cows treated with biosynthetic growth hormones: a case of regulatory abdication. Int J Health Serv. 1996;26(1):173–85.
＊16 Tate PL, Bibb R, Larcom LL. Milk stimulates growth of prostate cancer cells in culture. Nutr Cancer. 2011;63(8):1361–6.
＊17 Qin LQ, Xu JY, Wang PY, Kaneko T, Hoshi K, Sato A. Milk consumption is a risk factor for prostate cancer: meta-analysis of case-control studies. Nutr Cancer. 2004;48(1):22–7.
＊18 Qin LQ, Xu JY, Wang PY, Tong J, Hoshi K. Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. Asia Pac J Clin Nutr. 2007;16(3):467–76.
＊19 Aune D, Navarro Rosenblatt DA, Chan DS, et al. Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies. Am J Clin Nutr. 2015;101(1):87–117.
＊20 Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, et al. Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies. J Bone Miner Res. 2011;26(4):833–9.
＊21 Feskanich D, Bischoff-Ferrari HA, Frazier AL, Willett WC. Milk consumption during teenage years and risk of hip fractures in older adults. JAMA Pediatr. 2014;168(1):54–60.
＊22 Michaëlsson K, Wolk A, Langenskiöld S, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014;349:g6015.
＊23 Batey LA, Welt CK, Rohr F, et al. Skeletal health in adult patients with classic galactosemia. Osteoporos Int. 2013;24(2):501–9.
＊24 Michaëlsson K, Wolk A, Langenskiöld S, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014;349:g6015.
＊25 Cui X, Wang L, Zuo P, et al. D-galactose-caused life shortening in Drosophila melanogaster and Musca domestica is associated with oxidative stress. Biogerontology. 2004;5(5):317–25.
＊26 Cui X, Zuo P, Zhang Q, et al. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res. 2006;84(3):647–54.
＊27 Michaëlsson K, Wolk A, Langenskiöld S, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014;349:g6015.
＊28 Michaëlsson K, Wolk A, Langenskiöld S, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014;349:g6015.
＊29 Michaëlsson K, Wolk A, Langenskiöld S, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014;349:g6015.
＊30 Michaëlsson K, Wolk A, Langenskiöld S, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014;349:g6015.
＊31 Schooling CM. Milk and mortality. BMJ. 2014;349:g6205.
＊32 Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010;91(3):712–21.
＊33 Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010;91(3):712–21.
＊34 Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010;91(3):712–21.
＊35 Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010;91(3):712–21.
＊36 Johansson M, Van Guelpen B, Vollset SE, et al. One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1538–43.
＊37 Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010;91(3):712–21.
＊38 Richman EL, Kenfield SA, Stampfer MJ, et al. Choline intake and risk of lethal prostate cancer: incidence and survival. Am J Clin Nutr. 2012;96(4):855–63.
＊39 Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM. Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Cancer Prev Res (Phila). 2011;4(12):2110–21.
＊40 Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–84.
＊41 Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576–85.
＊42 Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–84.
＊43 Choline: there’s something fishy about this vitamin. Harv Health Lett. 2004;30(1):3.
＊44 Mitch Kanter, Ph.D., e-mail communication, January 6, 2010.
＊45 Hubbard JD, Inkeles S, Barnard RJ. Nathan Pritikin’s heart. N Engl J Med. 1985;313(1):52.
＊46 Ornish D, Weidner G, Fair WR, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174(3):1065–9.
＊47 Ornish D, Weidner G, Fair WR, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174(3):1065–9.
＊48 Barnard RJ, Gonzalez JH, Liva ME, Ngo TH. Effects of a low-fat, high-fiber diet and exercise program on breast cancer risk factors in vivo and tumor cell growth and apoptosis in vitro. Nutr Cancer. 2006;55(1):28–34.
＊49 Barnard RJ, Ngo TH, Leung PS, Aronson WJ, Golding LA. A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate. 2003;56(3):201–6.
＊50 Barnard RJ, Ngo TH, Leung PS, Aronson WJ, Golding LA. A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate. 2003;56(3):201–6.
＊51 Barnard RJ, Ngo TH, Leung PS, Aronson WJ, Golding LA. A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate. 2003;56(3):201–6.
＊52 Ornish D, Weidner G, Fair WR, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174(3):1065–9.
＊53 Ornish D, Weidner G, Fair WR, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174(3):1065–9.
＊54 Ornish D, Magbanua MJ, Weidner G, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA. 2008;105(24):8369–74.
＊55 Frattaroli J, Weidner G, Dnistrian AM, et al. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology. 2008;72(6):1319–23.
＊56 Frey AU, Sønksen J, Fode M. Neglected side effects after radical prostatectomy: a systematic review. J Sex Med. 2014;11(2):374–85.
＊57 Carmody JF, Olendzki BC, Merriam PA, Liu Q, Qiao Y, Ma Y. A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training. J Acad Nutr Diet. 2012;112(11):1822–7.
＊58 Blanchard CM, Courneya KS, Stein K. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol. 2008;26(13):2198–204.
＊59 Carmody JF, Olendzki BC, Merriam PA, Liu Q, Qiao Y, Ma Y. A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training. J Acad Nutr Diet. 2012;112(11):1822–7.
＊60 Carmody JF, Olendzki BC, Merriam PA, Liu Q, Qiao Y, Ma Y. A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training. J Acad Nutr Diet. 2012;112(11):1822–7.
＊61 Carmody JF, Olendzki BC, Merriam PA, Liu Q, Qiao Y, Ma Y. A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training. J Acad Nutr Diet. 2012;112(11):1822–7.
＊62 Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010;91(3):712–21.
＊63 Richman EL, Carroll PR, Chan JM. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer. 2012;131(1):201–10.
＊64 Allen NE, Appleby PN, Key TJ, et al. Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition. Int J Cancer. 2013;132(3):635–44.
＊65 Morton MS, Chan PS, Cheng C, et al. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate. 1997;32(2):122–8.
＊66 van Die MD, Bone KM, Williams SG, Pirotta MV. Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials. BJU Int. 2014;113(5b):E119–30.
＊67 Morton MS, Chan PS, Cheng C, et al. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate. 1997;32(2):122–8.
＊68 Lin X, Switzer BR, Demark-Wahnefried W. Effect of mammalian lignans on the growth of prostate cancer cell lines. Anticancer Res. 2001;21(6A):3995–9.
＊69 Demark-Wahnefried W, Price DT, Polascik TJ, et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001;58(1):47–52.
＊70 Leite KR, Camara-Lopes LH, Cury J, Dall’oglio MF, Sañudo A, Srougi M. Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy. Clinics (Sao Paulo). 2008;63(3):339–42.
＊71 Demark-Wahnefried W, Robertson CN, Walther PJ, Polascik TJ, Paulson DF, Vollmer RT. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology. 2004;63(5):900–4.
＊72 Demark-Wahnefried W, Polascik TJ, George SL, et al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3577–87.
＊73 Wei JT, Calhoun E, Jacobsen SJ. Urologic Diseases in America Project: benign prostatic hyperplasia. J Urol. 2008;179(5 Suppl):S75–80.
＊74 Burnett AL, Wein AJ. Benign prostatic hyperplasia in primary care: what you need to know. J Urol. 2006;175(3 Pt 2):S19–24.
＊75 Taub DA, Wei JT. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Curr Urol Rep. 2006;7(4):272–81.
＊76 Metcalfe C, Poon KS. Long-term results of surgical techniques and procedures in men withbenign prostatic hyperplasia. Curr Urol Rep. 2011;12(4):265–73.
＊77 Burnett AL, Wein AJ. Benign prostatic hyperplasia in primary care: what you need to know. J Urol. 2006;175(3 Pt 2):S19–24.
＊78 Burnett AL, Wein AJ. Benign prostatic hyperplasia in primary care: what you need to know. J Urol. 2006;175(3 Pt 2):S19–24.
＊79 Gu F. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China. Chin Med J. 2000;113(4):299–302.
＊80 Barnard RJ, Kobayashi N, Aronson WJ. Effect of diet and exercise intervention on the growth of prostate epithelial cells. Prostate Cancer Prostatic Dis. 2008;11(4):362–6.
＊81 Zhang W, Wang X, Liu Y, et al. Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia. J Med Food. 2008;11(2):207–14.
＊82 Galeone C, Pelucchi C, Talamini R, et al. Onion and garlic intake and the odds of benign prostatic hyperplasia. Urology. 2007;70(4):672–6.
＊83 Bravi F, Bosetti C, Dal Maso L, et al. Food groups and risk of benign prostatic hyperplasia. Urology. 2006;67(1):73–9.
＊84 Zhou Z, Wang Z, Chen C, et al. Transurethral prostate vaporization using an oval electrode in 82 cases of benign prostatic hyperplasia. Chin Med J. 1998;111(1):52–5.
＊85 Piantanelli L. Cancer and aging: from the kinetics of biological parameters to the kinetics of cancer incidence and mortality. Ann N Y Acad Sci. 1988;521:99–109.
＊86 Salvioli S, Capri M, Bucci L, et al. Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunol Immunother. 2009;58(12):1909–17.
＊87 Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol. 1999;17(9):2941–53.
＊88 Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer. 2009;124(10):2416–29.
＊89 Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3(70):70ra13.
＊90 Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1441–8.
＊91 Soliman S, Aronson WJ, Barnard RJ. Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention. Evid Based Complement Alternat Med. 2011;2011:529053.
＊92 Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control. 2002;13(10):929–35.
＊93 Allen NE, Appleby PN, Davey GK, Key TJ. Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer. 2000;83(1):95–7.
＊94 Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1441–8.
◆14 パーキンソン病で死なないために
＊1 Jafari S, Etminan M, Aminzadeh F, Samii A. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord. 2013;28(9):1222–9.
＊2 National Cancer Institute. President’s Cancer Panel. Reducing environmental cancer risk: what we can do now. http://deainfo.nci.nih.gov/advisory/pcp/annualReports/pcp08-09rpt/PCP_Report_08-09_508.pdf. April 2010. Accessed March 12, 2015.
＊3 Zeliger HI. Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases. Interdiscip Toxicol. 2013;6(3):103–10.
＊4 Woodruff TJ, Zota AR, Schwartz JM. Environmental chemicals in pregnant women in the United States: NHANES 2003–2004. Environ Health Perspect. 2011;119(6):878–85.
＊5 Woodruff TJ, Zota AR, Schwartz JM. Environmental chemicals in pregnant women in the United States: NHANES 2003–2004. Environ Health Perspect. 2011;119(6):878–85.
＊6 Mariscal-Arcas M, Lopez-Martinez C, Granada A, Olea N, Lorenzo-Tovar ML, Olea-Serrano F. Organochlorine pesticides in umbilical cord blood serum of women from Southern Spain and adherence to the Mediterranean diet. Food Chem Toxicol. 2010;48(5):1311–5.
＊7 Bjermo H, Darnerud PO, Lignell S, et al. Fish intake and breastfeeding time are associated with serum concentrations of organochlorines in a Swedish population. Environ Int. 2013;51:88–96.
＊8 Glynn A, Larsdotter M, Aune M, Darnerud PO, Bjerselius R, Bergman A. Changes in serum concentrations of polychlorinated biphenyls (PCBs), hydroxylated PCB metabolites and pentachlorophenol during pregnancy. Chemosphere. 2011;83(2):144–51.
＊9 Soechitram SD, Athanasiadou M, Hovander L, Bergman A, Sauer PJ. Fetal exposure to PCBs and their hydroxylated metabolites in a Dutch cohort. Environ Health Perspect. 2004;112(11):1208–12.
＊10 Ulaszewska MM, Zuccato E, Davoli E. PCDD/Fs and dioxin-like PCBs in human milk and estimation of infants’ daily intake: a review. Chemosphere. 2011;83(6):774–82.
＊11 Gallo MV, Schell LM, Decaprio AP, Jacobs A. Levels of persistent organic pollutant and their predictors among young adults. Chemosphere. 2011;83(10):1374–82.
＊12 Ulaszewska MM, Zuccato E, Davoli E. PCDD/Fs and dioxin-like PCBs in human milk and estimation of infants’ daily intake: a review. Chemosphere. 2011;83(6):774–82.
＊13 Aliyu MH, Alio AP, Salihu HM. To breastfeed or not to breastfeed: a review of the impact of lactational exposure to polychlorinated biphenyls (PCBs) on infants. J Environ Health. 2010;73(3): 8–14.
＊14 Vogt R, Bennett D, Cassady D, Frost J, Ritz B, Hertz-Picciotto I. Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment. Environ Health. 2012;11:83.
＊15 Vogt R, Bennett D, Cassady D, Frost J, Ritz B, Hertz-Picciotto I. Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment. Environ Health. 2012;11:Table S3. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551655/bin/1476-069X-11-83-S3.doc. Accessed March 28, 2015.
＊16 Vogt R, Bennett D, Cassady D, Frost J, Ritz B, Hertz-Picciotto I. Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment. Environ Health. 2012;11:83.
＊17 Dórea JG, Bezerra VL, Fajon V, Horvat M. Speciation of methyl-and ethyl-mercury in hair of breastfed infants acutely exposed to thimerosal-containing vaccines. Clin Chim Acta. 2011;412(17–18): 1563–6.
＊18 Zeilmaker MJ, Hoekstra J, van Eijkeren JC, et al. Fish consumption during child bearing age: a quantitative risk-benefit analysis on neurodevelopment. Food Chem Toxicol. 2013;54:30–4.
＊19 Fromberg A, Granby K, Højgård A, Fagt S, Larsen JC. Estimation of dietary intake of PCB and organochlorine pesticides for children and adults. Food Chem. 2011;125:1179–87.
＊20 European Food Safety Authority. Results of the monitoring of non dioxin-like PCBs in food and feed. EFSA Journal. 2010;8(7):1701.
＊21 Fromberg A, Granby K, Højgård A, Fagt S, Larsen JC. Estimation of dietary intake of PCB and organochlorine pesticides for children and adults. Food Chem. 2011;125:1179–87.
＊22 Zhang T, Sun HW, Wu Q, Zhang XZ, Yun SH, Kannan K. Perfluorochemicals in meat, eggs and indoor dust in China: assessment of sources and pathways of human exposure to perfluorochemicals. Environ Sci Technol. 2010;44(9):3572–9.
＊23 Schecter A, Cramer P, Boggess K, et al. Intake of dioxins and related compounds from food in the U.S. population. J Toxicol Environ Health Part A. 2001;63(1):1–18.
＊24 Aune D, De Stefani E, Ronco AL, et al. Egg consumption and the risk of cancer: a multisite case-control study in Uruguay. Asian Pac J Cancer Prev. 2009;10(5):869–76.
＊25 Yaginuma-Sakurai K, Murata K, Iwai-Shimada M, et al. Hair-to-blood ratio and biological halflife of mercury: experimental study of methylmercury exposure through fish consumption in humans. J Toxicol Sci. 2012;37(1):123–30.
＊26 Wimmerová S, Lancz K, Tihányi J, et al. Half-lives of serum PCB congener concentrations in environmentally exposed early adolescents. Chemosphere. 2011;82(5):687–91.
＊27 Hageman KJ, Hafner WD, Campbell DH, Jaffe DA, Landers DH, Simonich SL. Variability in pesticide deposition and source contributions to snowpack in Western U.S. national parks. Environ Sci Technol. 2010;44(12):4452–8.
＊28 Schecter A, Startin J, Wright C, et al. Congener-specific levels of dioxins and dibenzofurans in U.S. food and estimated daily dioxin toxic equivalent intake. Environ Health Perspect. 1994;102(11):962–6.
＊29 Fiedler H, Cooper KR, Bergek S, Hjelt M, Rappe C. Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans (PCDD/PCDF) in food samples collected in southern Mississippi, USA. Chemosphere. 1997;34(5–7):1411–9.
＊30 Rappe C, Bergek S, Fiedler H, Cooper KR. PCDD and PCDF contamination in catfish feed from Arkansas, USA. Chemosphere. 1998;36(13):2705–20.
＊31 Ferrario JB, Byrne CJ, Cleverly DH. 2,3,7,8-Dibenzo-p-dioxins in mined clay products from the United States: evidence for possible natural origin. Environ Sci Technol. 2000;34(21):4524–32.
＊32 US Department of Commerce. Broiler, turkey, and egg production: 1980 to 1999, No. 1143, p. 684. In Statistical Abstract of the United States, 2000. Washington, D.C.: Government Printing Office, 2000.
＊33 Hayward DG, Nortrup D, Gardner A, Clower M. Elevated TCDD in chicken eggs and farmraised catfish fed a diet with ball clay from a Southern United States mine. Environ Res. 1999;81(3):248–56.
＊34 Hayward DG, Nortrup D, Gardner A, Clower M. Elevated TCDD in chicken eggs and farmraised catfish fed a diet with ball clay from a Southern United States mine. Environ Res. 1999;81(3):248–56.
＊35 US Food and Drug Administration. Letter from Linda Tollefson to Producers or Users of Clay Products in Animal Feeds. https://web.archive.org/web/20081107120600/. http://www.fda.gov/cvm/Documents/ballclay.pdf. October 7, 1997. Accessed March 12, 2015.
＊36 Hanson T, Sites D. 2012 US catfish database. Fisheries and Allied Aquacultures Department Series No. 6. http://aurora.auburn.edu/repo/bitstream/handle/11200/44174/2012%20Catfish%20Database.pdf?sequence=1. March 2013. Accessed March 26, 2015.
＊37 Huwe JK, Archer JC. Dioxin congener patterns in commercial catfish from the United States and the indication of mineral clays as the potential source. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2013;30(2):331–8.
＊38 Rappe C, Bergek S, Fiedler H, Cooper KR. PCDD and PCDF contamination in catfish feed from Arkansas, USA. Chemosphere. 1998;36(13):2705–20.
＊39 Yaktine AL, Harrison GG, Lawrence RS. Reducing exposure to dioxins and related compounds through foods in the next generation. Nutr Rev. 2006;64(9):403–9.
＊40 Schecter A, Startin J, Wright C, et al. Congener-specific levels of dioxins and dibenzofurans in U.S. food and estimated daily dioxin toxic equivalent intake. Environ Health Perspect. 1994;102(11):962–6.
＊41 US Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
＊42 Lee PN. 1979 Surgeon General’s Report. http://legacy.library.ucsf.edu/tid/zkl36b00/pdf?search=%221979%20surgeon%20general%20s%20report%20lee%22. September 2, 1979. Accessed March 12, 2015.
＊43 Lee PN. 1979 Surgeon General’s Report. http://legacy.library.ucsf.edu/tid/zkl36b00/pdf?search=%221979%20surgeon%20general%20s%20report%20lee%22. September 2, 1979. Accessed March 12, 2015.
＊44 Hearings before the Subcommittee on Public Buildings and Grounds of the Committee on Public Works and Transportation to Prohibit Smoking in Federal Buildings. http://legacy.library.ucsf.edu/tid/fzt08h00/pdf?search=%22to%20prohibit%20smoking%20in%20federal%20buildings%20hearings%20jd%20047710%22. March 11; April 22, 1993. Accessed March 12, 2015.
＊45 Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893–901.
＊46 Morens DM, Grandinetti A, Davis JW, Ross GW, White LR, Reed D. Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. Am J Epidemiol. 1996;144(4):400–4.
＊47 Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893–901.
＊48 Allam MF, Campbell MJ, Del Castillo AS, Fernández-Crehuet Navajas R. Parkinson’s disease protects against smoking? Behav Neurol. 2004;15(3–4):65–71.
＊49 Tanner CM, Goldman SM, Aston DA, et al. Smoking and Parkinson’s disease in twins. Neurology. 2002;58(4):581–8.
＊50 O’Reilly EJ, Chen H, Gardener H, Gao X, Schwarzschild MA, Ascherio A. Smoking and Parkinson’s disease: using parental smoking as a proxy to explore causality. Am J Epidemiol. 2009;169(6): 678–82.
＊51 US Department of Health and Human Services. The Health Consequences of Smoking: 50 Yearsof Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
＊52 Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA. 1988;259(7):1025–9.
＊53 Quik M, Perez XA, Bordia T. Nicotine as a potential neuroprotective agent for Parkinson’s disease. Mov Disord. 2012;27(8):947–57.
＊54 Siegmund B, Leitner E, Pfannhauser W. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J Agric Food Chem. 1999;47(8):3113–20.
＊55 Brody AL, Mandelkern MA, London ED, et al. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry. 2006;63(8):907–15.
＊56 Searles Nielsen S, Gallagher LG, Lundin JI, et al. Environmental tobacco smoke and Parkinson’s disease. Mov Disord. 2012;27(2):293–6.
＊57 Siegmund B, Leitner E, Pfannhauser W. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J Agric Food Chem. 1999;47(8):3113–20.
＊58 Nielsen SS, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol. 2013;74(3):472–7.
＊59 Nielsen SS, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol. 2013;74(3):472–7.
＊60 Richardson JR, Shalat SL, Buckley B, et al. Elevated serum pesticide levels and risk of Parkinson disease. Arch Neurol. 2009;66(7):870–5.
＊61 Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson’s disease. J Toxicol Environ Health Part A. 2000;59(4):229–34.
＊62 Hatcher-Martin JM, Gearing M, Steenland K, Levey AI, Miller GW, Pennell KD. Association between polychlorinated biphenyls and Parkinson’s disease neuropathology. Neurotoxicology. 2012;33(5):1298–304.
＊63 Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V. Dieldrin-induced neurotoxicity: relevance to Parkinson’s disease pathogenesis. Neurotoxicology. 2005;26(4):701–19.
＊64 Arguin H, Sánchez M, Bray GA, et al. Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies. Br J Nutr. 2010;103(10):1433–41.
＊65 Jiang W, Ju C, Jiang H, Zhang D. Dairy foods intake and risk of Parkinson’s disease: a doseresponse meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014;29(9):613–9.
＊66 Park M, Ross GW, Petrovitch H, et al. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology. 2005;64(6):1047–51.
＊67 Kotake Y, Yoshida M, Ogawa M, Tasaki Y, Hirobe M, Ohta S. Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate. Neurosci Lett. 1996;217(1):69–71.
＊68 Niwa T, Yoshizumi H, Takeda N, Tatematsu A, Matsuura S, Nagatsu T. Detection of tetrahydroisoquinoline, a parkinsonism-related compound, in parkinsonian brains and foods by gas chromatography-mass spectrometry. Advances in Behavioral Biology. 1990;38A:313–6.
＊69 Niwa T, Yoshizumi H, Tatematsu A, Matsuura S, Nagatsu T. Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods. J Chromatogr. 1989;493(2):347–52.
＊70 Niwa T, Takeda N, Kaneda N, Hashizume Y, Nagatsu T. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains. Biochem Biophys Res Commun. 1987;144(2):1084–9.
＊71 Ułamek-Kozioł M, Bogucka-Kocka A, Kocki J, Pluta R. Good and bad sides of diet in Parkinson’s disease. Nutrition. 2013;29(2):474–5.
＊72 Ułamek-Kozioł M, Bogucka-Kocka A, Kocki J, Pluta R. Good and bad sides of diet in Parkinson’s disease. Nutrition. 2013;29(2):474–5.
＊73 Kistner A, Krack P. Parkinson’s disease: no milk today? Front Neurol. 2014;5:172.
＊74 Chen H, Zhang SM, Hernn MA, Willett WC, Ascherio A. Diet and Parkinson’s disease: a potential role of dairy products in men. Ann Neurol. 2002;52(6):793–801.
＊75 Jiang W, Ju C, Jiang H, Zhang D. Dairy foods intake and risk of Parkinson’s disease: a doseresponse meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014;29(9):613–9.
＊76 Michaëlsson K, Wolk A, Langenskiöld S, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014;349:g6015.
＊77 Ridel KR, Leslie ND, Gilbert DL. An updated review of the long-term neurological effects of galactosemia. Pediatr Neurol. 2005;33(3):153–61.
＊78 Marder K, Gu Y, Eberly S, et al. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol. 2013;70(11):1382–8.
＊79 Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA. 1981;78(11):6858–62.
＊80 Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP. Dietary folate defi-ciency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson’s disease. J Neurochem. 2002;80(1):101–10.
＊81 Auinger P, Kieburtz K, McDermott MP. The relationship between uric acid levels and Huntington’s disease progression. Mov Disord. 2010;25(2):224–8.
＊82 Schwarzschild MA, Schwid SR, Marek K, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol. 2008;65(6):716–23.
＊83 Shen C, Guo Y, Luo W, Lin C, Ding M. Serum urate and the risk of Parkinson’s disease: results from a meta-analysis. Can J Neurol Sci. 2013;40(1):73–9.
＊84 Fang P, Li X, Luo JJ, Wang H, Yang X. A double-edged sword: uric acid and neurological disorders. Brain Disord Ther. 2013;2(2):109.
＊85 Kutzing MK, Firestein BL. Altered uric acid levels and disease states. J Pharmacol Exp Ther. 2008;324(1):1–7.
＊86 Schmidt JA, Crowe FL, Appleby PN, Key TJ, Travis RC. Serum uric acid concentrations in meat eaters, fish eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort. PLoS ONE. 2013;8(2):e56339.
＊87 Kuo CF, See LC, Yu KH, Chou IJ, Chiou MJ, Luo SF. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford). 2013;52(1):127–34.
＊88 Arguin H, Sánchez M, Bray GA, et al. Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies. Br J Nutr. 2010;103(10):1433–41.
＊89 Siddiqui MK, Saxena MC, Krishna Murti CR. Storage of DDT and BHC in adipose tissue of Indian males. Int J Environ Anal Chem. 1981;10(3–4):197–204.
＊90 Norén K. Levels of organochlorine contaminants in human milk in relation to the dietary habits of the mothers. Acta Paediatr Scand. 1983;72(6):811–6.
＊91 Schecter A, Papke O. Comparison of blood dioxin, dibenzofuran and coplanar PCB levels in strict vegetarians (vegans) and the general United States population. Org Comps. 1998;38:179–82.
＊92 Schecter A, Harris TR, Päpke O, Tunga KC, Musumba A. Polybrominated diphenyl ether (PBDE) levels in the blood of pure vegetarians (vegans). Tox Env Chem. 2006;88(1):107–12.
＊93 Eskenazi B, Chevrier J, Rauch SA, et al. In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study. Environ Health Perspect. 2013;121(2):257–62.
＊94 Schecter A, Päpke O, Harris TR, et al. Polybrominated diphenyl ether (PBDE) levels in an expanded market basket survey of U.S. food and estimated PBDE dietary intake by age and sex. Environ Health Perspect. 2006;114(10):1515–20.
＊95 Fraser AJ, Webster TF, McClean MD. Diet contributes significantly to the body burden of PBDEs in the general U.S. population. Environ Health Perspect. 2009;117(10):1520–5.
＊96 Schecter A, Harris TR, Päpke O, Tunga KC, Musumba A. Polybrominated diphenyl ether (PBDE) levels in the blood of pure vegetarians (vegans). Tox Env Chem. 2006;88(1):107–12.
＊97 Huwe JK, West M. Polybrominated diphenyl ethers in U.S. meat and poultry from two statistically designed surveys showing trends and levels from 2002 to 2008. J Agric Food Chem. 2011;59(10):5428–34.
＊98 Dickman MD, Leung CK, Leong MK. Hong Kong male subfertility links to mercury in human hair and fish. Sci Total Environ. 1998;214:165–74.
＊99 Srikumar TS, Johansson GK, Ockerman PA, Gustafsson JA, Akesson B. Trace element status in healthy subjects switching from a mixed to a lactovegetarian diet for 12 mo. Am J Clin Nutr. 1992;55(4):885–90.
＊100 Wimmerová S, Lancz K, Tihányi J, et al. Half-lives of serum PCB congener concentrations in environmentally exposed early adolescents. Chemosphere. 2011;82(5):687–91.
＊101 Parkinson J. An Essay on the Shaking Palsy. London: Whittingham and Rowland for Sherwood, Neely and Jones, 1817:7.
＊102 Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001;57(3):456–62.
＊103 Ueki A, Otsuka M. Life style risks of Parkinson’s disease: association between decreased water intake and constipation. J Neurol. 2004;251 Suppl 7:vII18–23.
＊104 Gao X, Chen H, Schwarzschild MA, Ascherio A. A prospective study of bowel movement frequency and risk of Parkinson’s disease. Am J Epidemiol. 2011;174(5):546–51.
＊105 Kamel F. Epidemiology. Paths from pesticides to Parkinson’s. Science. 2013;341(6147):722–3.
＊106 Barnhill LM, Bronstein JM. Pesticides and Parkinson’s disease: is it in your genes? Neurodegener Dis Manag. 2014;4(3):197–200.
＊107 Wang A, Cockburn M, Ly TT, Bronstein JM, Ritz B. The association between ambient exposure to organophosphates and Parkinson’s disease risk. Occup Environ Med. 2014;71(4):275–81.
＊108 Narayan S, Liew Z, Paul K, et al. House hold organophosphorus pesticide use and Parkinson’s disease. Int J Epidemiol. 2013;42(5):1476–85.
＊109 Liu X, Ma T, Qu B, Ji Y, Liu Z. Pesticide-induced gene mutations and Parkinson disease risk: a meta-analysis. Genet Test Mol Biomarkers. 2013;17(11):826–32.
＊110 Lee SJ, Lim HS, Masliah E, Lee HJ. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives. Neurosci Res. 2011;70(4):339–48.
＊111 Chorfa A, Lazizzera C, Bétemps D, et al. A variety of pesticides trigger in vitro α-synuclein accumulation, a key event in Parkinson’s disease. Arch Toxicol. 2014;
＊112 Dunnett SB, Björklund SBA. Prospects for new restorative and neuroprotective treatments in Parkinson’s disease. Nature. 1999;399(6738 Suppl):A32–9.
＊113 Campdelacreu J. Parkinson disease and Alzheimer disease: environmental risk factors. Neurologia. 2014;29(9):541–9.
＊114 Meng X, Munishkina LA, Fink AL, Uversky VN. Effects of various flavonoids on the α-synuclein fibrillation pro cess. Parkinson’s Dis. 2010;2010:650794.
＊115 Strathearn KE, Yousef GG, Grace MH, Roy SA, et al. Neuroprotective effects of anthocyaninand proanthocyanidin-rich extracts in cellular models of Parkinson’s disease. Brain Res. 2014;1555:60–77.
＊116 Golbe LI, Farrell TM, Davis PH. Case-control study of early life dietary factors in Parkinson’s disease. Arch Neurol. 1988;45(12):1350–3.
＊117 Gao X, Cassidy A, Schwarzschild MA, Rimm EB, Ascherio A. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurol. 2012;78(15):1138–45.
＊118 Kukull WA. An apple a day to prevent Parkinson disease: reduction of risk by flavonoids. Neurol. 2012;78(15):1112–3.
＊119 Gao X, Cassidy A, Schwarzschild MA, Rimm EB, Ascherio A. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology. 2012;78(15):1138–45.
＊120 Serafini M, Testa MF, Villain D, et al. Antioxidant activity of blueberry fruit is impaired by association with milk. Free Radic Biol Med. 2009;46(6):769–74.
＊121 Jekanowski M. Survey says: a snapshot of rendering. Render Magazine. 2011;April:58–61.
＊122 Schepens PJ, Covaci A, Jorens PG, Hens L, Scharpé S, van Larebeke N. Surprising findings following a Belgian food contamination with polychlorobiphenyls and dioxins. Environ Health Perspect. 2001;109(2):101–3.
＊123 Dórea JG. Vegetarian diets and exposure to organochlorine pollutants, lead, and mercury. Am J Clin Nutr. 2004;80(1):237–8.
＊124 Dórea JG. Fish meal in animal feed and human exposure to persistent bioaccumulative and toxic substances. J Food Prot. 2006;69(11):2777–85.
＊125 Moser GA, McLachlan MS. The influence of dietary concentration on the absorption and excretion of persistent lipophilic organic pollutants in the human intestinal tract. Chemosphere. 2001;45(2):201–11.
＊126 Dórea JG. Vegetarian diets and exposure to organochlorine pollutants, lead, and mercury. Am J Clin Nutr. 2004;80(1):237–8.
＊127 Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893–901.
＊128 Barranco Quintana JL, Allam MF, Del Castillo AS, Navajas RF. Parkinson’s disease and tea: a quantitative review. J Am Coll Nutr. 2009;28(1):1–6.
＊129 Palacios N, Gao X, McCullough ML, et al. Caffeine and risk of Parkinson’s disease in a large cohort of men and women. Mov Disord. 2012;27(10):1276–82.
＊130 Nakaso K, Ito S, Nakashima K. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson’s disease model of SH-SY5Y cells. Neurosci Lett. 2008;432(2):146–50.
＊131 Postuma RB, Lang AE, Munhoz RP, et al. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012;79(7):651–8.
＊132 Postuma RB, Lang AE, Munhoz RP, et al. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012;79(7):651–8.
＊133 Grazina R, Massano J. Physical exercise and Parkinson’s disease: influence on symptoms, disease course and prevention. Rev Neurosci. 2013;24(2):139–52.
＊134 Chen J, Guan Z, Wang L, Song G, Ma B, Wang Y. Meta-analysis: overweight, obesity, and Parkinson’s disease. Int J Endocrinol. 2014;2014:203930.
◆15 医者にかかって死なないために
＊1 Pereira TV, Horwitz RI, Ioannidis JPA. Empirical evaluation of very large treatment effects of medical interventions. JAMA. 2012;308(16):1676–84.
＊2 Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5.
＊3 Starfield B. Is US health really the best in the world? JAMA. 2000;284(4):483–5.
＊4 Klevens RM, Edwards JR, Richards CL, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160–6.
＊5 Gilbert K, Stafford C, Crosby K, Fleming E, Gaynes R. Does hand hygiene compliance among health care workers change when patients are in contact precaution rooms in ICUs? Am J Infect Control. 2010;38(7):515–7.
＊6 Gilbert K, Stafford C, Crosby K, Fleming E, Gaynes R. Does hand hygiene compliance among health care workers change when patients are in contact precaution rooms in ICUs? Am J Infect Control. 2010;38(7):515–7.
＊7 Leape LL, Berwick DM. Five years after To Err Is Human: what have we learned? JAMA. 2005;293(19):2384–90.
＊8 Starfield B. Is US health really the best in the world? JAMA. 2000;284(4):483–5.
＊9 Institute of Medicine. To Err Is Human: building a safer health system. http://www.iom.edu/~/media/Files/Report%20Files/1999/To-Err-is-Human/To%20Err%20is%20Human%201999%20%20report%20brief.pdf. November, 1999. Accessed March 12, 2015.
＊10 Weingart SN, Wilson RM, Gibberd RW, Harrison B. Epidemiology of medical error. BMJ. 2000;320(7237):774–7.
＊11 Millenson ML. The silence. Health Aff (Millwood). 2003;22(2):103–12.
＊12 Mills DH. Medical insurance feasibility study. A technical summary. West J Med. 1978;128(4): 360–5.
＊13 Leape LL. Error in medicine. JAMA. 1994 Dec 21;272(23):1851–7.
＊14 Millenson ML. The silence. Health Aff (Millwood). 2003;22(2):103–12.
＊15 Institute of Medicine. To Err Is Human: building a safer health system. http://www.iom.edu/~/media/Files/Report%20Files/1999/To-Err-is-Human/To%20Err%20is%20Human%201999%20%20report%20brief.pdf. November, 1999. Accessed March 12, 2015.
＊16 Millenson ML. The silence. Health Aff (Millwood). 2003;22(2):103–12.
＊17 Lockley SW, Barger LK, Ayas NT, Rothschild JM, Czeisler CA, Landrigan CP. Effects of health care provider work hours and sleep deprivation on safety and performance. Jt Comm J Qual Patient Saf. 2007;33(11 Suppl):7–18.
＊18 Barger LK, Ayas NT, Cade BE, et al. Impact of extended-duration shifts on medical errors, adverse events, and attentional failures. PLoS Med. 2006;3(12):e487.
＊19 Millenson ML. The silence. Health Aff (Millwood). 2003;22(2):103–12.
＊20 Egger GJ, Binns AF, Rossner SR. The emergence of “lifestyle medicine” as a structured approach for management of chronic disease. Med J Aust. 2009;190(3):143–5.
＊21 Malone J, Guleria R, Craven C, et al. Justification of diagnostic medical exposures: some practical issues. Report of an International Atomic Energy Agency Consultation. Br J Radiol. 2012;85(1013):523–38.
＊22 Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950–1990. 1996. Radiat Res. 2012;178(2): AV61–87.
＊23 Brenner D, Elliston C, Hall E, Berdon WE. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001;176(2):289–96.
＊24 Rogers LF. Taking care of children: check out the parameters used for helical CT. AJR Am J Roentgenol. 2001;176(2):287.
＊25 Berrington de Gonzingt A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009;169(22): 2071–7.
＊26 Institute of Medicine. Breast cancer and the environment: a life course approach. Washington, D.C.: The National Academies Press; 2012.
＊27 Picano E. Informed consent and communication of risk from radiological and nuclear medicine examinations: how to escape from a communication inferno. BMJ. 2004;329(7470):849–51.
＊28 Schmidt CW. CT scans: balancing health risks and medical benefits. Environ Health Perspect. 2012;120(3):A118–21.
＊29 Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380(9840):499–505.
＊30 Limaye MR, Severance H. Pandora’s boxes: questions unleashed in airport scanner debate. J Am Osteopath Assoc. 2011;111(2):87–8, 119.
＊31 Friedberg W, Copeland K, Duke FE, O’Brien K, Darden EB. Radiation exposure during air travel: guidance provided by the Federal Aviation Administration for air carrier crews. Health Phys. 2000;79(5):591–5.
＊32 Yong LC, Petersen MR, Sigurdson AJ, Sampson LA, Ward EM. High dietary antioxidant intakes are associated with decreased chromosome translocation frequency in airline pilots. Am J Clin Nutr. 2009;90(5):1402–10.
＊33 Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature. 1998;392(6676):559.
＊34 Yong LC, Petersen MR, Sigurdson AJ, Sampson LA, Ward EM. High dietary antioxidant intakes are associated with decreased chromosome translocation frequency in airline pilots. Am J Clin Nutr. 2009;90(5):1402–10.
＊35 Yong LC, Petersen MR, Sigurdson AJ, Sampson LA, Ward EM. High dietary antioxidant intakes are associated with decreased chromosome translocation frequency in airline pilots. Am J Clin Nutr. 2009;90(5):1402–10.
＊36 Sauvaget C, Kasagi F, Waldren CA. Dietary factors and cancer mortality among atomic-bomb survivors. Mutat Res. 2004;551(1–2):145–52.
＊37 Kordysh EA, Emerit I, Goldsmith JR, et al. Dietary and clastogenic factors in children who immigrated to Israel from regions contaminated by the Chernobyl accident. Arch Environ Health. 2001;56(4):320–6.
＊38 Langham WH, Bassett H, Harris PS, Carter RE. Distribution and excretion of plutonium administered intravenously to man. Los Alamos: Los Alamos Scientific Laboratory, LAB1151. Health Physics. 1980;38:1,031B1,060.
＊39 Loscialpo MJ. Nontherapeutic human research experiments on institutionalized mentally retarded children: civil rights and remedies. 23 New Eng J on Crim & Civ Confinement. 1997;139:143–5.
＊40 Assistant to the Secretary of Defense for Nuclear and Chemical and Biological Defense Programs, Department of Defense. Report on search for human radiation experiment records 1944–1994. http://www.defense.gov/pubs/dodhre/. June 1997. Accessed March 12, 2015.
＊41 Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine: the first selective-target and broadspectrum radioprotector. Oncologist. 2007;12(6):738–47.
＊42 Rao BN, Archana PR, Aithal BK, Rao BSS. Protective effect of zingerone, a dietary compound against radiation induced Genetic damage and apoptosis in human lymphocytes. Eur J Pharmacol. 2011;657(1–3):59–66.
＊43 Arora R, Gupta D, Chawla R, et al. Radioprotection by plant products: present status and future prospects. Phytother Res. 2005;19(1):1–22.
＊44 Malekirad AA, Ranjbar A, Rahzani K, et al. Oxidative stress in radiology staff. Environ Toxicol Pharmacol. 2005;20(1):215–8.
＊45 Zeraatpishe A, Oryan S, Bagheri MH, et al. Effects of Melissa officinalis L. on oxidative status and DNA damage in subjects exposed to long-term low-dose ionizing radiation. Toxicol Ind Health. 2011;27(3):205–12.
＊46 Zhong W, Maradit-Kremers H, St Sauver JL, et al. Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc. 2013;88(7):697–707.
＊47 Lindsley CW. The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics. ACS Chem Neurosci. 2012;3(8):630–1.
＊48 Centers for Disease Control National Center for Health Statistics. National Ambulatory Medical Care Survey: 2010 Summary Tables. http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf. 2010. Accessed March 12, 2015.
＊49 Hudson B, Zarifeh A, Young L, Wells JE. Patients’ expectations of screening and preventive treatments. Ann Fam Med. 2012;10(6):495–502.
＊50 Lytsy P, Westerling R. Patient expectations on lipid-lowering drugs. Patient Educ Couns. 2007;67(1–2):143–50.
＊51 Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J. Are preventive drugs preventive enough? A study of patients’ expectation of benefit from preventive drugs. Clin Med. 2002;2(6):527–33.
＊52 Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J. Are preventive drugs preventive enough? A study of patients’ expectation of benefit from preventive drugs. Clin Med. 2002;2(6):527–33.
＊53 Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J. Are preventive drugs preventive enough? A study of patients’ expectation of benefit from preventive drugs. Clin Med. 2002;2(6):527–33.
＊54 Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J. Are preventive drugs preventive enough? A study of patients’ expectation of benefit from preventive drugs. Clin Med. 2002;2(6):527–33.
＊55 Esselstyn CB Jr, Gendy G, Doyle J, Golubic M, Roizen MF. A way to reverse CAD? J Fam Pract. 2014;63(7):356–364b.
＊56 Esselstyn CB Jr, Gendy G, Doyle J, Golubic M, Roizen MF. A way to reverse CAD? J Fam Pract. 2014;63(7):356–364b.
＊57 Duthie GG, Wood AD. Natural salicylates: foods, functions and disease prevention. Food Funct. 2011;2(9):515–20.
＊58 Fuster V, Sweeny JM. Aspirin: a historical and contemporary therapeutic overview. Circulation. 2011;123(7):768–78.
＊59 Pasche B, Wang M, Pennison M, Jimenez H. Prevention and treatment of cancer with aspirin: where do we stand? Semin Oncol. 2014;41(3):397–401.
＊60 Karnezis T, Shayan R, Fox S, Achen MG, Stacker SA. The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway. Oncotarget. 2012;3(8):893–906.
＊61 Macdonald S. Aspirin use to be banned in under 16 year olds. BMJ. 2002;325(7371):988.
＊62 Siller-Matula JM. Hemorrhagic complications associated with aspirin: an underestimated hazard in clinical practice? JAMA. 2012;307(21):2318–20.
＊63 Sutcliffe P, Connock M, Gurung T, et al. Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials. PLoS ONE. 2013;8(12):e81970.
＊64 Thun MJ, Jacobs EJ, Patrono C. The role of aspirin in cancer prevention. Nat Rev Clin Oncol. 2012;9(5):259–67.
＊65 McCarty MF. Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention. Med Hypotheses. 2012;78(1):45–57.
＊66 Duthie GG, Wood AD. Natural salicylates: foods, functions and disease prevention. Food Funct. 2011;2(9):515–20.
＊67 Paterson JR, Blacklock C, Campbell G, Wiles D, Lawrence JR. The identification of salicylates as normal constituents of serum: a link between diet and health? J Clin Pathol. 1998;51(7): 502–5.
＊68 Rinelli S, Spadafranca A, Fiorillo G, Cocucci M, Bertoli S, Battezzati A. Circulating salicylic acid and metabolic and inflammatory responses after fruit ingestion. Plant Foods Hum Nutr. 2012;67(1):100–4.
＊69 Blacklock CJ, Lawrence JR, Wiles D, et al. Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J Clin Pathol. 2001;54(7):553–5.
＊70 Knutsen SF. Lifestyle and the use of health Services. Am J Clin Nutr. 1994;59(5 Suppl):1171S-1175S.
＊71 McCarty MF. Dietary nitrate and reductive polyphenols may potentiate the vascular benefit and alleviate the ulcerative risk of low-dose aspirin. Med Hypotheses. 2013;80(2):186–90.
＊72 Willcox BJ, Willcox DC, Todoriki H, et al. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world’s longest-lived people and its potential impact on morbidity and life span. Ann N Y Acad Sci. 2007;1114:434–55.
＊73 McCarty MF. Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention. Med Hypotheses. 2012;78(1):45–57.
＊74 Paterson JR, Srivastava R, Baxter GJ, Graham AB, Lawrence JR. Salicylic acid content of spices and its implications. J Agric Food Chem. 2006;54(8):2891–6.
＊75 Paterson JR, Srivastava R, Baxter GJ, Graham AB, Lawrence JR. Salicylic acid content of spices and its implications. J Agric Food Chem. 2006;54(8):2891–6.
＊76 Pasche B, Wang M, Pennison M, Jimenez H. Prevention and treatment of cancer with aspirin: where do we stand? Semin Oncol. 2014;41(3):397–401.
＊77 Paterson JR, Srivastava R, Baxter GJ, Graham AB, Lawrence JR. Salicylic acid content of spices and its implications. J Agric Food Chem. 2006;54(8):2891–6.
＊78 Baxter GJ, Graham AB, Lawrence JR, Wiles D, Paterson JR. Salicylic acid in soups prepared from organically and non-organically grown vegetables. Eur J Nutr. 2001;40(6):289–92.
＊79 Scheier L. Salicylic acid: one more reason to eat your fruits and vegetables. J Am Diet Assoc. 2001;101(12):1406–8.
＊80 Duthie GG, Wood AD. Natural salicylates: foods, functions and disease prevention. Food Funct. 2011;2(9):515–20.
＊81 Seeff LC, Richards TB, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC’s survey of endoscopic capacity. Gastroenterology. 2004;127(6):1670–7.
＊82 McLachlan SA, Clements A, Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context—a systematic review of the literature. Patient Educ Couns. 2012;86(2):137–46.
＊83 Lobel EZ, Korelitz BI. Postendoscopy syndrome: “the doctor never talked to me.” J Clin Gastroenterol. 2001;33(5):353–4.
＊84 McLachlan SA, Clements A, Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context—a systematic review of the literature. Patient Educ Couns. 2012;86(2):137–46.
＊85 Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9): 638–58.
＊86 Manner H, Plum N, Pech O, Ell C, Enderle MD. Colon explosion during argon plasma coagulation. Gastrointest Endosc. 2008;67(7):1123–7.
＊87 Ko CW, Dominitz JA. Complications of colonoscopy: magnitude and management. Gastrointest Endosc Clin N Am. 2010;20(4):659–71.
＊88 Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638–58.
＊89 van Hees F, Habbema JD, Meester RG, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med. 2014;160(11):750–9.
＊90 Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638–58.
＊91 Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:g2467.
＊92 Swan H, Siddiqui AA, Myers RE. International colorectal cancer screening programs: population contact strategies, testing methods and screening rates. Pract Gastroenter. 2012;36(8):20–9.
＊93 Ling BS, Trauth JM, Fine MJ, et al. Informed decision-making and colorectal cancer screening: is it occurring in primary care? Med Care. 2008;46(9 Suppl 1):S23–9.
＊94 Ling BS, Trauth JM, Fine MJ, et al. Informed decision-making and colorectal cancer screening: is it occurring in primary care? Med Care. 2008;46(9 Suppl 1):S23–9.
＊95 Brett AS. Flexible sigmoidoscopy for colorectal cancer screening: more evidence, persistent ironies. JAMA. 2014;312(6):601–2.
＊96 Yabroff KR, Klabunde CN, Yuan G, et al. Are physicians’ recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med. 2011;26(2):177–84.
＊97 Swan H, Siddiqui AA, Myers RE. International colorectal cancer screening programs: population contact strategies, testing methods and screening rates. Pract Gastroenter. 2012;36(8):20–9.
＊98 Swan H, Siddiqui AA, Myers RE. International colorectal cancer screening programs: population contact strategies, testing methods and screening rates. Pract Gastroenter. 2012;36(8):20–9.
＊99 Butterfield S. Changes coming for colon cancer screening. ACP Internist. 2014;34(7):10–11.
＊100 Rosenthal E. The $2.7 trillion medical bill: colonoscopies explain why U.S. leads the world in health expenditures. New York Times. http://www.nytimes.com/2013/06/02/health/colonoscopies-explain-why-us-leads-the-world-in-health-expenditures.html. June 1, 2013. Accessed March 12, 2015.
＊101 Whoriskey P, Keating D. How a secretive panel uses data that distorts doctors’ pay. Washington Post. http://www.washingtonpost.com/business/economy/how-a-secretive-panel-uses-data-that-distorts-doctors-pay/2013/07/20/ee134e3a-eda8-11e2-9008-61e94a7ea20d_story.html. July 20, 2013. Accessed March 12, 2015.
＊102 US Government Accountability Office. Medicare: action needed to address higher use of anatomic pathology Services by providers who self-refer. GAO-13-445. http://www.gao.gov/products/GAO-13-445. June 24, 2013. Accessed March 12, 2015.
＊103 Stange KC. Barbara Starfield: passage of the pathfinder of primary care. Ann Fam Med. 2011;9(4):292–6.
＊104 Starfield B. Is US health really the best in the world? JAMA. 2000;284(4):483–5.
＊105 Rappoport J. An exclusive interview with Dr. Barbara Starfield: medically caused death in America. Jon Rappoport’s Blog. https://jonrappoport.wordpress.com/2009/12/09/an-exclusive-interview-with-dr-barbara-starfield-medically-caused-death-in-america/. December 9, 2009. Accessed March 12, 2015.
＊106 Millenson ML. The silence. Health Aff (Millwood). 2003;22(2):103–12.
＊107 Holtzman NA. Chronicle of an unforetold death. Arch Intern Med. 2012;172(15):1174–7.
＊108 Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29(7):932–40.
※WEBサイトへのリンクは2017年7月31日現在。
